BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 574913 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O4/c1-33-23-9-6-17(14-22(23)29-24(31)16-30-10-12-34-13-11-30)25(32)28-18-7-8-21(27-15-18)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) SBSHXXHJRFEVEN-UHFFFAOYSA-N 300431 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 1 Protein Wnt-3a Human 1140 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300431&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293210 381749212 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574914 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O4/c1-33-23-9-6-17(14-22(23)29-24(31)16-30-10-12-34-13-11-30)25(32)28-18-7-8-21(27-15-18)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) SBSHXXHJRFEVEN-UHFFFAOYSA-N 300431 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 1 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300431&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293210 381749212 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574915 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CC5CCC(C4)O5 InChI=1S/C27H27FN4O4/c1-35-25-11-6-17(12-24(25)31-26(33)16-32-14-19-8-9-20(15-32)36-19)27(34)30-18-7-10-23(29-13-18)21-4-2-3-5-22(21)28/h2-7,10-13,19-20H,8-9,14-16H2,1H3,(H,30,34)(H,31,33) XSNUAYHLXKXWHA-UHFFFAOYSA-N 300432 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]benzamide::US10130633, Example 2 Protein Wnt-3a Human 133 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300432&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293211 381749213 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574916 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CC5CCC(C4)O5 InChI=1S/C27H27FN4O4/c1-35-25-11-6-17(12-24(25)31-26(33)16-32-14-19-8-9-20(15-32)36-19)27(34)30-18-7-10-23(29-13-18)21-4-2-3-5-22(21)28/h2-7,10-13,19-20H,8-9,14-16H2,1H3,(H,30,34)(H,31,33) XSNUAYHLXKXWHA-UHFFFAOYSA-N 300432 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]benzamide::US10130633, Example 2 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300432&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293211 381749213 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574917 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4C[C@@H]5C[C@H]4CO5 InChI=1S/C26H25FN4O4/c1-34-24-9-6-16(10-23(24)30-25(32)14-31-13-19-11-18(31)15-35-19)26(33)29-17-7-8-22(28-12-17)20-4-2-3-5-21(20)27/h2-10,12,18-19H,11,13-15H2,1H3,(H,29,33)(H,30,32) ONWIBYINFMXPQJ-UHFFFAOYSA-N 300433 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-{[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-ylacetyl]amino}benzamide::US10130633, Example 3 Protein Wnt-3a Human 1800 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300433 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300433&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608508 381749214 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574918 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4C[C@@H]5C[C@H]4CO5 InChI=1S/C26H25FN4O4/c1-34-24-9-6-16(10-23(24)30-25(32)14-31-13-19-11-18(31)15-35-19)26(33)29-17-7-8-22(28-12-17)20-4-2-3-5-21(20)27/h2-10,12,18-19H,11,13-15H2,1H3,(H,29,33)(H,30,32) ONWIBYINFMXPQJ-UHFFFAOYSA-N 300433 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-{[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-ylacetyl]amino}benzamide::US10130633, Example 3 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300433 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300433&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608508 381749214 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574919 COc3ccc(C(=O)Nc2ccc(c1ccccc1)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H26N4O4/c1-32-23-10-7-19(15-22(23)28-24(30)17-29-11-13-33-14-12-29)25(31)27-20-8-9-21(26-16-20)18-5-3-2-4-6-18/h2-10,15-16H,11-14,17H2,1H3,(H,27,31)(H,28,30) NOXLRKCEKOUKBD-UHFFFAOYSA-N 300434 4-methoxy-3-[(morpholin-4-ylacetyl)amino]-N-(6-phenylpyridin-3-yl)benzamide::US10130633, Example 4 Protein Wnt-3a Human 300 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300434&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459661 381749215 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574920 COc3ccc(C(=O)Nc2ccc(c1ccccc1)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H26N4O4/c1-32-23-10-7-19(15-22(23)28-24(30)17-29-11-13-33-14-12-29)25(31)27-20-8-9-21(26-16-20)18-5-3-2-4-6-18/h2-10,15-16H,11-14,17H2,1H3,(H,27,31)(H,28,30) NOXLRKCEKOUKBD-UHFFFAOYSA-N 300434 4-methoxy-3-[(morpholin-4-ylacetyl)amino]-N-(6-phenylpyridin-3-yl)benzamide::US10130633, Example 4 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300434&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459661 381749215 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574921 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C25H22F4N4O4/c26-19-4-2-1-3-18(19)20-7-6-17(14-30-20)31-24(35)16-5-8-22(37-25(27,28)29)21(13-16)32-23(34)15-33-9-11-36-12-10-33/h1-8,13-14H,9-12,15H2,(H,31,35)(H,32,34) YYDOKRGOMSJJFH-UHFFFAOYSA-N 300435 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 5 Protein Wnt-3a Human 40.3 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300435 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300435&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293212 381749216 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574922 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C25H22F4N4O4/c26-19-4-2-1-3-18(19)20-7-6-17(14-30-20)31-24(35)16-5-8-22(37-25(27,28)29)21(13-16)32-23(34)15-33-9-11-36-12-10-33/h1-8,13-14H,9-12,15H2,(H,31,35)(H,32,34) YYDOKRGOMSJJFH-UHFFFAOYSA-N 300435 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 5 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300435 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300435&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293212 381749216 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574923 O=C(CN1CC2CCC(C1)O2)Nc5cc(C(=O)Nc4ccc(c3ccccc3F)nc4)ccc5OC(F)(F)F InChI=1S/C27H24F4N4O4/c28-21-4-2-1-3-20(21)22-9-6-17(12-32-22)33-26(37)16-5-10-24(39-27(29,30)31)23(11-16)34-25(36)15-35-13-18-7-8-19(14-35)38-18/h1-6,9-12,18-19H,7-8,13-15H2,(H,33,37)(H,34,36) QUECETJBQMLUHM-UHFFFAOYSA-N 300436 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 6 Protein Wnt-3a Human 60.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300436&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293213 381749217 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574924 O=C(CN1CC2CCC(C1)O2)Nc5cc(C(=O)Nc4ccc(c3ccccc3F)nc4)ccc5OC(F)(F)F InChI=1S/C27H24F4N4O4/c28-21-4-2-1-3-20(21)22-9-6-17(12-32-22)33-26(37)16-5-10-24(39-27(29,30)31)23(11-16)34-25(36)15-35-13-18-7-8-19(14-35)38-18/h1-6,9-12,18-19H,7-8,13-15H2,(H,33,37)(H,34,36) QUECETJBQMLUHM-UHFFFAOYSA-N 300436 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 6 Protein Wnt-3a Human 8900 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300436&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293213 381749217 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574925 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300437 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 7 Protein Wnt-3a Human 23.7 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300437&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293397 381749218 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574926 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300437 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 7 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300437&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293397 381749218 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574927 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300438 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 8 Protein Wnt-3a Human 51.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300438&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459788 381749219 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574928 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300438 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 8 Protein Wnt-3a Human 8350 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300438&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459788 381749219 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574929 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300439 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 9 Protein Wnt-3a Human 14.2 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300439&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459954 381749220 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574930 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300439 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 9 Protein Wnt-3a Human 20200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300439&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459954 381749220 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574931 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H25F3N4O4/c1-17(33-11-13-36-14-12-33)24(34)32-22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-17H,11-14H2,1H3,(H,31,35)(H,32,34) FWSLMXRDOJIPST-UHFFFAOYSA-N 300440 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 208::US10130633, Example 10 Protein Wnt-3a Human 11.2 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300440&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293398 381749221 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574932 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H25F3N4O4/c1-17(33-11-13-36-14-12-33)24(34)32-22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-17H,11-14H2,1H3,(H,31,35)(H,32,34) FWSLMXRDOJIPST-UHFFFAOYSA-N 300440 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 208::US10130633, Example 10 Protein Wnt-3a Human 15000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300440&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293398 381749221 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574933 CC(C)(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C27H26F4N4O4/c1-26(2,35-11-13-38-14-12-35)25(37)34-22-15-17(7-10-23(22)39-27(29,30)31)24(36)33-18-8-9-21(32-16-18)19-5-3-4-6-20(19)28/h3-10,15-16H,11-14H2,1-2H3,(H,33,36)(H,34,37) IAVWNBZQCNIJPT-UHFFFAOYSA-N 300441 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-methyl-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 11 Protein Wnt-3a Human 727 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300441&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459548 381749222 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574934 CC(C)(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C27H26F4N4O4/c1-26(2,35-11-13-38-14-12-35)25(37)34-22-15-17(7-10-23(22)39-27(29,30)31)24(36)33-18-8-9-21(32-16-18)19-5-3-4-6-20(19)28/h3-10,15-16H,11-14H2,1-2H3,(H,33,36)(H,34,37) IAVWNBZQCNIJPT-UHFFFAOYSA-N 300441 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-methyl-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 11 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300441&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459548 381749222 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574935 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ncc(c2ccccc2)s3)ccc4C(F)(F)F InChI=1S/C23H21F3N4O3S/c24-23(25,26)17-7-6-16(12-18(17)28-20(31)14-30-8-10-33-11-9-30)21(32)29-22-27-13-19(34-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,31)(H,27,29,32) VSGJPJQOEZVFCY-UHFFFAOYSA-N 300442 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 12 Protein Wnt-3a Human 530 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300442 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300442&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293019 381749223 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574936 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ncc(c2ccccc2)s3)ccc4C(F)(F)F InChI=1S/C23H21F3N4O3S/c24-23(25,26)17-7-6-16(12-18(17)28-20(31)14-30-8-10-33-11-9-30)21(32)29-22-27-13-19(34-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,31)(H,27,29,32) VSGJPJQOEZVFCY-UHFFFAOYSA-N 300442 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 12 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300442 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300442&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293019 381749223 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574937 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)nc3)ccc4C(F)(F)F InChI=1S/C25H23F3N4O3/c26-25(27,28)20-8-6-18(14-22(20)31-23(33)16-32-10-12-35-13-11-32)24(34)30-19-7-9-21(29-15-19)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) XUZHPPZMZXTXTB-UHFFFAOYSA-N 300443 3-[(morpholin-4-ylacetyl)amino]-N-(6-phenylpyridin-3-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 13 Protein Wnt-3a Human 362 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300443 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300443&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293020 381749224 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574938 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)nc3)ccc4C(F)(F)F InChI=1S/C25H23F3N4O3/c26-25(27,28)20-8-6-18(14-22(20)31-23(33)16-32-10-12-35-13-11-32)24(34)30-19-7-9-21(29-15-19)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) XUZHPPZMZXTXTB-UHFFFAOYSA-N 300443 3-[(morpholin-4-ylacetyl)amino]-N-(6-phenylpyridin-3-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 13 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300443 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300443&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293020 381749224 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574939 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ncc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)28-20(31)14-30-8-10-33-11-9-30)21(32)29-22-27-13-19(35-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,31)(H,27,29,32) SVMPHFGGFLOGKM-UHFFFAOYSA-N 300444 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 14 Protein Wnt-3a Human 190 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300444&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293021 381749225 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574940 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ncc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)28-20(31)14-30-8-10-33-11-9-30)21(32)29-22-27-13-19(35-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,31)(H,27,29,32) SVMPHFGGFLOGKM-UHFFFAOYSA-N 300444 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 14 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300444&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293021 381749225 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574941 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)nc3)ccc4OC(F)(F)F InChI=1S/C25H23F3N4O4/c26-25(27,28)36-22-9-6-18(14-21(22)31-23(33)16-32-10-12-35-13-11-32)24(34)30-19-7-8-20(29-15-19)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) PLVWMVVYKNZXLO-UHFFFAOYSA-N 300445 3-[(morpholin-4-ylacetyl)amino]-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 15 Protein Wnt-3a Human 137 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300445&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293209 381749226 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574942 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)nc3)ccc4OC(F)(F)F InChI=1S/C25H23F3N4O4/c26-25(27,28)36-22-9-6-18(14-21(22)31-23(33)16-32-10-12-35-13-11-32)24(34)30-19-7-8-20(29-15-19)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) PLVWMVVYKNZXLO-UHFFFAOYSA-N 300445 3-[(morpholin-4-ylacetyl)amino]-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 15 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300445&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293209 381749226 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574943 FC(F)(F)Oc1ccc(NC(=O)c2ncc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)29-20(31)14-30-8-10-33-11-9-30)28-21(32)22-27-13-19(35-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,32)(H,29,31) XODAASDFJSXPKD-UHFFFAOYSA-N 300446 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1,3-thiazole-2-carboxamide::US10130633, Example 16 Protein Wnt-3a Human 17.8 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300446&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293399 381749227 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574944 FC(F)(F)Oc1ccc(NC(=O)c2ncc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)29-20(31)14-30-8-10-33-11-9-30)28-21(32)22-27-13-19(35-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,32)(H,29,31) XODAASDFJSXPKD-UHFFFAOYSA-N 300446 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1,3-thiazole-2-carboxamide::US10130633, Example 16 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300446&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293399 381749227 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574945 FC(F)(F)Oc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H22F3N3O4S/c25-24(26,27)34-19-7-6-17(14-18(19)29-22(31)15-30-10-12-33-13-11-30)28-23(32)21-9-8-20(35-21)16-4-2-1-3-5-16/h1-9,14H,10-13,15H2,(H,28,32)(H,29,31) JZIIDZNSPCRDLE-UHFFFAOYSA-N 300447 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 17 Protein Wnt-3a Human 43.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300447&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293588 381749228 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574946 FC(F)(F)Oc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H22F3N3O4S/c25-24(26,27)34-19-7-6-17(14-18(19)29-22(31)15-30-10-12-33-13-11-30)28-23(32)21-9-8-20(35-21)16-4-2-1-3-5-16/h1-9,14H,10-13,15H2,(H,28,32)(H,29,31) JZIIDZNSPCRDLE-UHFFFAOYSA-N 300447 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 17 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300447&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293588 381749228 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574947 CC(C)(C)c1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C28H32N4O3/c1-28(2,3)23-11-10-22(17-25(23)31-26(33)19-32-13-15-35-16-14-32)30-27(34)21-9-12-24(29-18-21)20-7-5-4-6-8-20/h4-12,17-18H,13-16,19H2,1-3H3,(H,30,34)(H,31,33) QYNVEPFFZUNDPY-UHFFFAOYSA-N 300448 N-{4-tert-butyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-6-phenylnicotinamide::US10130633, Example 18 Protein Wnt-3a Human 444 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300448&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293587 381749229 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574948 CC(C)(C)c1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C28H32N4O3/c1-28(2,3)23-11-10-22(17-25(23)31-26(33)19-32-13-15-35-16-14-32)30-27(34)21-9-12-24(29-18-21)20-7-5-4-6-8-20/h4-12,17-18H,13-16,19H2,1-3H3,(H,30,34)(H,31,33) QYNVEPFFZUNDPY-UHFFFAOYSA-N 300448 N-{4-tert-butyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-6-phenylnicotinamide::US10130633, Example 18 Protein Wnt-3a Human 9900 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300448&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293587 381749229 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574949 CC(C)(C)c1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C27H31N3O3S/c1-27(2,3)21-10-9-20(17-22(21)29-25(31)18-30-13-15-33-16-14-30)28-26(32)24-12-11-23(34-24)19-7-5-4-6-8-19/h4-12,17H,13-16,18H2,1-3H3,(H,28,32)(H,29,31) BCIZWNGRDUPVKI-UHFFFAOYSA-N 300449 N-{4-tert-butyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 19 Protein Wnt-3a Human 26.2 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300449&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293400 381749230 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574950 CC(C)(C)c1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C27H31N3O3S/c1-27(2,3)21-10-9-20(17-22(21)29-25(31)18-30-13-15-33-16-14-30)28-26(32)24-12-11-23(34-24)19-7-5-4-6-8-19/h4-12,17H,13-16,18H2,1-3H3,(H,28,32)(H,29,31) BCIZWNGRDUPVKI-UHFFFAOYSA-N 300449 N-{4-tert-butyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 19 Protein Wnt-3a Human 11000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300449&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293400 381749230 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574951 COc1ccc(NC(=O)c2ncc(o2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H24N4O5/c1-30-19-8-7-17(13-18(19)26-21(28)15-27-9-11-31-12-10-27)25-22(29)23-24-14-20(32-23)16-5-3-2-4-6-16/h2-8,13-14H,9-12,15H2,1H3,(H,25,29)(H,26,28) MVMRWWRDURQEGG-UHFFFAOYSA-N 300450 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1,3-oxazole-2-carboxamide::US10130633, Example 20 Protein Wnt-3a Human 2460 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300450&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293586 381749231 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574952 COc1ccc(NC(=O)c2ncc(o2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H24N4O5/c1-30-19-8-7-17(13-18(19)26-21(28)15-27-9-11-31-12-10-27)25-22(29)23-24-14-20(32-23)16-5-3-2-4-6-16/h2-8,13-14H,9-12,15H2,1H3,(H,25,29)(H,26,28) MVMRWWRDURQEGG-UHFFFAOYSA-N 300450 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1,3-oxazole-2-carboxamide::US10130633, Example 20 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300450&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293586 381749231 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574953 Clc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H22ClN3O3S/c24-18-7-6-17(14-19(18)26-22(28)15-27-10-12-30-13-11-27)25-23(29)21-9-8-20(31-21)16-4-2-1-3-5-16/h1-9,14H,10-13,15H2,(H,25,29)(H,26,28) INKOFQFGQJTKKN-UHFFFAOYSA-N 300451 N-{4-chloro-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 21 Protein Wnt-3a Human 285 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300451&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293585 381749232 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574954 Clc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H22ClN3O3S/c24-18-7-6-17(14-19(18)26-22(28)15-27-10-12-30-13-11-27)25-23(29)21-9-8-20(31-21)16-4-2-1-3-5-16/h1-9,14H,10-13,15H2,(H,25,29)(H,26,28) INKOFQFGQJTKKN-UHFFFAOYSA-N 300451 N-{4-chloro-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 21 Protein Wnt-3a Human 9200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300451&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293585 381749232 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574955 Cc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H25N3O3S/c1-17-7-8-19(15-20(17)26-23(28)16-27-11-13-30-14-12-27)25-24(29)22-10-9-21(31-22)18-5-3-2-4-6-18/h2-10,15H,11-14,16H2,1H3,(H,25,29)(H,26,28) RCFXBGWEFKEYKH-UHFFFAOYSA-N 300452 N-{4-methyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 22 Protein Wnt-3a Human 695 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300452&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293401 381749233 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574956 Cc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H25N3O3S/c1-17-7-8-19(15-20(17)26-23(28)16-27-11-13-30-14-12-27)25-24(29)22-10-9-21(31-22)18-5-3-2-4-6-18/h2-10,15H,11-14,16H2,1H3,(H,25,29)(H,26,28) RCFXBGWEFKEYKH-UHFFFAOYSA-N 300452 N-{4-methyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 22 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300452&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293401 381749233 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574957 COc1ccc(NC(=O)c2ncc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H24N4O4S/c1-30-19-8-7-17(13-18(19)26-21(28)15-27-9-11-31-12-10-27)25-22(29)23-24-14-20(32-23)16-5-3-2-4-6-16/h2-8,13-14H,9-12,15H2,1H3,(H,25,29)(H,26,28) RGOHAWKKRURUQP-UHFFFAOYSA-N 300453 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1,3-thiazole-2-carboxamide::US10130633, Example 23 Protein Wnt-3a Human 98.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300453 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300453&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293589 381749234 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574958 COc1ccc(NC(=O)c2ncc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H24N4O4S/c1-30-19-8-7-17(13-18(19)26-21(28)15-27-9-11-31-12-10-27)25-22(29)23-24-14-20(32-23)16-5-3-2-4-6-16/h2-8,13-14H,9-12,15H2,1H3,(H,25,29)(H,26,28) RGOHAWKKRURUQP-UHFFFAOYSA-N 300453 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1,3-thiazole-2-carboxamide::US10130633, Example 23 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300453 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300453&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293589 381749234 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574959 COc1ccc(NC(=O)c2ccc([nH]2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H26N4O4/c1-31-22-10-7-18(15-21(22)27-23(29)16-28-11-13-32-14-12-28)25-24(30)20-9-8-19(26-20)17-5-3-2-4-6-17/h2-10,15,26H,11-14,16H2,1H3,(H,25,30)(H,27,29) YSYRMCKCULKEPJ-UHFFFAOYSA-N 300454 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1H-pyrrole-2-carboxamide::US10130633, Example 24 Protein Wnt-3a Human 1110 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300454&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293590 381749235 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574960 COc1ccc(NC(=O)c2ccc([nH]2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H26N4O4/c1-31-22-10-7-18(15-21(22)27-23(29)16-28-11-13-32-14-12-28)25-24(30)20-9-8-19(26-20)17-5-3-2-4-6-17/h2-10,15,26H,11-14,16H2,1H3,(H,25,30)(H,27,29) YSYRMCKCULKEPJ-UHFFFAOYSA-N 300454 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1H-pyrrole-2-carboxamide::US10130633, Example 24 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300454&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293590 381749235 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574961 COc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H25N3O4S/c1-30-20-8-7-18(15-19(20)26-23(28)16-27-11-13-31-14-12-27)25-24(29)22-10-9-21(32-22)17-5-3-2-4-6-17/h2-10,15H,11-14,16H2,1H3,(H,25,29)(H,26,28) XEPLIBHQDIWXCP-UHFFFAOYSA-N 300455 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 25 Protein Wnt-3a Human 326 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300455&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293781 381749236 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574962 COc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H25N3O4S/c1-30-20-8-7-18(15-19(20)26-23(28)16-27-11-13-31-14-12-27)25-24(29)22-10-9-21(32-22)17-5-3-2-4-6-17/h2-10,15H,11-14,16H2,1H3,(H,25,29)(H,26,28) XEPLIBHQDIWXCP-UHFFFAOYSA-N 300455 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 25 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300455&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293781 381749236 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574963 Fc1cccc(c1F)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-18-3-1-2-17(23(18)27)19-6-4-15(13-31-19)24(36)32-16-5-7-21(38-25(28,29)30)20(12-16)33-22(35)14-34-8-10-37-11-9-34/h1-7,12-13H,8-11,14H2,(H,32,36)(H,33,35) ADMFSAXASSRTEU-UHFFFAOYSA-N 300456 6-(2,3-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 26 Protein Wnt-3a Human 118 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300456&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293782 381749237 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574964 Fc1cccc(c1F)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-18-3-1-2-17(23(18)27)19-6-4-15(13-31-19)24(36)32-16-5-7-21(38-25(28,29)30)20(12-16)33-22(35)14-34-8-10-37-11-9-34/h1-7,12-13H,8-11,14H2,(H,32,36)(H,33,35) ADMFSAXASSRTEU-UHFFFAOYSA-N 300456 6-(2,3-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 26 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300456&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293782 381749237 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574965 Fc1cc(F)cc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-17-9-16(10-18(27)11-17)20-3-1-15(13-31-20)24(36)32-19-2-4-22(38-25(28,29)30)21(12-19)33-23(35)14-34-5-7-37-8-6-34/h1-4,9-13H,5-8,14H2,(H,32,36)(H,33,35) DSQGNQYHKXRLFE-UHFFFAOYSA-N 300457 6-(3,5-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 27 Protein Wnt-3a Human 65.7 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300457&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293783 381749238 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574966 Fc1cc(F)cc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-17-9-16(10-18(27)11-17)20-3-1-15(13-31-20)24(36)32-19-2-4-22(38-25(28,29)30)21(12-19)33-23(35)14-34-5-7-37-8-6-34/h1-4,9-13H,5-8,14H2,(H,32,36)(H,33,35) DSQGNQYHKXRLFE-UHFFFAOYSA-N 300457 6-(3,5-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 27 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300457&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293783 381749238 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574967 Fc1cccc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H22F4N4O4/c26-18-3-1-2-16(12-18)20-6-4-17(14-30-20)24(35)31-19-5-7-22(37-25(27,28)29)21(13-19)32-23(34)15-33-8-10-36-11-9-33/h1-7,12-14H,8-11,15H2,(H,31,35)(H,32,34) FIXTUTUYLQVSOC-UHFFFAOYSA-N 300458 6-(3-fluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 28 Protein Wnt-3a Human 52.3 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300458&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293784 381749239 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574968 Fc1cccc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H22F4N4O4/c26-18-3-1-2-16(12-18)20-6-4-17(14-30-20)24(35)31-19-5-7-22(37-25(27,28)29)21(13-19)32-23(34)15-33-8-10-36-11-9-33/h1-7,12-14H,8-11,15H2,(H,31,35)(H,32,34) FIXTUTUYLQVSOC-UHFFFAOYSA-N 300458 6-(3-fluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 28 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300458&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293784 381749239 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574969 Fc1cccc(F)c1-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-17-2-1-3-18(27)23(17)19-6-4-15(13-31-19)24(36)32-16-5-7-21(38-25(28,29)30)20(12-16)33-22(35)14-34-8-10-37-11-9-34/h1-7,12-13H,8-11,14H2,(H,32,36)(H,33,35) WAUZUWGJYWOAOY-UHFFFAOYSA-N 300459 6-(2,6-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 29 Protein Wnt-3a Human 156 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300459&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293785 381749240 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574970 Fc1cccc(F)c1-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-17-2-1-3-18(27)23(17)19-6-4-15(13-31-19)24(36)32-16-5-7-21(38-25(28,29)30)20(12-16)33-22(35)14-34-8-10-37-11-9-34/h1-7,12-13H,8-11,14H2,(H,32,36)(H,33,35) WAUZUWGJYWOAOY-UHFFFAOYSA-N 300459 6-(2,6-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 29 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300459&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293785 381749240 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574971 Fc1ccccc1-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H22F4N4O4/c26-19-4-2-1-3-18(19)20-7-5-16(14-30-20)24(35)31-17-6-8-22(37-25(27,28)29)21(13-17)32-23(34)15-33-9-11-36-12-10-33/h1-8,13-14H,9-12,15H2,(H,31,35)(H,32,34) LMEAJULYWCIHIQ-UHFFFAOYSA-N 300460 6-(2-fluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 30 Protein Wnt-3a Human 90.1 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300460 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300460&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293968 381749241 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574972 Fc1ccccc1-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H22F4N4O4/c26-19-4-2-1-3-18(19)20-7-5-16(14-30-20)24(35)31-17-6-8-22(37-25(27,28)29)21(13-17)32-23(34)15-33-9-11-36-12-10-33/h1-8,13-14H,9-12,15H2,(H,31,35)(H,32,34) LMEAJULYWCIHIQ-UHFFFAOYSA-N 300460 6-(2-fluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 30 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300460 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300460&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293968 381749241 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574973 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2F)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H25FN4O4/c1-33-23-9-7-18(14-22(23)29-24(31)16-30-10-12-34-13-11-30)28-25(32)17-6-8-21(27-15-17)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) SROZDHRPAYBXCR-UHFFFAOYSA-N 300461 6-(2-fluorophenyl)-N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}nicotinamide::US10130633, Example 31 Protein Wnt-3a Human 805 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300461 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300461&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293969 381749242 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574974 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2F)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H25FN4O4/c1-33-23-9-7-18(14-22(23)29-24(31)16-30-10-12-34-13-11-30)28-25(32)17-6-8-21(27-15-17)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) SROZDHRPAYBXCR-UHFFFAOYSA-N 300461 6-(2-fluorophenyl)-N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}nicotinamide::US10130633, Example 31 Protein Wnt-3a Human 36000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300461 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300461&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293969 381749242 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574975 COc1ccc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H25FN4O4/c1-33-23-8-6-20(14-22(23)29-24(31)16-30-9-11-34-12-10-30)28-25(32)18-5-7-21(27-15-18)17-3-2-4-19(26)13-17/h2-8,13-15H,9-12,16H2,1H3,(H,28,32)(H,29,31) ASXQKWUUHVJUIZ-UHFFFAOYSA-N 300462 6-(3-fluorophenyl)-N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}nicotinamide::US10130633, Example 32 Protein Wnt-3a Human 925 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300462&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293970 381749243 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574976 COc1ccc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H25FN4O4/c1-33-23-8-6-20(14-22(23)29-24(31)16-30-9-11-34-12-10-30)28-25(32)18-5-7-21(27-15-18)17-3-2-4-19(26)13-17/h2-8,13-15H,9-12,16H2,1H3,(H,28,32)(H,29,31) ASXQKWUUHVJUIZ-UHFFFAOYSA-N 300462 6-(3-fluorophenyl)-N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}nicotinamide::US10130633, Example 32 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300462&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293970 381749243 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574977 FC(F)(F)Oc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H23F3N4O4/c26-25(27,28)36-22-9-7-19(14-21(22)31-23(33)16-32-10-12-35-13-11-32)30-24(34)18-6-8-20(29-15-18)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) SOMPCIKDNUVLIX-UHFFFAOYSA-N 300463 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-6-phenylnicotinamide::US10130633, Example 33 Protein Wnt-3a Human 111 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300463&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293971 381749244 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574978 FC(F)(F)Oc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H23F3N4O4/c26-25(27,28)36-22-9-7-19(14-21(22)31-23(33)16-32-10-12-35-13-11-32)30-24(34)18-6-8-20(29-15-18)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) SOMPCIKDNUVLIX-UHFFFAOYSA-N 300463 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-6-phenylnicotinamide::US10130633, Example 33 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300463&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293971 381749244 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574979 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H26N4O4/c1-32-23-10-8-20(15-22(23)28-24(30)17-29-11-13-33-14-12-29)27-25(31)19-7-9-21(26-16-19)18-5-3-2-4-6-18/h2-10,15-16H,11-14,17H2,1H3,(H,27,31)(H,28,30) BRKGQWYGRLRACQ-UHFFFAOYSA-N 300464 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-6-phenylnicotinamide::US10130633, Example 34 Protein Wnt-3a Human 1220 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300464 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300464&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293972 381749245 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574980 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H26N4O4/c1-32-23-10-8-20(15-22(23)28-24(30)17-29-11-13-33-14-12-29)27-25(31)19-7-9-21(26-16-19)18-5-3-2-4-6-18/h2-10,15-16H,11-14,17H2,1H3,(H,27,31)(H,28,30) BRKGQWYGRLRACQ-UHFFFAOYSA-N 300464 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-6-phenylnicotinamide::US10130633, Example 34 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300464 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300464&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293972 381749245 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574981 COc1ccc(cc1)-c1ccc(s1)C(=O)Nc1ccc(OC)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H27N3O5S/c1-31-19-6-3-17(4-7-19)22-9-10-23(34-22)25(30)26-18-5-8-21(32-2)20(15-18)27-24(29)16-28-11-13-33-14-12-28/h3-10,15H,11-14,16H2,1-2H3,(H,26,30)(H,27,29) VUUXDGFUVGYIJN-UHFFFAOYSA-N 300465 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-(4-methoxyphenyl)thiophene-2-carboxamide::US10130633, Example 35 Protein Wnt-3a Human 1250 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300465&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294150 381749246 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574982 COc1ccc(cc1)-c1ccc(s1)C(=O)Nc1ccc(OC)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H27N3O5S/c1-31-19-6-3-17(4-7-19)22-9-10-23(34-22)25(30)26-18-5-8-21(32-2)20(15-18)27-24(29)16-28-11-13-33-14-12-28/h3-10,15H,11-14,16H2,1-2H3,(H,26,30)(H,27,29) VUUXDGFUVGYIJN-UHFFFAOYSA-N 300465 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-(4-methoxyphenyl)thiophene-2-carboxamide::US10130633, Example 35 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300465&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294150 381749246 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574983 COc1ccc(NC(=O)c2ccc(s2)-c2ccc(F)cc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H24FN3O4S/c1-31-20-7-6-18(14-19(20)27-23(29)15-28-10-12-32-13-11-28)26-24(30)22-9-8-21(33-22)16-2-4-17(25)5-3-16/h2-9,14H,10-13,15H2,1H3,(H,26,30)(H,27,29) NBQLKDMGEXFHCR-UHFFFAOYSA-N 300466 5-(4-fluorophenyl)-N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}thiophene-2-carboxamide::US10130633, Example 36 Protein Wnt-3a Human 1200 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300466 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300466&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294151 381749247 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574984 COc1ccc(NC(=O)c2ccc(s2)-c2ccc(F)cc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H24FN3O4S/c1-31-20-7-6-18(14-19(20)27-23(29)15-28-10-12-32-13-11-28)26-24(30)22-9-8-21(33-22)16-2-4-17(25)5-3-16/h2-9,14H,10-13,15H2,1H3,(H,26,30)(H,27,29) NBQLKDMGEXFHCR-UHFFFAOYSA-N 300466 5-(4-fluorophenyl)-N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}thiophene-2-carboxamide::US10130633, Example 36 Protein Wnt-3a Human 22000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300466 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300466&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294151 381749247 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574985 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(OC(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H23F2N5O4S/c25-22(26)35-18-7-6-16(19(32)28-23-30-29-20(36-23)15-4-2-1-3-5-15)14-17(18)27-21(33)24(8-9-24)31-10-12-34-13-11-31/h1-7,14,22H,8-13H2,(H,27,33)(H,28,30,32) CJUIOOKKKHRBDW-UHFFFAOYSA-N 300467 4-(difluoromethoxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 37 Protein Wnt-3a Human 20.8 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300467&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294152 381749248 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574986 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(OC(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H23F2N5O4S/c25-22(26)35-18-7-6-16(19(32)28-23-30-29-20(36-23)15-4-2-1-3-5-15)14-17(18)27-21(33)24(8-9-24)31-10-12-34-13-11-31/h1-7,14,22H,8-13H2,(H,27,33)(H,28,30,32) CJUIOOKKKHRBDW-UHFFFAOYSA-N 300467 4-(difluoromethoxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 37 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300467&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294152 381749248 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574987 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C27H28F2N6O3S/c28-25(29)38-21-9-6-18(22(36)31-26-33-32-23(39-26)17-4-2-1-3-5-17)16-20(21)30-24(37)27(10-11-27)35-14-12-34(13-15-35)19-7-8-19/h1-6,9,16,19,25H,7-8,10-15H2,(H,30,37)(H,31,33,36) JRAKYUMORODASZ-UHFFFAOYSA-N 300468 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-(difluoromethoxy)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 38 Protein Wnt-3a Human 27.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300468&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294153 381749249 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574988 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C27H28F2N6O3S/c28-25(29)38-21-9-6-18(22(36)31-26-33-32-23(39-26)17-4-2-1-3-5-17)16-20(21)30-24(37)27(10-11-27)35-14-12-34(13-15-35)19-7-8-19/h1-6,9,16,19,25H,7-8,10-15H2,(H,30,37)(H,31,33,36) JRAKYUMORODASZ-UHFFFAOYSA-N 300468 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-(difluoromethoxy)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 38 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300468&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294153 381749249 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574989 CN5CCN(C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)CC4)CC5 InChI=1S/C25H26F2N6O3S/c1-32-11-13-33(14-12-32)25(9-10-25)22(35)28-18-15-17(7-8-19(18)36-23(26)27)20(34)29-24-31-30-21(37-24)16-5-3-2-4-6-16/h2-8,15,23H,9-14H2,1H3,(H,28,35)(H,29,31,34) MHPHVFZOANJXNT-UHFFFAOYSA-N 300469 4-(difluoromethoxy)-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 39 Protein Wnt-3a Human 33.8 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300469 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300469&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294154 381749250 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574990 CN5CCN(C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)CC4)CC5 InChI=1S/C25H26F2N6O3S/c1-32-11-13-33(14-12-32)25(9-10-25)22(35)28-18-15-17(7-8-19(18)36-23(26)27)20(34)29-24-31-30-21(37-24)16-5-3-2-4-6-16/h2-8,15,23H,9-14H2,1H3,(H,28,35)(H,29,31,34) MHPHVFZOANJXNT-UHFFFAOYSA-N 300469 4-(difluoromethoxy)-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 39 Protein Wnt-3a Human 32000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300469 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300469&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294154 381749250 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574991 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)CC4 InChI=1S/C23H24F2N6O3S/c1-30-9-11-31(12-10-30)14-19(32)26-17-13-16(7-8-18(17)34-22(24)25)20(33)27-23-29-28-21(35-23)15-5-3-2-4-6-15/h2-8,13,22H,9-12,14H2,1H3,(H,26,32)(H,27,29,33) RZAYXPOLDBZMMO-UHFFFAOYSA-N 300470 4-(difluoromethoxy)-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 40 Protein Wnt-3a Human 52.4 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300470&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294337 381749251 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574992 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)CC4 InChI=1S/C23H24F2N6O3S/c1-30-9-11-31(12-10-30)14-19(32)26-17-13-16(7-8-18(17)34-22(24)25)20(33)27-23-29-28-21(35-23)15-5-3-2-4-6-15/h2-8,13,22H,9-12,14H2,1H3,(H,26,32)(H,27,29,33) RZAYXPOLDBZMMO-UHFFFAOYSA-N 300470 4-(difluoromethoxy)-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 40 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300470&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294337 381749251 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574993 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OC(F)F InChI=1S/C25H26F2N6O3S/c26-24(27)36-20-9-6-17(22(35)29-25-31-30-23(37-25)16-4-2-1-3-5-16)14-19(20)28-21(34)15-32-10-12-33(13-11-32)18-7-8-18/h1-6,9,14,18,24H,7-8,10-13,15H2,(H,28,34)(H,29,31,35) PFGQKZRTHFZWDT-UHFFFAOYSA-N 300471 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-4-(difluoromethoxy)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 41 Protein Wnt-3a Human 149 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300471&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294338 381749252 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574994 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OC(F)F InChI=1S/C25H26F2N6O3S/c26-24(27)36-20-9-6-17(22(35)29-25-31-30-23(37-25)16-4-2-1-3-5-16)14-19(20)28-21(34)15-32-10-12-33(13-11-32)18-7-8-18/h1-6,9,14,18,24H,7-8,10-13,15H2,(H,28,34)(H,29,31,35) PFGQKZRTHFZWDT-UHFFFAOYSA-N 300471 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-4-(difluoromethoxy)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 41 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300471&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294338 381749252 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574995 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)N4CCN(C)CC4 InChI=1S/C24H26F2N6O3S/c1-15(32-12-10-31(2)11-13-32)20(33)27-18-14-17(8-9-19(18)35-23(25)26)21(34)28-24-30-29-22(36-24)16-6-4-3-5-7-16/h3-9,14-15,23H,10-13H2,1-2H3,(H,27,33)(H,28,30,34) YIQDKSIDVLRXSB-UHFFFAOYSA-N 300472 4-(difluoromethoxy)-3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide trifluoroacetate (1:1)::US10130633, Example 42 Protein Wnt-3a Human 242 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300472&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462561 381749253 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574996 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)N4CCN(C)CC4 InChI=1S/C24H26F2N6O3S/c1-15(32-12-10-31(2)11-13-32)20(33)27-18-14-17(8-9-19(18)35-23(25)26)21(34)28-24-30-29-22(36-24)16-6-4-3-5-7-16/h3-9,14-15,23H,10-13H2,1-2H3,(H,27,33)(H,28,30,34) YIQDKSIDVLRXSB-UHFFFAOYSA-N 300472 4-(difluoromethoxy)-3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide trifluoroacetate (1:1)::US10130633, Example 42 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300472&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462561 381749253 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574997 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C25H27N5O4S/c1-33-16-19-8-7-18(21(31)27-24-29-28-22(35-24)17-5-3-2-4-6-17)15-20(19)26-23(32)25(9-10-25)30-11-13-34-14-12-30/h2-8,15H,9-14,16H2,1H3,(H,26,32)(H,27,29,31) BGQBRJJYUADPJT-UHFFFAOYSA-N 300473 4-(methoxymethyl)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 43 Protein Wnt-3a Human 49.1 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300473&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294339 381749254 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574998 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C25H27N5O4S/c1-33-16-19-8-7-18(21(31)27-24-29-28-22(35-24)17-5-3-2-4-6-17)15-20(19)26-23(32)25(9-10-25)30-11-13-34-14-12-30/h2-8,15H,9-14,16H2,1H3,(H,26,32)(H,27,29,31) BGQBRJJYUADPJT-UHFFFAOYSA-N 300473 4-(methoxymethyl)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 43 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300473&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294339 381749254 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 574999 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C6(N5CCN(C4CC4)CC5)CC6 InChI=1S/C28H32N6O3S/c1-37-18-21-8-7-20(24(35)30-27-32-31-25(38-27)19-5-3-2-4-6-19)17-23(21)29-26(36)28(11-12-28)34-15-13-33(14-16-34)22-9-10-22/h2-8,17,22H,9-16,18H2,1H3,(H,29,36)(H,30,32,35) PYXKGNMJTOCFNK-UHFFFAOYSA-N 300474 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-(methoxymethyl)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 44 Protein Wnt-3a Human 366 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300474&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294340 381749255 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575000 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C6(N5CCN(C4CC4)CC5)CC6 InChI=1S/C28H32N6O3S/c1-37-18-21-8-7-20(24(35)30-27-32-31-25(38-27)19-5-3-2-4-6-19)17-23(21)29-26(36)28(11-12-28)34-15-13-33(14-16-34)22-9-10-22/h2-8,17,22H,9-16,18H2,1H3,(H,29,36)(H,30,32,35) PYXKGNMJTOCFNK-UHFFFAOYSA-N 300474 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-(methoxymethyl)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 44 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300474&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294340 381749255 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575001 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCN(C)CC4)CC5 InChI=1S/C26H30N6O3S/c1-31-12-14-32(15-13-31)26(10-11-26)24(34)27-21-16-19(8-9-20(21)17-35-2)22(33)28-25-30-29-23(36-25)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,34)(H,28,30,33) YYIIMHWKKZNWNN-UHFFFAOYSA-N 300475 4-(methoxymethyl)-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide hydrochloride (1:1)::US10130633, Example 45 Protein Wnt-3a Human 198 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300475&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461487 381749256 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575002 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCN(C)CC4)CC5 InChI=1S/C26H30N6O3S/c1-31-12-14-32(15-13-31)26(10-11-26)24(34)27-21-16-19(8-9-20(21)17-35-2)22(33)28-25-30-29-23(36-25)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,34)(H,28,30,33) YYIIMHWKKZNWNN-UHFFFAOYSA-N 300475 4-(methoxymethyl)-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide hydrochloride (1:1)::US10130633, Example 45 Protein Wnt-3a Human 26500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300475&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461487 381749256 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575003 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C24H28N6O3S/c1-29-10-12-30(13-11-29)15-21(31)25-20-14-18(8-9-19(20)16-33-2)22(32)26-24-28-27-23(34-24)17-6-4-3-5-7-17/h3-9,14H,10-13,15-16H2,1-2H3,(H,25,31)(H,26,28,32) QUSUGGQCMYEKLG-UHFFFAOYSA-N 300476 4-(methoxymethyl)-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 46 Protein Wnt-3a Human 164 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300476&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294341 381749257 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575004 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C24H28N6O3S/c1-29-10-12-30(13-11-29)15-21(31)25-20-14-18(8-9-19(20)16-33-2)22(32)26-24-28-27-23(34-24)17-6-4-3-5-7-17/h3-9,14H,10-13,15-16H2,1-2H3,(H,25,31)(H,26,28,32) QUSUGGQCMYEKLG-UHFFFAOYSA-N 300476 4-(methoxymethyl)-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 46 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300476&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294341 381749257 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575005 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C25H27N5O5S2/c1-37(33,34)16-19-8-7-18(21(31)27-24-29-28-22(36-24)17-5-3-2-4-6-17)15-20(19)26-23(32)25(9-10-25)30-11-13-35-14-12-30/h2-8,15H,9-14,16H2,1H3,(H,26,32)(H,27,29,31) XPXFEVSLAOPVTB-UHFFFAOYSA-N 300477 4-[(methylsulfonyl)methyl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 47 Protein Wnt-3a Human 39.8 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300477&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294542 381749258 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575006 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C25H27N5O5S2/c1-37(33,34)16-19-8-7-18(21(31)27-24-29-28-22(36-24)17-5-3-2-4-6-17)15-20(19)26-23(32)25(9-10-25)30-11-13-35-14-12-30/h2-8,15H,9-14,16H2,1H3,(H,26,32)(H,27,29,31) XPXFEVSLAOPVTB-UHFFFAOYSA-N 300477 4-[(methylsulfonyl)methyl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 47 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300477&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294542 381749258 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575007 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C6(N5CCN(C4CC4)CC5)CC6 InChI=1S/C28H32N6O4S2/c1-40(37,38)18-21-8-7-20(24(35)30-27-32-31-25(39-27)19-5-3-2-4-6-19)17-23(21)29-26(36)28(11-12-28)34-15-13-33(14-16-34)22-9-10-22/h2-8,17,22H,9-16,18H2,1H3,(H,29,36)(H,30,32,35) LMXNQMCNDQEEEI-UHFFFAOYSA-N 300478 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 48 Protein Wnt-3a Human 73.7 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300478&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294543 381749259 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575008 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C6(N5CCN(C4CC4)CC5)CC6 InChI=1S/C28H32N6O4S2/c1-40(37,38)18-21-8-7-20(24(35)30-27-32-31-25(39-27)19-5-3-2-4-6-19)17-23(21)29-26(36)28(11-12-28)34-15-13-33(14-16-34)22-9-10-22/h2-8,17,22H,9-16,18H2,1H3,(H,29,36)(H,30,32,35) LMXNQMCNDQEEEI-UHFFFAOYSA-N 300478 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 48 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300478&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294543 381749259 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575009 CN5CCN(C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)CC4)CC5 InChI=1S/C26H30N6O4S2/c1-31-12-14-32(15-13-31)26(10-11-26)24(34)27-21-16-19(8-9-20(21)17-38(2,35)36)22(33)28-25-30-29-23(37-25)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,34)(H,28,30,33) DYFZAXBGBVBDTJ-UHFFFAOYSA-N 300479 3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 49 Protein Wnt-3a Human 46.6 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300479&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294544 381749260 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575010 CN5CCN(C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)CC4)CC5 InChI=1S/C26H30N6O4S2/c1-31-12-14-32(15-13-31)26(10-11-26)24(34)27-21-16-19(8-9-20(21)17-38(2,35)36)22(33)28-25-30-29-23(37-25)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,34)(H,28,30,33) DYFZAXBGBVBDTJ-UHFFFAOYSA-N 300479 3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 49 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300479&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294544 381749260 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575011 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H22F3N5O4S/c25-24(26,27)36-18-7-6-16(19(33)29-22-31-30-20(37-22)15-4-2-1-3-5-15)14-17(18)28-21(34)23(8-9-23)32-10-12-35-13-11-32/h1-7,14H,8-13H2,(H,28,34)(H,29,31,33) BXYZWBYNNCMHGD-UHFFFAOYSA-N 300480 3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 50 Protein Wnt-3a Human 46.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300480&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294545 381749261 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575012 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H22F3N5O4S/c25-24(26,27)36-18-7-6-16(19(33)29-22-31-30-20(37-22)15-4-2-1-3-5-15)14-17(18)28-21(34)23(8-9-23)32-10-12-35-13-11-32/h1-7,14H,8-13H2,(H,28,34)(H,29,31,33) BXYZWBYNNCMHGD-UHFFFAOYSA-N 300480 3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 50 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300480&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294545 381749261 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575013 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC(F)(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C27H27F3N6O3S/c28-27(29,30)39-21-9-6-18(22(37)32-25-34-33-23(40-25)17-4-2-1-3-5-17)16-20(21)31-24(38)26(10-11-26)36-14-12-35(13-15-36)19-7-8-19/h1-6,9,16,19H,7-8,10-15H2,(H,31,38)(H,32,34,37) KSVSLGRGYJVNII-UHFFFAOYSA-N 300481 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 51 Protein Wnt-3a Human 119 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300481&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294546 381749262 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575014 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC(F)(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C27H27F3N6O3S/c28-27(29,30)39-21-9-6-18(22(37)32-25-34-33-23(40-25)17-4-2-1-3-5-17)16-20(21)31-24(38)26(10-11-26)36-14-12-35(13-15-36)19-7-8-19/h1-6,9,16,19H,7-8,10-15H2,(H,31,38)(H,32,34,37) KSVSLGRGYJVNII-UHFFFAOYSA-N 300481 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 51 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300481&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294546 381749262 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575015 CN5CCN(C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4)CC5 InChI=1S/C25H25F3N6O3S/c1-33-11-13-34(14-12-33)24(9-10-24)22(36)29-18-15-17(7-8-19(18)37-25(26,27)28)20(35)30-23-32-31-21(38-23)16-5-3-2-4-6-16/h2-8,15H,9-14H2,1H3,(H,29,36)(H,30,32,35) DZVKVGUMYHRZEX-UHFFFAOYSA-N 300482 3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 52 Protein Wnt-3a Human 26.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300482&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291643 381749263 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575016 CN5CCN(C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4)CC5 InChI=1S/C25H25F3N6O3S/c1-33-11-13-34(14-12-33)24(9-10-24)22(36)29-18-15-17(7-8-19(18)37-25(26,27)28)20(35)30-23-32-31-21(38-23)16-5-3-2-4-6-16/h2-8,15H,9-14H2,1H3,(H,29,36)(H,30,32,35) DZVKVGUMYHRZEX-UHFFFAOYSA-N 300482 3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 52 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300482&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291643 381749263 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575017 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OC(F)(F)F InChI=1S/C25H25F3N6O3S/c26-25(27,28)37-20-9-6-17(22(36)30-24-32-31-23(38-24)16-4-2-1-3-5-16)14-19(20)29-21(35)15-33-10-12-34(13-11-33)18-7-8-18/h1-6,9,14,18H,7-8,10-13,15H2,(H,29,35)(H,30,32,36) NDIHTZSIBMIILM-UHFFFAOYSA-N 300483 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 53 Protein Wnt-3a Human 181 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300483&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291644 381749264 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575018 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OC(F)(F)F InChI=1S/C25H25F3N6O3S/c26-25(27,28)37-20-9-6-17(22(36)30-24-32-31-23(38-24)16-4-2-1-3-5-16)14-19(20)29-21(35)15-33-10-12-34(13-11-33)18-7-8-18/h1-6,9,14,18H,7-8,10-13,15H2,(H,29,35)(H,30,32,36) NDIHTZSIBMIILM-UHFFFAOYSA-N 300483 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 53 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300483&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291644 381749264 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575019 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H23F3N6O3S/c1-31-9-11-32(12-10-31)14-19(33)27-17-13-16(7-8-18(17)35-23(24,25)26)20(34)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,27,33)(H,28,30,34) BUDSEUSTGYWPCA-UHFFFAOYSA-N 300484 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 54 Protein Wnt-3a Human 104 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300484&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 78425808 381749265 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575020 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H23F3N6O3S/c1-31-9-11-32(12-10-31)14-19(33)27-17-13-16(7-8-18(17)35-23(24,25)26)20(34)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,27,33)(H,28,30,34) BUDSEUSTGYWPCA-UHFFFAOYSA-N 300484 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 54 Protein Wnt-3a Human 28000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300484&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 78425808 381749265 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575021 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C22H20F3N5O4S/c23-22(24,25)34-17-7-6-15(12-16(17)26-18(31)13-30-8-10-33-11-9-30)19(32)27-21-29-28-20(35-21)14-4-2-1-3-5-14/h1-7,12H,8-11,13H2,(H,26,31)(H,27,29,32) GQWHFEOHWKHMBE-UHFFFAOYSA-N 300485 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 55 Protein Wnt-3a Human 150 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300485&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291645 381749266 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575022 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C22H20F3N5O4S/c23-22(24,25)34-17-7-6-15(12-16(17)26-18(31)13-30-8-10-33-11-9-30)19(32)27-21-29-28-20(35-21)14-4-2-1-3-5-14/h1-7,12H,8-11,13H2,(H,26,31)(H,27,29,32) GQWHFEOHWKHMBE-UHFFFAOYSA-N 300485 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 55 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300485&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291645 381749266 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575023 NC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C24H24N6O4S/c25-19(31)17-7-6-16(20(32)27-23-29-28-21(35-23)15-4-2-1-3-5-15)14-18(17)26-22(33)24(8-9-24)30-10-12-34-13-11-30/h1-7,14H,8-13H2,(H2,25,31)(H,26,33)(H,27,29,32) NNRFVLAYYGPARZ-UHFFFAOYSA-N 300486 2-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-4-(5-phenyl-1,3,4-thiadiazol-2-yl)terephthalamide::US10130633, Example 56 Protein Wnt-3a Human 104 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300486&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291646 381749267 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575024 NC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C24H24N6O4S/c25-19(31)17-7-6-16(20(32)27-23-29-28-21(35-23)15-4-2-1-3-5-15)14-18(17)26-22(33)24(8-9-24)30-10-12-34-13-11-30/h1-7,14H,8-13H2,(H2,25,31)(H,26,33)(H,27,29,32) NNRFVLAYYGPARZ-UHFFFAOYSA-N 300486 2-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-4-(5-phenyl-1,3,4-thiadiazol-2-yl)terephthalamide::US10130633, Example 56 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300486&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291646 381749267 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575025 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O4S/c1-14(31-9-11-34-12-10-31)19(32)27-17-13-16(7-8-18(17)35-23(24,25)26)20(33)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) NZNXXRYDQGCBFK-UHFFFAOYSA-N 300487 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 57 Protein Wnt-3a Human 124 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300487&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291647 381749268 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575026 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O4S/c1-14(31-9-11-34-12-10-31)19(32)27-17-13-16(7-8-18(17)35-23(24,25)26)20(33)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) NZNXXRYDQGCBFK-UHFFFAOYSA-N 300487 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 57 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300487&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291647 381749268 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575027 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O3S/c1-15(33-12-10-32(2)11-13-33)20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) QWBOSJFOAGJZPT-UHFFFAOYSA-N 300488 US10130633, Example 260::3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 273::US10130633, Example 58 Protein Wnt-3a Human 83.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300488&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291851 381749269 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575028 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O3S/c1-15(33-12-10-32(2)11-13-33)20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) QWBOSJFOAGJZPT-UHFFFAOYSA-N 300488 US10130633, Example 260::3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 273::US10130633, Example 58 Protein Wnt-3a Human 20000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300488&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291851 381749269 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575029 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3C(F)(F)F)CC4 InChI=1S/C23H23F3N6O2S/c1-31-9-11-32(12-10-31)14-19(33)27-18-13-16(7-8-17(18)23(24,25)26)20(34)28-22-30-29-21(35-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,27,33)(H,28,30,34) MZJDILZHTFQSKX-UHFFFAOYSA-N 300489 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 59 Protein Wnt-3a Human 385 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300489&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291852 381749270 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575030 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3C(F)(F)F)CC4 InChI=1S/C23H23F3N6O2S/c1-31-9-11-32(12-10-31)14-19(33)27-18-13-16(7-8-17(18)23(24,25)26)20(34)28-22-30-29-21(35-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,27,33)(H,28,30,34) MZJDILZHTFQSKX-UHFFFAOYSA-N 300489 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 59 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300489&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291852 381749270 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575031 Fc1cc(F)cc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)C2(CC2)N2CCOCC2)c1 InChI=1S/C27H23F5N4O4/c28-18-11-17(12-19(29)13-18)21-3-1-16(15-33-21)24(37)34-20-2-4-23(40-27(30,31)32)22(14-20)35-25(38)26(5-6-26)36-7-9-39-10-8-36/h1-4,11-15H,5-10H2,(H,34,37)(H,35,38) PXNZOIRDQDZNGP-UHFFFAOYSA-N 300490 6-(3,5-difluorophenyl)-N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]nicotinamide::US10130633, Example 60 Protein Wnt-3a Human 20.2 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300490&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291853 381749271 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575032 Fc1cc(F)cc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)C2(CC2)N2CCOCC2)c1 InChI=1S/C27H23F5N4O4/c28-18-11-17(12-19(29)13-18)21-3-1-16(15-33-21)24(37)34-20-2-4-23(40-27(30,31)32)22(14-20)35-25(38)26(5-6-26)36-7-9-39-10-8-36/h1-4,11-15H,5-10H2,(H,34,37)(H,35,38) PXNZOIRDQDZNGP-UHFFFAOYSA-N 300490 6-(3,5-difluorophenyl)-N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]nicotinamide::US10130633, Example 60 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300490&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291853 381749271 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575033 FC(F)(F)Oc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H25F3N4O4/c28-27(29,30)38-23-9-7-20(16-22(23)33-25(36)26(10-11-26)34-12-14-37-15-13-34)32-24(35)19-6-8-21(31-17-19)18-4-2-1-3-5-18/h1-9,16-17H,10-15H2,(H,32,35)(H,33,36) ZIRCYRARYKCFJB-UHFFFAOYSA-N 300491 N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]-6-phenylnicotinamide::US10130633, Example 61 Protein Wnt-3a Human 26.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300491&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291855 381749272 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575034 FC(F)(F)Oc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H25F3N4O4/c28-27(29,30)38-23-9-7-20(16-22(23)33-25(36)26(10-11-26)34-12-14-37-15-13-34)32-24(35)19-6-8-21(31-17-19)18-4-2-1-3-5-18/h1-9,16-17H,10-15H2,(H,32,35)(H,33,36) ZIRCYRARYKCFJB-UHFFFAOYSA-N 300491 N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]-6-phenylnicotinamide::US10130633, Example 61 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300491&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291855 381749272 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575035 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2F)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H27FN4O4/c1-35-24-9-7-19(16-23(24)31-26(34)27(10-11-27)32-12-14-36-15-13-32)30-25(33)18-6-8-22(29-17-18)20-4-2-3-5-21(20)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) XMMJCCFKGWLHAG-UHFFFAOYSA-N 300492 6-(2-fluorophenyl)-N-[4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)phenyl]nicotinamide::US10130633, Example 62 Protein Wnt-3a Human 67.3 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300492&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458826 381749273 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575036 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2F)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H27FN4O4/c1-35-24-9-7-19(16-23(24)31-26(34)27(10-11-27)32-12-14-36-15-13-32)30-25(33)18-6-8-22(29-17-18)20-4-2-3-5-21(20)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) XMMJCCFKGWLHAG-UHFFFAOYSA-N 300492 6-(2-fluorophenyl)-N-[4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)phenyl]nicotinamide::US10130633, Example 62 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300492&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458826 381749273 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575037 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4ccc(c3ccccc3F)nc4)ccc5OC(F)(F)F InChI=1S/C28H27F4N5O3/c29-22-4-2-1-3-21(22)23-9-6-19(16-33-23)34-27(39)18-5-10-25(40-28(30,31)32)24(15-18)35-26(38)17-36-11-13-37(14-12-36)20-7-8-20/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,34,39)(H,35,38) HCSYYUWBSJWLDC-UHFFFAOYSA-N 300493 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 63 Protein Wnt-3a Human 50.8 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300493&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291854 381749274 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575038 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4ccc(c3ccccc3F)nc4)ccc5OC(F)(F)F InChI=1S/C28H27F4N5O3/c29-22-4-2-1-3-21(22)23-9-6-19(16-33-23)34-27(39)18-5-10-25(40-28(30,31)32)24(15-18)35-26(38)17-36-11-13-37(14-12-36)20-7-8-20/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,34,39)(H,35,38) HCSYYUWBSJWLDC-UHFFFAOYSA-N 300493 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 63 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300493&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291854 381749274 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575039 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300494 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 64 Protein Wnt-3a Human 23.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300494&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292056 381749275 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575040 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300494 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 64 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300494&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292056 381749275 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575041 C[C@@H](N1CCN(C)CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300495 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 65 Protein Wnt-3a Human 5.20 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300495&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293217 381749276 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575042 C[C@@H](N1CCN(C)CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300495 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 65 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300495&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293217 381749276 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575043 C[C@H](N1CCN(C)CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300496 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 66 Protein Wnt-3a Human 11.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300496&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460173 381749277 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575044 C[C@H](N1CCN(C)CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300496 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 66 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300496&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460173 381749277 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575045 O=C(Nc2ccc(c1ccccc1F)nc2)c6ccc(OC(F)(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C30H29F4N5O3/c31-23-4-2-1-3-22(23)24-9-6-20(18-35-24)36-27(40)19-5-10-26(42-30(32,33)34)25(17-19)37-28(41)29(11-12-29)39-15-13-38(14-16-39)21-7-8-21/h1-6,9-10,17-18,21H,7-8,11-16H2,(H,36,40)(H,37,41) LZIDJDMKKTZXMT-UHFFFAOYSA-N 300497 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 67 Protein Wnt-3a Human 29.6 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300497&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292057 381749278 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575046 O=C(Nc2ccc(c1ccccc1F)nc2)c6ccc(OC(F)(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C30H29F4N5O3/c31-23-4-2-1-3-22(23)24-9-6-20(18-35-24)36-27(40)19-5-10-26(42-30(32,33)34)25(17-19)37-28(41)29(11-12-29)39-15-13-38(14-16-39)21-7-8-21/h1-6,9-10,17-18,21H,7-8,11-16H2,(H,36,40)(H,37,41) LZIDJDMKKTZXMT-UHFFFAOYSA-N 300497 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 67 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300497&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292057 381749278 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575047 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H24F4N4O4/c28-20-4-2-1-3-19(20)21-7-6-18(16-32-21)33-24(36)17-5-8-23(39-27(29,30)31)22(15-17)34-25(37)26(9-10-26)35-11-13-38-14-12-35/h1-8,15-16H,9-14H2,(H,33,36)(H,34,37) CWKJBWOIRXMPCC-UHFFFAOYSA-N 300498 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 68 Protein Wnt-3a Human 7.72 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300498&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292058 381749279 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575048 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H24F4N4O4/c28-20-4-2-1-3-19(20)21-7-6-18(16-32-21)33-24(36)17-5-8-23(39-27(29,30)31)22(15-17)34-25(37)26(9-10-26)35-11-13-38-14-12-35/h1-8,15-16H,9-14H2,(H,33,36)(H,34,37) CWKJBWOIRXMPCC-UHFFFAOYSA-N 300498 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 68 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300498&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292058 381749279 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575049 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-18(5-8-23(22)38-26(28,29)30)25(36)32-20-6-7-21(31-15-20)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) CPGGPSNHWZNRFF-UHFFFAOYSA-N 300499 N-[6-(3-fluorophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 69 Protein Wnt-3a Human 14.8 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300499&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292059 381749280 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575050 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-18(5-8-23(22)38-26(28,29)30)25(36)32-20-6-7-21(31-15-20)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) CPGGPSNHWZNRFF-UHFFFAOYSA-N 300499 N-[6-(3-fluorophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 69 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300499&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292059 381749280 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575051 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-18(5-10-25(24)40-28(30,31)32)27(38)34-20-6-9-23(33-13-20)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) XTYSNFAOAGFDBE-UHFFFAOYSA-N 300500 N-[6-(3-fluorophenyl)pyridin-3-yl]-3-{[2-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 70 Protein Wnt-3a Human 24.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300500&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292060 381749281 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575052 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-18(5-10-25(24)40-28(30,31)32)27(38)34-20-6-9-23(33-13-20)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) XTYSNFAOAGFDBE-UHFFFAOYSA-N 300500 N-[6-(3-fluorophenyl)pyridin-3-yl]-3-{[2-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 70 Protein Wnt-3a Human 4600 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300500&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292060 381749281 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575053 O=C(Nc2ccc(c1cc(F)cc(F)c1)nc2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H23F5N4O4/c28-18-11-17(12-19(29)14-18)21-3-2-20(15-33-21)34-24(37)16-1-4-23(40-27(30,31)32)22(13-16)35-25(38)26(5-6-26)36-7-9-39-10-8-36/h1-4,11-15H,5-10H2,(H,34,37)(H,35,38) MLVCMJLSFJONIA-UHFFFAOYSA-N 300501 N-[6-(3,5-difluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 71 Protein Wnt-3a Human 29.2 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300501&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292247 381749282 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575054 O=C(Nc2ccc(c1cc(F)cc(F)c1)nc2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H23F5N4O4/c28-18-11-17(12-19(29)14-18)21-3-2-20(15-33-21)34-24(37)16-1-4-23(40-27(30,31)32)22(13-16)35-25(38)26(5-6-26)36-7-9-39-10-8-36/h1-4,11-15H,5-10H2,(H,34,37)(H,35,38) MLVCMJLSFJONIA-UHFFFAOYSA-N 300501 N-[6-(3,5-difluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 71 Protein Wnt-3a Human 45000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300501&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292247 381749282 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575055 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2cc(F)cc(F)c2)nc3)ccc4OC(F)(F)F InChI=1S/C25H21F5N4O4/c26-17-9-16(10-18(27)12-17)20-3-2-19(13-31-20)32-24(36)15-1-4-22(38-25(28,29)30)21(11-15)33-23(35)14-34-5-7-37-8-6-34/h1-4,9-13H,5-8,14H2,(H,32,36)(H,33,35) IYUPRDIKQBFHNY-UHFFFAOYSA-N 300502 N-[6-(3,5-difluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 72 Protein Wnt-3a Human 106 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300502&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292248 381749283 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575056 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2cc(F)cc(F)c2)nc3)ccc4OC(F)(F)F InChI=1S/C25H21F5N4O4/c26-17-9-16(10-18(27)12-17)20-3-2-19(13-31-20)32-24(36)15-1-4-22(38-25(28,29)30)21(11-15)33-23(35)14-34-5-7-37-8-6-34/h1-4,9-13H,5-8,14H2,(H,32,36)(H,33,35) IYUPRDIKQBFHNY-UHFFFAOYSA-N 300502 N-[6-(3,5-difluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 72 Protein Wnt-3a Human 8000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300502&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292248 381749283 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575057 O=C(CN1CC2CCC(C1)O2)Nc5cc(C(=O)Nc4ccc(c3cc(F)cc(F)c3)nc4)ccc5OC(F)(F)F InChI=1S/C27H23F5N4O4/c28-17-7-16(8-18(29)10-17)22-5-2-19(11-33-22)34-26(38)15-1-6-24(40-27(30,31)32)23(9-15)35-25(37)14-36-12-20-3-4-21(13-36)39-20/h1-2,5-11,20-21H,3-4,12-14H2,(H,34,38)(H,35,37) XEOZOQLXPLVFIL-UHFFFAOYSA-N 300503 N-[6-(3,5-difluorophenyl)pyridin-3-yl]-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 73 Protein Wnt-3a Human 98.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300503&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292249 381749284 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575058 O=C(CN1CC2CCC(C1)O2)Nc5cc(C(=O)Nc4ccc(c3cc(F)cc(F)c3)nc4)ccc5OC(F)(F)F InChI=1S/C27H23F5N4O4/c28-17-7-16(8-18(29)10-17)22-5-2-19(11-33-22)34-26(38)15-1-6-24(40-27(30,31)32)23(9-15)35-25(37)14-36-12-20-3-4-21(13-36)39-20/h1-2,5-11,20-21H,3-4,12-14H2,(H,34,38)(H,35,37) XEOZOQLXPLVFIL-UHFFFAOYSA-N 300503 N-[6-(3,5-difluorophenyl)pyridin-3-yl]-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 73 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300503&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292249 381749284 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575059 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4C(F)(F)F InChI=1S/C25H22F4N4O3/c26-20-4-2-1-3-18(20)21-8-6-17(14-30-21)31-24(35)16-5-7-19(25(27,28)29)22(13-16)32-23(34)15-33-9-11-36-12-10-33/h1-8,13-14H,9-12,15H2,(H,31,35)(H,32,34) XPFYDOVEAXXSQB-UHFFFAOYSA-N 300504 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethyl)benzamide::US10130633, Example 74 Protein Wnt-3a Human 85.8 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300504&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292250 381749285 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575060 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4C(F)(F)F InChI=1S/C25H22F4N4O3/c26-20-4-2-1-3-18(20)21-8-6-17(14-30-21)31-24(35)16-5-7-19(25(27,28)29)22(13-16)32-23(34)15-33-9-11-36-12-10-33/h1-8,13-14H,9-12,15H2,(H,31,35)(H,32,34) XPFYDOVEAXXSQB-UHFFFAOYSA-N 300504 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethyl)benzamide::US10130633, Example 74 Protein Wnt-3a Human 42200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300504&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292250 381749285 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575061 NC(=O)c3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H26FN5O4/c28-21-4-2-1-3-19(21)22-8-6-18(16-30-22)31-25(35)17-5-7-20(24(29)34)23(15-17)32-26(36)27(9-10-27)33-11-13-37-14-12-33/h1-8,15-16H,9-14H2,(H2,29,34)(H,31,35)(H,32,36) LSZLMEPWOXYMJR-UHFFFAOYSA-N 300505 N4-[6-(2-fluorophenyl)pyridin-3-yl]-2-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)terephthalamide::US10130633, Example 75 Protein Wnt-3a Human 18.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300505&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608465 381749286 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575062 NC(=O)c3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H26FN5O4/c28-21-4-2-1-3-19(21)22-8-6-18(16-30-22)31-25(35)17-5-7-20(24(29)34)23(15-17)32-26(36)27(9-10-27)33-11-13-37-14-12-33/h1-8,15-16H,9-14H2,(H2,29,34)(H,31,35)(H,32,36) LSZLMEPWOXYMJR-UHFFFAOYSA-N 300505 N4-[6-(2-fluorophenyl)pyridin-3-yl]-2-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)terephthalamide::US10130633, Example 75 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300505&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608465 381749286 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575063 Cc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H27FN4O3/c1-18-6-7-19(16-24(18)31-26(34)27(10-11-27)32-12-14-35-15-13-32)25(33)30-20-8-9-23(29-17-20)21-4-2-3-5-22(21)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) UHDJRDQGPOCDFM-UHFFFAOYSA-N 300506 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methyl-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 76 Protein Wnt-3a Human 31.4 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300506&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292251 381749287 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575064 Cc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H27FN4O3/c1-18-6-7-19(16-24(18)31-26(34)27(10-11-27)32-12-14-35-15-13-32)25(33)30-20-8-9-23(29-17-20)21-4-2-3-5-22(21)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) UHDJRDQGPOCDFM-UHFFFAOYSA-N 300506 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methyl-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 76 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300506&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292251 381749287 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575065 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C26H24F2N4O3/c27-20-4-2-1-3-19(20)22-8-6-18(16-29-22)30-24(33)17-5-7-21(28)23(15-17)31-25(34)26(9-10-26)32-11-13-35-14-12-32/h1-8,15-16H,9-14H2,(H,30,33)(H,31,34) XZGSUUWTOBZRPM-UHFFFAOYSA-N 300507 4-fluoro-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 77 Protein Wnt-3a Human 370 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300507&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292439 381749288 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575066 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C26H24F2N4O3/c27-20-4-2-1-3-19(20)22-8-6-18(16-29-22)30-24(33)17-5-7-21(28)23(15-17)31-25(34)26(9-10-26)32-11-13-35-14-12-32/h1-8,15-16H,9-14H2,(H,30,33)(H,31,34) XZGSUUWTOBZRPM-UHFFFAOYSA-N 300507 4-fluoro-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 77 Protein Wnt-3a Human 14000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300507&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292439 381749288 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575067 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C23H22FN5O3S/c24-17-7-6-16(19(30)26-22-28-27-20(33-22)15-4-2-1-3-5-15)14-18(17)25-21(31)23(8-9-23)29-10-12-32-13-11-29/h1-7,14H,8-13H2,(H,25,31)(H,26,28,30) YYTSGFNHMTVHOY-UHFFFAOYSA-N 300508 4-fluoro-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 78 Protein Wnt-3a Human 508 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300508&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292440 381749289 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575068 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C23H22FN5O3S/c24-17-7-6-16(19(30)26-22-28-27-20(33-22)15-4-2-1-3-5-15)14-18(17)25-21(31)23(8-9-23)29-10-12-32-13-11-29/h1-7,14H,8-13H2,(H,25,31)(H,26,28,30) YYTSGFNHMTVHOY-UHFFFAOYSA-N 300508 4-fluoro-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 78 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300508&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292440 381749289 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575069 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(Cl)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C26H24ClFN4O3/c27-20-7-5-17(15-23(20)31-25(34)26(9-10-26)32-11-13-35-14-12-32)24(33)30-18-6-8-22(29-16-18)19-3-1-2-4-21(19)28/h1-8,15-16H,9-14H2,(H,30,33)(H,31,34) PYKWRQILRWMKNC-UHFFFAOYSA-N 300509 4-chloro-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 79 Protein Wnt-3a Human 20.4 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300509&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292441 381749290 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575070 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(Cl)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C26H24ClFN4O3/c27-20-7-5-17(15-23(20)31-25(34)26(9-10-26)32-11-13-35-14-12-32)24(33)30-18-6-8-22(29-16-18)19-3-1-2-4-21(19)28/h1-8,15-16H,9-14H2,(H,30,33)(H,31,34) PYKWRQILRWMKNC-UHFFFAOYSA-N 300509 4-chloro-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 79 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300509&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292441 381749290 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575071 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H27FN4O4/c1-35-24-9-6-18(16-23(24)31-26(34)27(10-11-27)32-12-14-36-15-13-32)25(33)30-19-7-8-22(29-17-19)20-4-2-3-5-21(20)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) OYXSUAHLPHEGQU-UHFFFAOYSA-N 300510 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 80 Protein Wnt-3a Human 27.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300510&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292442 381749291 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575072 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H27FN4O4/c1-35-24-9-6-18(16-23(24)31-26(34)27(10-11-27)32-12-14-36-15-13-32)25(33)30-19-7-8-22(29-17-19)20-4-2-3-5-21(20)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) OYXSUAHLPHEGQU-UHFFFAOYSA-N 300510 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 80 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300510&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292442 381749291 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575073 COc3ccc(C(=O)Nc2ccc(c1ccccc1)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H28N4O4/c1-34-24-10-7-20(17-23(24)30-26(33)27(11-12-27)31-13-15-35-16-14-31)25(32)29-21-8-9-22(28-18-21)19-5-3-2-4-6-19/h2-10,17-18H,11-16H2,1H3,(H,29,32)(H,30,33) PLWUISXQMGAZMN-UHFFFAOYSA-N 300511 4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(6-phenylpyridin-3-yl)benzamide::US10130633, Example 81 Protein Wnt-3a Human 23.1 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300511&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292443 381749292 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575074 COc3ccc(C(=O)Nc2ccc(c1ccccc1)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H28N4O4/c1-34-24-10-7-20(17-23(24)30-26(33)27(11-12-27)31-13-15-35-16-14-31)25(32)29-21-8-9-22(28-18-21)19-5-3-2-4-6-19/h2-10,17-18H,11-16H2,1H3,(H,29,32)(H,30,33) PLWUISXQMGAZMN-UHFFFAOYSA-N 300511 4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(6-phenylpyridin-3-yl)benzamide::US10130633, Example 81 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300511&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292443 381749292 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575075 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CCC5 InChI=1S/C28H29FN4O4/c1-36-25-10-7-19(17-24(25)32-27(35)28(11-4-12-28)33-13-15-37-16-14-33)26(34)31-20-8-9-23(30-18-20)21-5-2-3-6-22(21)29/h2-3,5-10,17-18H,4,11-16H2,1H3,(H,31,34)(H,32,35) MZPKBIWWNAZZBB-UHFFFAOYSA-N 300512 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-({[1-(morpholin-4-yl)cyclobutyl]carbonyl}amino)benzamide::US10130633, Example 82 Protein Wnt-3a Human 2550 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300512&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292639 381749293 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575076 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CCC5 InChI=1S/C28H29FN4O4/c1-36-25-10-7-19(17-24(25)32-27(35)28(11-4-12-28)33-13-15-37-16-14-33)26(34)31-20-8-9-23(30-18-20)21-5-2-3-6-22(21)29/h2-3,5-10,17-18H,4,11-16H2,1H3,(H,31,34)(H,32,35) MZPKBIWWNAZZBB-UHFFFAOYSA-N 300512 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-({[1-(morpholin-4-yl)cyclobutyl]carbonyl}amino)benzamide::US10130633, Example 82 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300512&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292639 381749293 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575077 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C23H25N5O4S/c1-31-15-18-8-7-17(13-19(18)24-20(29)14-28-9-11-32-12-10-28)21(30)25-23-27-26-22(33-23)16-5-3-2-4-6-16/h2-8,13H,9-12,14-15H2,1H3,(H,24,29)(H,25,27,30) FROHSVALPKCMOM-UHFFFAOYSA-N 300513 4-(methoxymethyl)-3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 83 Protein Wnt-3a Human 515 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300513&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292640 381749294 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575078 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C23H25N5O4S/c1-31-15-18-8-7-17(13-19(18)24-20(29)14-28-9-11-32-12-10-28)21(30)25-23-27-26-22(33-23)16-5-3-2-4-6-16/h2-8,13H,9-12,14-15H2,1H3,(H,24,29)(H,25,27,30) FROHSVALPKCMOM-UHFFFAOYSA-N 300513 4-(methoxymethyl)-3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 83 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300513&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292640 381749294 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575079 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN5CCN(C4CC4)CC5 InChI=1S/C26H30N6O3S/c1-35-17-20-8-7-19(24(34)28-26-30-29-25(36-26)18-5-3-2-4-6-18)15-22(20)27-23(33)16-31-11-13-32(14-12-31)21-9-10-21/h2-8,15,21H,9-14,16-17H2,1H3,(H,27,33)(H,28,30,34) PBESRUKRYUWGCB-UHFFFAOYSA-N 300514 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-4-(methoxymethyl)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 84 Protein Wnt-3a Human 453 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300514&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292641 381749295 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575080 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN5CCN(C4CC4)CC5 InChI=1S/C26H30N6O3S/c1-35-17-20-8-7-19(24(34)28-26-30-29-25(36-26)18-5-3-2-4-6-18)15-22(20)27-23(33)16-31-11-13-32(14-12-31)21-9-10-21/h2-8,15,21H,9-14,16-17H2,1H3,(H,27,33)(H,28,30,34) PBESRUKRYUWGCB-UHFFFAOYSA-N 300514 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-4-(methoxymethyl)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 84 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300514&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292641 381749295 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575081 COCCN(C)CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F InChI=1S/C22H22F3N5O4S/c1-30(10-11-33-2)13-18(31)26-16-12-15(8-9-17(16)34-22(23,24)25)19(32)27-21-29-28-20(35-21)14-6-4-3-5-7-14/h3-9,12H,10-11,13H2,1-2H3,(H,26,31)(H,27,29,32) VSMGPLDKOKDHHN-UHFFFAOYSA-N 300515 3-{[N-(2-methoxyethyl)-N-methylglycyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 85 Protein Wnt-3a Human 150 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300515&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292642 381749296 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575082 COCCN(C)CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F InChI=1S/C22H22F3N5O4S/c1-30(10-11-33-2)13-18(31)26-16-12-15(8-9-17(16)34-22(23,24)25)19(32)27-21-29-28-20(35-21)14-6-4-3-5-7-14/h3-9,12H,10-11,13H2,1-2H3,(H,26,31)(H,27,29,32) VSMGPLDKOKDHHN-UHFFFAOYSA-N 300515 3-{[N-(2-methoxyethyl)-N-methylglycyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 85 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300515&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292642 381749296 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575083 FC(F)Oc1ccc(cc1NC(=O)CN1CC2CCC(C1)O2)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C24H23F2N5O4S/c25-23(26)35-19-9-6-15(21(33)28-24-30-29-22(36-24)14-4-2-1-3-5-14)10-18(19)27-20(32)13-31-11-16-7-8-17(12-31)34-16/h1-6,9-10,16-17,23H,7-8,11-13H2,(H,27,32)(H,28,30,33) FQBKQLAPHQIKOU-UHFFFAOYSA-N 300516 4-(difluoromethoxy)-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 86 Protein Wnt-3a Human 890 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300516&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292643 381749297 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575084 FC(F)Oc1ccc(cc1NC(=O)CN1CC2CCC(C1)O2)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C24H23F2N5O4S/c25-23(26)35-19-9-6-15(21(33)28-24-30-29-22(36-24)14-4-2-1-3-5-14)10-18(19)27-20(32)13-31-11-16-7-8-17(12-31)34-16/h1-6,9-10,16-17,23H,7-8,11-13H2,(H,27,32)(H,28,30,33) FQBKQLAPHQIKOU-UHFFFAOYSA-N 300516 4-(difluoromethoxy)-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 86 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300516&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292643 381749297 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575085 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)N4CCOCC4 InChI=1S/C24H27N5O5S2/c1-16(29-10-12-34-13-11-29)21(30)25-20-14-18(8-9-19(20)15-36(2,32)33)22(31)26-24-28-27-23(35-24)17-6-4-3-5-7-17/h3-9,14,16H,10-13,15H2,1-2H3,(H,25,30)(H,26,28,31) LEXYYYQSYQYHHY-UHFFFAOYSA-N 300517 4-[(methylsulfonyl)methyl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 87 Protein Wnt-3a Human 858 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300517&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292833 381749298 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575086 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)N4CCOCC4 InChI=1S/C24H27N5O5S2/c1-16(29-10-12-34-13-11-29)21(30)25-20-14-18(8-9-19(20)15-36(2,32)33)22(31)26-24-28-27-23(35-24)17-6-4-3-5-7-17/h3-9,14,16H,10-13,15H2,1-2H3,(H,25,30)(H,26,28,31) LEXYYYQSYQYHHY-UHFFFAOYSA-N 300517 4-[(methylsulfonyl)methyl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 87 Protein Wnt-3a Human 48000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300517&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292833 381749298 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575087 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)N4CCN(C)CC4 InChI=1S/C25H30N6O4S2/c1-17(31-13-11-30(2)12-14-31)22(32)26-21-15-19(9-10-20(21)16-37(3,34)35)23(33)27-25-29-28-24(36-25)18-7-5-4-6-8-18/h4-10,15,17H,11-14,16H2,1-3H3,(H,26,32)(H,27,29,33) TUXONIDNAJFNRA-UHFFFAOYSA-N 300518 3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 88 Protein Wnt-3a Human 417 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300518&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292834 381749299 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575088 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)N4CCN(C)CC4 InChI=1S/C25H30N6O4S2/c1-17(31-13-11-30(2)12-14-31)22(32)26-21-15-19(9-10-20(21)16-37(3,34)35)23(33)27-25-29-28-24(36-25)18-7-5-4-6-8-18/h4-10,15,17H,11-14,16H2,1-3H3,(H,26,32)(H,27,29,33) TUXONIDNAJFNRA-UHFFFAOYSA-N 300518 3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 88 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300518&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292834 381749299 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575089 O=C(Nc2nnc(c1ccccc1F)s2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H21F4N5O4S/c25-16-4-2-1-3-15(16)20-31-32-22(38-20)30-19(34)14-5-6-18(37-24(26,27)28)17(13-14)29-21(35)23(7-8-23)33-9-11-36-12-10-33/h1-6,13H,7-12H2,(H,29,35)(H,30,32,34) UIRJNEQFJAASIK-UHFFFAOYSA-N 300519 N-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 89 Protein Wnt-3a Human 216 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300519&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292835 381749300 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575090 O=C(Nc2nnc(c1ccccc1F)s2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H21F4N5O4S/c25-16-4-2-1-3-15(16)20-31-32-22(38-20)30-19(34)14-5-6-18(37-24(26,27)28)17(13-14)29-21(35)23(7-8-23)33-9-11-36-12-10-33/h1-6,13H,7-12H2,(H,29,35)(H,30,32,34) UIRJNEQFJAASIK-UHFFFAOYSA-N 300519 N-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 89 Protein Wnt-3a Human 44000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300519&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292835 381749300 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575091 O=C(Nc2nnc(c1ccc(F)cc1)s2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H21F4N5O4S/c25-16-4-1-14(2-5-16)20-31-32-22(38-20)30-19(34)15-3-6-18(37-24(26,27)28)17(13-15)29-21(35)23(7-8-23)33-9-11-36-12-10-33/h1-6,13H,7-12H2,(H,29,35)(H,30,32,34) JZCVROXKWLZHAE-UHFFFAOYSA-N 300520 N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 90 Protein Wnt-3a Human 173 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300520&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292836 381749301 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575092 O=C(Nc2nnc(c1ccc(F)cc1)s2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H21F4N5O4S/c25-16-4-1-14(2-5-16)20-31-32-22(38-20)30-19(34)15-3-6-18(37-24(26,27)28)17(13-15)29-21(35)23(7-8-23)33-9-11-36-12-10-33/h1-6,13H,7-12H2,(H,29,35)(H,30,32,34) JZCVROXKWLZHAE-UHFFFAOYSA-N 300520 N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 90 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300520&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292836 381749301 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575093 COc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C23H26N6O3S/c1-28-10-12-29(13-11-28)15-20(30)24-18-14-17(8-9-19(18)32-2)21(31)25-23-27-26-22(33-23)16-6-4-3-5-7-16/h3-9,14H,10-13,15H2,1-2H3,(H,24,30)(H,25,27,31) OARWIDXZGSNKBM-UHFFFAOYSA-N 300521 4-methoxy-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 91 Protein Wnt-3a Human 650 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300521&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292837 381749302 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575094 COc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C23H26N6O3S/c1-28-10-12-29(13-11-28)15-20(30)24-18-14-17(8-9-19(18)32-2)21(31)25-23-27-26-22(33-23)16-6-4-3-5-7-16/h3-9,14H,10-13,15H2,1-2H3,(H,24,30)(H,25,27,31) OARWIDXZGSNKBM-UHFFFAOYSA-N 300521 4-methoxy-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 91 Protein Wnt-3a Human 44000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300521&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292837 381749302 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575095 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OCc3ccccc3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C30H29N5O4S/c36-26(32-29-34-33-27(40-29)22-9-5-2-6-10-22)23-11-12-25(39-20-21-7-3-1-4-8-21)24(19-23)31-28(37)30(13-14-30)35-15-17-38-18-16-35/h1-12,19H,13-18,20H2,(H,31,37)(H,32,34,36) HMYGTSNBLQXQMG-UHFFFAOYSA-N 300522 4-(benzyloxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 92 Protein Wnt-3a Human 360 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300522&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293022 381749303 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575096 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OCc3ccccc3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C30H29N5O4S/c36-26(32-29-34-33-27(40-29)22-9-5-2-6-10-22)23-11-12-25(39-20-21-7-3-1-4-8-21)24(19-23)31-28(37)30(13-14-30)35-15-17-38-18-16-35/h1-12,19H,13-18,20H2,(H,31,37)(H,32,34,36) HMYGTSNBLQXQMG-UHFFFAOYSA-N 300522 4-(benzyloxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 92 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300522&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293022 381749303 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575097 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(O)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C23H23N5O4S/c29-18-7-6-16(19(30)25-22-27-26-20(33-22)15-4-2-1-3-5-15)14-17(18)24-21(31)23(8-9-23)28-10-12-32-13-11-28/h1-7,14,29H,8-13H2,(H,24,31)(H,25,27,30) WSKTTZMMHNBICS-UHFFFAOYSA-N 300523 4-hydroxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 93 Protein Wnt-3a Human 240 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300523&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293023 381749304 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575098 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(O)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C23H23N5O4S/c29-18-7-6-16(19(30)25-22-27-26-20(33-22)15-4-2-1-3-5-15)14-17(18)24-21(31)23(8-9-23)28-10-12-32-13-11-28/h1-7,14,29H,8-13H2,(H,24,31)(H,25,27,30) WSKTTZMMHNBICS-UHFFFAOYSA-N 300523 4-hydroxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 93 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300523&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293023 381749304 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575099 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3Br)CC4 InChI=1S/C22H23BrN6O2S/c1-28-9-11-29(12-10-28)14-19(30)24-18-13-16(7-8-17(18)23)20(31)25-22-27-26-21(32-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,24,30)(H,25,27,31) XDZRJIUHBAORHK-UHFFFAOYSA-N 300524 4-bromo-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 94 Protein Wnt-3a Human 433 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300524&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293024 381749305 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575100 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3Br)CC4 InChI=1S/C22H23BrN6O2S/c1-28-9-11-29(12-10-28)14-19(30)24-18-13-16(7-8-17(18)23)20(31)25-22-27-26-21(32-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,24,30)(H,25,27,31) XDZRJIUHBAORHK-UHFFFAOYSA-N 300524 4-bromo-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 94 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300524&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293024 381749305 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575101 O=C(Nc2ccc(c1ccccc1)cn2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H25F3N4O4/c28-27(29,30)38-22-8-6-19(16-21(22)32-25(36)26(10-11-26)34-12-14-37-15-13-34)24(35)33-23-9-7-20(17-31-23)18-4-2-1-3-5-18/h1-9,16-17H,10-15H2,(H,32,36)(H,31,33,35) MCDAQFFHHGMCAQ-UHFFFAOYSA-N 300525 3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 95 Protein Wnt-3a Human 58.1 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300525&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459673 381749306 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575102 O=C(Nc2ccc(c1ccccc1)cn2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H25F3N4O4/c28-27(29,30)38-22-8-6-19(16-21(22)32-25(36)26(10-11-26)34-12-14-37-15-13-34)24(35)33-23-9-7-20(17-31-23)18-4-2-1-3-5-18/h1-9,16-17H,10-15H2,(H,32,36)(H,31,33,35) MCDAQFFHHGMCAQ-UHFFFAOYSA-N 300525 3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 95 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300525&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459673 381749306 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575103 Cc4cccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCOCC1)c2)s3)c4 InChI=1S/C23H22F3N5O4S/c1-14-3-2-4-16(11-14)21-29-30-22(36-21)28-20(33)15-5-6-18(35-23(24,25)26)17(12-15)27-19(32)13-31-7-9-34-10-8-31/h2-6,11-12H,7-10,13H2,1H3,(H,27,32)(H,28,30,33) RPHHRJDPNDVVQC-UHFFFAOYSA-N 300526 N-[5-(3-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 96 Protein Wnt-3a Human 855 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300526&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462109 381749307 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575104 Cc4cccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCOCC1)c2)s3)c4 InChI=1S/C23H22F3N5O4S/c1-14-3-2-4-16(11-14)21-29-30-22(36-21)28-20(33)15-5-6-18(35-23(24,25)26)17(12-15)27-19(32)13-31-7-9-34-10-8-31/h2-6,11-12H,7-10,13H2,1H3,(H,27,32)(H,28,30,33) RPHHRJDPNDVVQC-UHFFFAOYSA-N 300526 N-[5-(3-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 96 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300526&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462109 381749307 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575105 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccc([N+](=O)[O-])cc2)s3)ccc4OC(F)(F)F InChI=1S/C22H19F3N6O6S/c23-22(24,25)37-17-6-3-14(11-16(17)26-18(32)12-30-7-9-36-10-8-30)19(33)27-21-29-28-20(38-21)13-1-4-15(5-2-13)31(34)35/h1-6,11H,7-10,12H2,(H,26,32)(H,27,29,33) HAXREAGPNGBQTL-UHFFFAOYSA-N 300527 3-[(morpholin-4-ylacetyl)amino]-N-[5-(4-nitrophenyl)-1,3,4-thiadiazol-2-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 97 Protein Wnt-3a Human 1930 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300527&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462570 381749308 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575106 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccc([N+](=O)[O-])cc2)s3)ccc4OC(F)(F)F InChI=1S/C22H19F3N6O6S/c23-22(24,25)37-17-6-3-14(11-16(17)26-18(32)12-30-7-9-36-10-8-30)19(33)27-21-29-28-20(38-21)13-1-4-15(5-2-13)31(34)35/h1-6,11H,7-10,12H2,(H,26,32)(H,27,29,33) HAXREAGPNGBQTL-UHFFFAOYSA-N 300527 3-[(morpholin-4-ylacetyl)amino]-N-[5-(4-nitrophenyl)-1,3,4-thiadiazol-2-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 97 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300527&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462570 381749308 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575107 Cc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c3)s4 InChI=1S/C23H22F3N5O4S/c1-14-4-2-3-5-16(14)21-29-30-22(36-21)28-20(33)15-6-7-18(35-23(24,25)26)17(12-15)27-19(32)13-31-8-10-34-11-9-31/h2-7,12H,8-11,13H2,1H3,(H,27,32)(H,28,30,33) HXHDDLGXGUELFX-UHFFFAOYSA-N 300528 N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 98 Protein Wnt-3a Human 87.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300528&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462184 381749309 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575108 Cc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c3)s4 InChI=1S/C23H22F3N5O4S/c1-14-4-2-3-5-16(14)21-29-30-22(36-21)28-20(33)15-6-7-18(35-23(24,25)26)17(12-15)27-19(32)13-31-8-10-34-11-9-31/h2-7,12H,8-11,13H2,1H3,(H,27,32)(H,28,30,33) HXHDDLGXGUELFX-UHFFFAOYSA-N 300528 N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 98 Protein Wnt-3a Human 26400 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300528&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462184 381749309 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575109 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccc(F)cc2)s3)ccc4OC(F)(F)F InChI=1S/C22H19F4N5O4S/c23-15-4-1-13(2-5-15)20-29-30-21(36-20)28-19(33)14-3-6-17(35-22(24,25)26)16(11-14)27-18(32)12-31-7-9-34-10-8-31/h1-6,11H,7-10,12H2,(H,27,32)(H,28,30,33) FFTZNHQHLAIZGC-UHFFFAOYSA-N 300529 N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 99 Protein Wnt-3a Human 935 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300529&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293025 381749310 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575110 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccc(F)cc2)s3)ccc4OC(F)(F)F InChI=1S/C22H19F4N5O4S/c23-15-4-1-13(2-5-15)20-29-30-21(36-20)28-19(33)14-3-6-17(35-22(24,25)26)16(11-14)27-18(32)12-31-7-9-34-10-8-31/h1-6,11H,7-10,12H2,(H,27,32)(H,28,30,33) FFTZNHQHLAIZGC-UHFFFAOYSA-N 300529 N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 99 Protein Wnt-3a Human 9300 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300529&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293025 381749310 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575111 O=C(CN1CCN(CC(F)F)CC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C27H25F6N5O3/c28-20-4-2-1-3-19(20)21-7-6-18(14-34-21)35-26(40)17-5-8-23(41-27(31,32)33)22(13-17)36-25(39)16-38-11-9-37(10-12-38)15-24(29)30/h1-8,13-14,24H,9-12,15-16H2,(H,35,40)(H,36,39) XNEZKBMOWBLDCT-UHFFFAOYSA-N 300530 3-({[4-(2,2-difluoroethyl)piperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 100 Protein Wnt-3a Human 858 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300530&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293026 381749311 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575112 O=C(CN1CCN(CC(F)F)CC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C27H25F6N5O3/c28-20-4-2-1-3-19(20)21-7-6-18(14-34-21)35-26(40)17-5-8-23(41-27(31,32)33)22(13-17)36-25(39)16-38-11-9-37(10-12-38)15-24(29)30/h1-8,13-14,24H,9-12,15-16H2,(H,35,40)(H,36,39) XNEZKBMOWBLDCT-UHFFFAOYSA-N 300530 3-({[4-(2,2-difluoroethyl)piperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 100 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300530&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293026 381749311 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575113 COc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)(F)F)c(NC(=O)CN2CCN(C)CC2)c3)s4 InChI=1S/C24H25F3N6O4S/c1-32-9-11-33(12-10-32)14-20(34)28-17-13-15(7-8-19(17)37-24(25,26)27)21(35)29-23-31-30-22(38-23)16-5-3-4-6-18(16)36-2/h3-8,13H,9-12,14H2,1-2H3,(H,28,34)(H,29,31,35) RWRQUCFBSJAFDC-UHFFFAOYSA-N 300531 N-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 101 Protein Wnt-3a Human 3200 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300531&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293214 381749312 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575114 COc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)(F)F)c(NC(=O)CN2CCN(C)CC2)c3)s4 InChI=1S/C24H25F3N6O4S/c1-32-9-11-33(12-10-32)14-20(34)28-17-13-15(7-8-19(17)37-24(25,26)27)21(35)29-23-31-30-22(38-23)16-5-3-4-6-18(16)36-2/h3-8,13H,9-12,14H2,1-2H3,(H,28,34)(H,29,31,35) RWRQUCFBSJAFDC-UHFFFAOYSA-N 300531 N-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 101 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300531&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293214 381749312 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575115 Cc4ccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCN(C)CC1)c2)s3)cc4 InChI=1S/C24H25F3N6O3S/c1-15-3-5-16(6-4-15)22-30-31-23(37-22)29-21(35)17-7-8-19(36-24(25,26)27)18(13-17)28-20(34)14-33-11-9-32(2)10-12-33/h3-8,13H,9-12,14H2,1-2H3,(H,28,34)(H,29,31,35) CHILFIOFPBIWTA-UHFFFAOYSA-N 300532 N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 102 Protein Wnt-3a Human 458 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300532&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293215 381749313 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575116 Cc4ccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCN(C)CC1)c2)s3)cc4 InChI=1S/C24H25F3N6O3S/c1-15-3-5-16(6-4-15)22-30-31-23(37-22)29-21(35)17-7-8-19(36-24(25,26)27)18(13-17)28-20(34)14-33-11-9-32(2)10-12-33/h3-8,13H,9-12,14H2,1-2H3,(H,28,34)(H,29,31,35) CHILFIOFPBIWTA-UHFFFAOYSA-N 300532 N-[5-(4-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 102 Protein Wnt-3a Human 19500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300532&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293215 381749313 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575117 Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C24H25N5O3S/c1-16-7-8-18(20(30)26-23-28-27-21(33-23)17-5-3-2-4-6-17)15-19(16)25-22(31)24(9-10-24)29-11-13-32-14-12-29/h2-8,15H,9-14H2,1H3,(H,25,31)(H,26,28,30) MKPGFZUPYDOWEM-UHFFFAOYSA-N 300533 4-methyl-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 103 Protein Wnt-3a Human 752 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300533&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293216 381749314 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575118 Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C24H25N5O3S/c1-16-7-8-18(20(30)26-23-28-27-21(33-23)17-5-3-2-4-6-17)15-19(16)25-22(31)24(9-10-24)29-11-13-32-14-12-29/h2-8,15H,9-14H2,1H3,(H,25,31)(H,26,28,30) MKPGFZUPYDOWEM-UHFFFAOYSA-N 300533 4-methyl-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 103 Protein Wnt-3a Human 21000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300533&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293216 381749314 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575119 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)CC4 InChI=1S/C24H28N6O4S2/c1-29-10-12-30(13-11-29)15-21(31)25-20-14-18(8-9-19(20)16-36(2,33)34)22(32)26-24-28-27-23(35-24)17-6-4-3-5-7-17/h3-9,14H,10-13,15-16H2,1-2H3,(H,25,31)(H,26,28,32) LAGOEPIRJRQLBQ-UHFFFAOYSA-N 300534 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 104 Protein Wnt-3a Human 2030 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300534&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462214 381749315 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575120 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)CC4 InChI=1S/C24H28N6O4S2/c1-29-10-12-30(13-11-29)15-21(31)25-20-14-18(8-9-19(20)16-36(2,33)34)22(32)26-24-28-27-23(35-24)17-6-4-3-5-7-17/h3-9,14H,10-13,15-16H2,1-2H3,(H,25,31)(H,26,28,32) LAGOEPIRJRQLBQ-UHFFFAOYSA-N 300534 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 104 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300534&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462214 381749315 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575121 COC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C24H26N6O4S/c1-29-10-12-30(13-11-29)15-20(31)25-19-14-17(8-9-18(19)23(33)34-2)21(32)26-24-28-27-22(35-24)16-6-4-3-5-7-16/h3-9,14H,10-13,15H2,1-2H3,(H,25,31)(H,26,28,32) XMSVDRORLCIVKG-UHFFFAOYSA-N 300535 methyl 2-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-[(5-phenyl-1,3,4-thiadiazol-2-yl)carbamoyl]benzoate::US10130633, Example 105 Protein Wnt-3a Human 64.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300535&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462207 381749316 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575122 COC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C24H26N6O4S/c1-29-10-12-30(13-11-29)15-20(31)25-19-14-17(8-9-18(19)23(33)34-2)21(32)26-24-28-27-22(35-24)16-6-4-3-5-7-16/h3-9,14H,10-13,15H2,1-2H3,(H,25,31)(H,26,28,32) XMSVDRORLCIVKG-UHFFFAOYSA-N 300535 methyl 2-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-[(5-phenyl-1,3,4-thiadiazol-2-yl)carbamoyl]benzoate::US10130633, Example 105 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300535&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462207 381749316 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575123 COC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C23H23N5O5S/c1-32-22(31)17-8-7-16(13-18(17)24-19(29)14-28-9-11-33-12-10-28)20(30)25-23-27-26-21(34-23)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,24,29)(H,25,27,30) GLPXNIQHSJPKAA-UHFFFAOYSA-N 300536 methyl 2-[(morpholin-4-ylacetyl)amino]-4-[(5-phenyl-1,3,4-thiadiazol-2-yl)carbamoyl]benzoate::US10130633, Example 106 Protein Wnt-3a Human 285 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300536&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461635 381749317 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575124 COC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C23H23N5O5S/c1-32-22(31)17-8-7-16(13-18(17)24-19(29)14-28-9-11-33-12-10-28)20(30)25-23-27-26-21(34-23)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,24,29)(H,25,27,30) GLPXNIQHSJPKAA-UHFFFAOYSA-N 300536 methyl 2-[(morpholin-4-ylacetyl)amino]-4-[(5-phenyl-1,3,4-thiadiazol-2-yl)carbamoyl]benzoate::US10130633, Example 106 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300536&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461635 381749317 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575125 COc1ccc(NC(=O)c2cnc(s2)-c2ccccc2)cc1NC(=O)C(C)N1CCOCC1 InChI=1S/C24H26N4O4S/c1-16(28-10-12-32-13-11-28)22(29)27-19-14-18(8-9-20(19)31-2)26-23(30)21-15-25-24(33-21)17-6-4-3-5-7-17/h3-9,14-16H,10-13H2,1-2H3,(H,26,30)(H,27,29) JDVQIXVEHPAFKV-UHFFFAOYSA-N 300537 N-(4-methoxy-3-{[2-(morpholin-4-yl)propanoyl]amino}phenyl)-2-phenyl-1,3-thiazole-5-carboxamide::US10130633, Example 107 Protein Wnt-3a Human 209 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300537&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462400 381749318 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575126 COc1ccc(NC(=O)c2cnc(s2)-c2ccccc2)cc1NC(=O)C(C)N1CCOCC1 InChI=1S/C24H26N4O4S/c1-16(28-10-12-32-13-11-28)22(29)27-19-14-18(8-9-20(19)31-2)26-23(30)21-15-25-24(33-21)17-6-4-3-5-7-17/h3-9,14-16H,10-13H2,1-2H3,(H,26,30)(H,27,29) JDVQIXVEHPAFKV-UHFFFAOYSA-N 300537 N-(4-methoxy-3-{[2-(morpholin-4-yl)propanoyl]amino}phenyl)-2-phenyl-1,3-thiazole-5-carboxamide::US10130633, Example 107 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300537&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462400 381749318 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575127 FC(F)(F)Oc1ccc(NC(=O)c2cnc(s2)-c2ccccc2)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C25H23F3N4O4S/c26-25(27,28)36-19-7-6-17(30-21(33)20-15-29-22(37-20)16-4-2-1-3-5-16)14-18(19)31-23(34)24(8-9-24)32-10-12-35-13-11-32/h1-7,14-15H,8-13H2,(H,30,33)(H,31,34) RXNMRYNJASCBFP-UHFFFAOYSA-N 300538 N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]-2-phenyl-1,3-thiazole-5-carboxamide::US10130633, Example 108 Protein Wnt-3a Human 463 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300538&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462033 381749319 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575128 FC(F)(F)Oc1ccc(NC(=O)c2cnc(s2)-c2ccccc2)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C25H23F3N4O4S/c26-25(27,28)36-19-7-6-17(30-21(33)20-15-29-22(37-20)16-4-2-1-3-5-16)14-18(19)31-23(34)24(8-9-24)32-10-12-35-13-11-32/h1-7,14-15H,8-13H2,(H,30,33)(H,31,34) RXNMRYNJASCBFP-UHFFFAOYSA-N 300538 N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]-2-phenyl-1,3-thiazole-5-carboxamide::US10130633, Example 108 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300538&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462033 381749319 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575129 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(O)cc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O5/c1-15(34-8-10-38-11-9-34)24(36)33-22-12-16(2-7-23(22)39-26(28,29)30)25(37)32-17-3-6-21(31-14-17)19-5-4-18(35)13-20(19)27/h2-7,12-15,35H,8-11H2,1H3,(H,32,37)(H,33,36) JAUXZLMGHDLLLH-UHFFFAOYSA-N 300539 N-[6-(2-fluoro-4-hydroxyphenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 109 Protein Wnt-3a Human 208 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300539&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 136644358 381749320 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575130 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(O)cc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O5/c1-15(34-8-10-38-11-9-34)24(36)33-22-12-16(2-7-23(22)39-26(28,29)30)25(37)32-17-3-6-21(31-14-17)19-5-4-18(35)13-20(19)27/h2-7,12-15,35H,8-11H2,1H3,(H,32,37)(H,33,36) JAUXZLMGHDLLLH-UHFFFAOYSA-N 300539 N-[6-(2-fluoro-4-hydroxyphenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 109 Protein Wnt-3a Human 29900 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300539&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 136644358 381749320 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575131 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(O)c(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O5/c1-15(34-8-10-38-11-9-34)24(36)33-21-13-17(3-7-23(21)39-26(28,29)30)25(37)32-18-4-5-20(31-14-18)16-2-6-22(35)19(27)12-16/h2-7,12-15,35H,8-11H2,1H3,(H,32,37)(H,33,36) KSMMSWLXXZENCV-UHFFFAOYSA-N 300540 N-[6-(3-fluoro-4-hydroxyphenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 110 Protein Wnt-3a Human 450 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300540&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 136644339 381749321 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575132 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(O)c(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O5/c1-15(34-8-10-38-11-9-34)24(36)33-21-13-17(3-7-23(21)39-26(28,29)30)25(37)32-18-4-5-20(31-14-18)16-2-6-22(35)19(27)12-16/h2-7,12-15,35H,8-11H2,1H3,(H,32,37)(H,33,36) KSMMSWLXXZENCV-UHFFFAOYSA-N 300540 N-[6-(3-fluoro-4-hydroxyphenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 110 Protein Wnt-3a Human 42000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300540&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 136644339 381749321 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575133 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(N)cc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300541 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 111 Protein Wnt-3a Human 32.2 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300541&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459603 381749322 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575134 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(N)cc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300541 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 111 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300541&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459603 381749322 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575135 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(C(F)F)cc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C27H25F5N4O4/c1-16(36-10-12-39-13-11-36)25(37)35-22-14-19(6-9-23(22)40-27(30,31)32)26(38)34-20-7-8-21(33-15-20)17-2-4-18(5-3-17)24(28)29/h2-9,14-16,24H,10-13H2,1H3,(H,34,38)(H,35,37) FJXNQTNRVQCBSY-UHFFFAOYSA-N 300542 N-{6-[4-(difluoromethyl)phenyl]pyridin-3-yl}-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 112 Protein Wnt-3a Human 270 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300542&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460202 381749323 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575136 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(C(F)F)cc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C27H25F5N4O4/c1-16(36-10-12-39-13-11-36)25(37)35-22-14-19(6-9-23(22)40-27(30,31)32)26(38)34-20-7-8-21(33-15-20)17-2-4-18(5-3-17)24(28)29/h2-9,14-16,24H,10-13H2,1H3,(H,34,38)(H,35,37) FJXNQTNRVQCBSY-UHFFFAOYSA-N 300542 N-{6-[4-(difluoromethyl)phenyl]pyridin-3-yl}-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 112 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300542&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460202 381749323 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575137 CC(=O)Nc4ccc(c3ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)C(C)N1CCOCC1)c2)cn3)cc4 InChI=1S/C28H28F3N5O5/c1-17(36-11-13-40-14-12-36)26(38)35-24-15-20(5-10-25(24)41-28(29,30)31)27(39)34-22-8-9-23(32-16-22)19-3-6-21(7-4-19)33-18(2)37/h3-10,15-17H,11-14H2,1-2H3,(H,33,37)(H,34,39)(H,35,38) RRHCZKGLBZOYOW-UHFFFAOYSA-N 300543 N-[6-(4-acetamidophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 113 Protein Wnt-3a Human 23.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300543&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459377 381749324 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575138 CC(=O)Nc4ccc(c3ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)C(C)N1CCOCC1)c2)cn3)cc4 InChI=1S/C28H28F3N5O5/c1-17(36-11-13-40-14-12-36)26(38)35-24-15-20(5-10-25(24)41-28(29,30)31)27(39)34-22-8-9-23(32-16-22)19-3-6-21(7-4-19)33-18(2)37/h3-10,15-17H,11-14H2,1-2H3,(H,33,37)(H,34,39)(H,35,38) RRHCZKGLBZOYOW-UHFFFAOYSA-N 300543 N-[6-(4-acetamidophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 113 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300543&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459377 381749324 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575139 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(N(C)C)cc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C28H30F3N5O4/c1-18(36-12-14-39-15-13-36)26(37)34-24-16-20(6-11-25(24)40-28(29,30)31)27(38)33-21-7-10-23(32-17-21)19-4-8-22(9-5-19)35(2)3/h4-11,16-18H,12-15H2,1-3H3,(H,33,38)(H,34,37) YDONXTCQJOTDAZ-UHFFFAOYSA-N 300544 N-{6-[4-(dimethylamino)phenyl]pyridin-3-yl}-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 114 Protein Wnt-3a Human 46.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300544&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458930 381749325 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575140 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(N(C)C)cc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C28H30F3N5O4/c1-18(36-12-14-39-15-13-36)26(37)34-24-16-20(6-11-25(24)40-28(29,30)31)27(38)33-21-7-10-23(32-17-21)19-4-8-22(9-5-19)35(2)3/h4-11,16-18H,12-15H2,1-3H3,(H,33,38)(H,34,37) YDONXTCQJOTDAZ-UHFFFAOYSA-N 300544 N-{6-[4-(dimethylamino)phenyl]pyridin-3-yl}-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 114 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300544&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458930 381749325 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575141 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(cc1)N(C)C |r| InChI=1S/C28H30F3N5O4/c1-18(36-12-14-39-15-13-36)26(37)34-24-16-20(6-11-25(24)40-28(29,30)31)27(38)33-21-7-10-23(32-17-21)19-4-8-22(9-5-19)35(2)3/h4-11,16-18H,12-15H2,1-3H3,(H,33,38)(H,34,37) YDONXTCQJOTDAZ-UHFFFAOYSA-N 300545 N-{6-[4-(dimethylamino)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 115 Protein Wnt-3a Human 8.80 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300545&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459980 381749326 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575142 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(cc1)N(C)C |r| InChI=1S/C28H30F3N5O4/c1-18(36-12-14-39-15-13-36)26(37)34-24-16-20(6-11-25(24)40-28(29,30)31)27(38)33-21-7-10-23(32-17-21)19-4-8-22(9-5-19)35(2)3/h4-11,16-18H,12-15H2,1-3H3,(H,33,38)(H,34,37) YDONXTCQJOTDAZ-UHFFFAOYSA-N 300545 N-{6-[4-(dimethylamino)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 115 Protein Wnt-3a Human 2200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300545&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459980 381749326 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575143 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(cc1)N(C)C |r| InChI=1S/C28H30F3N5O4/c1-18(36-12-14-39-15-13-36)26(37)34-24-16-20(6-11-25(24)40-28(29,30)31)27(38)33-21-7-10-23(32-17-21)19-4-8-22(9-5-19)35(2)3/h4-11,16-18H,12-15H2,1-3H3,(H,33,38)(H,34,37) YDONXTCQJOTDAZ-UHFFFAOYSA-N 300546 N-{6-[4-(dimethylamino)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 116 Protein Wnt-3a Human 84.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300546&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459827 381749327 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575144 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(cc1)N(C)C |r| InChI=1S/C28H30F3N5O4/c1-18(36-12-14-39-15-13-36)26(37)34-24-16-20(6-11-25(24)40-28(29,30)31)27(38)33-21-7-10-23(32-17-21)19-4-8-22(9-5-19)35(2)3/h4-11,16-18H,12-15H2,1-3H3,(H,33,38)(H,34,37) YDONXTCQJOTDAZ-UHFFFAOYSA-N 300546 N-{6-[4-(dimethylamino)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 116 Protein Wnt-3a Human 8100 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300546&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459827 381749327 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575145 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(N)cc1 |r| InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300547 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[(2R)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 117 Protein Wnt-3a Human 18.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300547&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459482 381749328 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575146 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(N)cc1 |r| InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300547 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[(2R)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 117 Protein Wnt-3a Human 44500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300547&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459482 381749328 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575147 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(N)cc1 |r| InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300548 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[(2R)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 118 Protein Wnt-3a Human 12.6 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300548&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460397 381749329 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575148 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(N)cc1 |r| InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300548 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[(2R)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 118 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300548&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460397 381749329 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575149 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(CO)cc1 |r| InChI=1S/C27H27F3N4O5/c1-17(34-10-12-38-13-11-34)25(36)33-23-14-20(6-9-24(23)39-27(28,29)30)26(37)32-21-7-8-22(31-15-21)19-4-2-18(16-35)3-5-19/h2-9,14-15,17,35H,10-13,16H2,1H3,(H,32,37)(H,33,36) GBNHPZORLVXBCU-UHFFFAOYSA-N 300549 N-{6-[4-(hydroxymethyl)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 119 Protein Wnt-3a Human 650 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300549&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459905 381749330 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575150 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(CO)cc1 |r| InChI=1S/C27H27F3N4O5/c1-17(34-10-12-38-13-11-34)25(36)33-23-14-20(6-9-24(23)39-27(28,29)30)26(37)32-21-7-8-22(31-15-21)19-4-2-18(16-35)3-5-19/h2-9,14-15,17,35H,10-13,16H2,1H3,(H,32,37)(H,33,36) GBNHPZORLVXBCU-UHFFFAOYSA-N 300549 N-{6-[4-(hydroxymethyl)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 119 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300549&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459905 381749330 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575151 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(CO)cc1 |r| InChI=1S/C27H27F3N4O5/c1-17(34-10-12-38-13-11-34)25(36)33-23-14-20(6-9-24(23)39-27(28,29)30)26(37)32-21-7-8-22(31-15-21)19-4-2-18(16-35)3-5-19/h2-9,14-15,17,35H,10-13,16H2,1H3,(H,32,37)(H,33,36) GBNHPZORLVXBCU-UHFFFAOYSA-N 300550 N-{6-[4-(hydroxymethyl)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 120 Protein Wnt-3a Human 105 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300550&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459565 381749331 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575152 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(CO)cc1 |r| InChI=1S/C27H27F3N4O5/c1-17(34-10-12-38-13-11-34)25(36)33-23-14-20(6-9-24(23)39-27(28,29)30)26(37)32-21-7-8-22(31-15-21)19-4-2-18(16-35)3-5-19/h2-9,14-15,17,35H,10-13,16H2,1H3,(H,32,37)(H,33,36) GBNHPZORLVXBCU-UHFFFAOYSA-N 300550 N-{6-[4-(hydroxymethyl)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 120 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300550&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459565 381749331 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575153 FC(F)(F)Oc1ccc(NC(=O)c2noc(n2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C22H20F3N5O5/c23-22(24,25)34-17-7-6-15(12-16(17)27-18(31)13-30-8-10-33-11-9-30)26-20(32)19-28-21(35-29-19)14-4-2-1-3-5-14/h1-7,12H,8-11,13H2,(H,26,32)(H,27,31) VSQFRPSRMBKKOE-UHFFFAOYSA-N 300551 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1,2,4-oxadiazole-3-carboxamide::US10130633, Example 121 Protein Wnt-3a Human 825 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300551&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462215 381749332 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575154 FC(F)(F)Oc1ccc(NC(=O)c2noc(n2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C22H20F3N5O5/c23-22(24,25)34-17-7-6-15(12-16(17)27-18(31)13-30-8-10-33-11-9-30)26-20(32)19-28-21(35-29-19)14-4-2-1-3-5-14/h1-7,12H,8-11,13H2,(H,26,32)(H,27,31) VSQFRPSRMBKKOE-UHFFFAOYSA-N 300551 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1,2,4-oxadiazole-3-carboxamide::US10130633, Example 121 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300551&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462215 381749332 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575155 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3cnc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)28-19(31)14-30-8-10-33-11-9-30)21(32)29-20-13-27-22(35-20)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,31)(H,29,32) ZXDWASAPUBVSNN-UHFFFAOYSA-N 300552 3-[(morpholin-4-ylacetyl)amino]-N-(2-phenyl-1,3-thiazol-5-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 122 Protein Wnt-3a Human 202 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300552&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460240 381749333 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575156 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3cnc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)28-19(31)14-30-8-10-33-11-9-30)21(32)29-20-13-27-22(35-20)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,31)(H,29,32) ZXDWASAPUBVSNN-UHFFFAOYSA-N 300552 3-[(morpholin-4-ylacetyl)amino]-N-(2-phenyl-1,3-thiazol-5-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 122 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300552&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460240 381749333 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575157 Cn1nc(cc1-c1ccccc1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C24H24F3N5O4/c1-31-20(16-5-3-2-4-6-16)14-19(30-31)23(34)28-17-7-8-21(36-24(25,26)27)18(13-17)29-22(33)15-32-9-11-35-12-10-32/h2-8,13-14H,9-12,15H2,1H3,(H,28,34)(H,29,33) PWDFOYVZPHGTPV-UHFFFAOYSA-N 300553 1-methyl-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1H-pyrazole-3-carboxamide::US10130633, Example 123 Protein Wnt-3a Human 560 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300553&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608507 381749334 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575158 Cn1nc(cc1-c1ccccc1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C24H24F3N5O4/c1-31-20(16-5-3-2-4-6-16)14-19(30-31)23(34)28-17-7-8-21(36-24(25,26)27)18(13-17)29-22(33)15-32-9-11-35-12-10-32/h2-8,13-14H,9-12,15H2,1H3,(H,28,34)(H,29,33) PWDFOYVZPHGTPV-UHFFFAOYSA-N 300553 1-methyl-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1H-pyrazole-3-carboxamide::US10130633, Example 123 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300553&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608507 381749334 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575159 FC(F)(F)Oc1ccc(NC(=O)c2cc([nH]n2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H22F3N5O4/c24-23(25,26)35-20-7-6-16(12-18(20)28-21(32)14-31-8-10-34-11-9-31)27-22(33)19-13-17(29-30-19)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,27,33)(H,28,32)(H,29,30) KDVHWTVDKJTZQT-UHFFFAOYSA-N 300554 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1H-pyrazole-3-carboxamide::US10130633, Example 124 Protein Wnt-3a Human 72.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300554&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 137553939 381749335 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575160 FC(F)(F)Oc1ccc(NC(=O)c2cc([nH]n2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H22F3N5O4/c24-23(25,26)35-20-7-6-16(12-18(20)28-21(32)14-31-8-10-34-11-9-31)27-22(33)19-13-17(29-30-19)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,27,33)(H,28,32)(H,29,30) KDVHWTVDKJTZQT-UHFFFAOYSA-N 300554 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1H-pyrazole-3-carboxamide::US10130633, Example 124 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300554&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 137553939 381749335 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575161 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nc(c2ccccc2)no3)ccc4OC(F)(F)F InChI=1S/C22H20F3N5O5/c23-22(24,25)34-17-7-6-15(12-16(17)26-18(31)13-30-8-10-33-11-9-30)20(32)28-21-27-19(29-35-21)14-4-2-1-3-5-14/h1-7,12H,8-11,13H2,(H,26,31)(H,27,28,29,32) FKGHJQGUYZULAF-UHFFFAOYSA-N 300555 3-[(morpholin-4-ylacetyl)amino]-N-(3-phenyl-1,2,4-oxadiazol-5-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 125 Protein Wnt-3a Human 1700 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300555 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300555&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462315 381749336 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575162 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nc(c2ccccc2)no3)ccc4OC(F)(F)F InChI=1S/C22H20F3N5O5/c23-22(24,25)34-17-7-6-15(12-16(17)26-18(31)13-30-8-10-33-11-9-30)20(32)28-21-27-19(29-35-21)14-4-2-1-3-5-14/h1-7,12H,8-11,13H2,(H,26,31)(H,27,28,29,32) FKGHJQGUYZULAF-UHFFFAOYSA-N 300555 3-[(morpholin-4-ylacetyl)amino]-N-(3-phenyl-1,2,4-oxadiazol-5-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 125 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300555 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300555&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462315 381749336 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575163 Nc4ccc(c3ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCOCC1)c2)cn3)cc4 InChI=1S/C25H24F3N5O4/c26-25(27,28)37-22-8-3-17(13-21(22)32-23(34)15-33-9-11-36-12-10-33)24(35)31-19-6-7-20(30-14-19)16-1-4-18(29)5-2-16/h1-8,13-14H,9-12,15,29H2,(H,31,35)(H,32,34) HBBUYRQYTWGYPU-UHFFFAOYSA-N 300556 N-[6-(4-aminophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 126 Protein Wnt-3a Human 52.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300556&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459663 381749337 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575164 Nc4ccc(c3ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCOCC1)c2)cn3)cc4 InChI=1S/C25H24F3N5O4/c26-25(27,28)37-22-8-3-17(13-21(22)32-23(34)15-33-9-11-36-12-10-33)24(35)31-19-6-7-20(30-14-19)16-1-4-18(29)5-2-16/h1-8,13-14H,9-12,15,29H2,(H,31,35)(H,32,34) HBBUYRQYTWGYPU-UHFFFAOYSA-N 300556 N-[6-(4-aminophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 126 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300556&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459663 381749337 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575165 Fc1ccccc1-c1nnc(s1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C22H19F4N5O4S/c23-15-4-2-1-3-14(15)20-29-30-21(36-20)19(33)27-13-5-6-17(35-22(24,25)26)16(11-13)28-18(32)12-31-7-9-34-10-8-31/h1-6,11H,7-10,12H2,(H,27,33)(H,28,32) RUZUPHRIYDTINJ-UHFFFAOYSA-N 300557 N-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 127 Protein Wnt-3a Human 885 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300557 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300557&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122533807 381749338 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575166 Fc1ccccc1-c1nnc(s1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C22H19F4N5O4S/c23-15-4-2-1-3-14(15)20-29-30-21(36-20)19(33)27-13-5-6-17(35-22(24,25)26)16(11-13)28-18(32)12-31-7-9-34-10-8-31/h1-6,11H,7-10,12H2,(H,27,33)(H,28,32) RUZUPHRIYDTINJ-UHFFFAOYSA-N 300557 N-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 127 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300557 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300557&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122533807 381749338 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575167 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3C(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O3S/c1-14(31-9-11-34-12-10-31)19(32)27-18-13-16(7-8-17(18)23(24,25)26)20(33)28-22-30-29-21(35-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) QPWRDXFNAPYYKK-UHFFFAOYSA-N 300558 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 128 Protein Wnt-3a Human 710 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300558&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462267 381749339 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575168 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3C(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O3S/c1-14(31-9-11-34-12-10-31)19(32)27-18-13-16(7-8-17(18)23(24,25)26)20(33)28-22-30-29-21(35-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) QPWRDXFNAPYYKK-UHFFFAOYSA-N 300558 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 128 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300558&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462267 381749339 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575169 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3C(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O2S/c1-15(33-12-10-32(2)11-13-33)20(34)28-19-14-17(8-9-18(19)24(25,26)27)21(35)29-23-31-30-22(36-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) RDJNTVVRRTZZNI-UHFFFAOYSA-N 300559 3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 129 Protein Wnt-3a Human 900 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300559 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300559&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608427 381749340 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575170 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3C(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O2S/c1-15(33-12-10-32(2)11-13-33)20(34)28-19-14-17(8-9-18(19)24(25,26)27)21(35)29-23-31-30-22(36-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) RDJNTVVRRTZZNI-UHFFFAOYSA-N 300559 3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethyl)benzamide::US10130633, Example 129 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300559 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300559&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608427 381749340 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575171 COc1ccc(NC(=O)c2nnc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C22H23N5O4S/c1-30-18-8-7-16(13-17(18)24-19(28)14-27-9-11-31-12-10-27)23-20(29)22-26-25-21(32-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,23,29)(H,24,28) SVGOXPZALTZNTI-UHFFFAOYSA-N 300560 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1,3,4-thiadiazole-2-carboxamide::US10130633, Example 130 Protein Wnt-3a Human 318 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300560&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462336 381749341 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575172 COc1ccc(NC(=O)c2nnc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C22H23N5O4S/c1-30-18-8-7-16(13-17(18)24-19(28)14-27-9-11-31-12-10-27)23-20(29)22-26-25-21(32-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,23,29)(H,24,28) SVGOXPZALTZNTI-UHFFFAOYSA-N 300560 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1,3,4-thiadiazole-2-carboxamide::US10130633, Example 130 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300560&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462336 381749341 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575173 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)cn3)ccc4OC(F)(F)F InChI=1S/C25H23F3N4O4/c26-25(27,28)36-21-8-6-18(14-20(21)30-23(33)16-32-10-12-35-13-11-32)24(34)31-22-9-7-19(15-29-22)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,33)(H,29,31,34) OEZXPVZTYHPRBN-UHFFFAOYSA-N 300561 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 131 Protein Wnt-3a Human 51.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300561&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459713 381749342 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575174 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)cn3)ccc4OC(F)(F)F InChI=1S/C25H23F3N4O4/c26-25(27,28)36-21-8-6-18(14-20(21)30-23(33)16-32-10-12-35-13-11-32)24(34)31-22-9-7-19(15-29-22)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,33)(H,29,31,34) OEZXPVZTYHPRBN-UHFFFAOYSA-N 300561 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 131 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300561&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459713 381749342 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575175 CC4CCN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)cn2)ccc3OC(F)(F)F)CC4 InChI=1S/C27H27F3N4O3/c1-18-11-13-34(14-12-18)17-25(35)32-22-15-20(7-9-23(22)37-27(28,29)30)26(36)33-24-10-8-21(16-31-24)19-5-3-2-4-6-19/h2-10,15-16,18H,11-14,17H2,1H3,(H,32,35)(H,31,33,36) CMAIWNCQGOARKU-UHFFFAOYSA-N 300562 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide formiate::US10130633, Example 132 Protein Wnt-3a Human 35.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300562&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122535834 381749343 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575176 CC4CCN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)cn2)ccc3OC(F)(F)F)CC4 InChI=1S/C27H27F3N4O3/c1-18-11-13-34(14-12-18)17-25(35)32-22-15-20(7-9-23(22)37-27(28,29)30)26(36)33-24-10-8-21(16-31-24)19-5-3-2-4-6-19/h2-10,15-16,18H,11-14,17H2,1H3,(H,32,35)(H,31,33,36) CMAIWNCQGOARKU-UHFFFAOYSA-N 300562 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide formiate::US10130633, Example 132 Protein Wnt-3a Human 20000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300562&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122535834 381749343 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575177 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC5CC5 InChI=1S/C27H27FN4O4/c28-22-4-2-1-3-21(22)23-9-6-19(16-29-23)30-27(34)18-5-10-25(36-20-7-8-20)24(15-18)31-26(33)17-32-11-13-35-14-12-32/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,30,34)(H,31,33) HBSDSTAAGRGCRW-UHFFFAOYSA-N 300563 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 133 Protein Wnt-3a Human 54.6 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300563&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459826 381749344 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575178 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC5CC5 InChI=1S/C27H27FN4O4/c28-22-4-2-1-3-21(22)23-9-6-19(16-29-23)30-27(34)18-5-10-25(36-20-7-8-20)24(15-18)31-26(33)17-32-11-13-35-14-12-32/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,30,34)(H,31,33) HBSDSTAAGRGCRW-UHFFFAOYSA-N 300563 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 133 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300563&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459826 381749344 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575179 O=C(Nc2ccc(c1ccccc1F)nc2)c6ccc(OC3CC3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C29H29FN4O4/c30-23-4-2-1-3-22(23)24-9-6-20(18-31-24)32-27(35)19-5-10-26(38-21-7-8-21)25(17-19)33-28(36)29(11-12-29)34-13-15-37-16-14-34/h1-6,9-10,17-18,21H,7-8,11-16H2,(H,32,35)(H,33,36) OTOQGUOSYIPQCP-UHFFFAOYSA-N 300564 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 134 Protein Wnt-3a Human 16.6 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300564&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460134 381749345 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575180 O=C(Nc2ccc(c1ccccc1F)nc2)c6ccc(OC3CC3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C29H29FN4O4/c30-23-4-2-1-3-22(23)24-9-6-20(18-31-24)32-27(35)19-5-10-26(38-21-7-8-21)25(17-19)33-28(36)29(11-12-29)34-13-15-37-16-14-34/h1-6,9-10,17-18,21H,7-8,11-16H2,(H,32,35)(H,33,36) OTOQGUOSYIPQCP-UHFFFAOYSA-N 300564 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 134 Protein Wnt-3a Human 5200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300564&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460134 381749345 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575181 CN6CCN(C5(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC4CC4)CC5)CC6 InChI=1S/C30H32FN5O3/c1-35-14-16-36(17-15-35)30(12-13-30)29(38)34-26-18-20(6-11-27(26)39-22-8-9-22)28(37)33-21-7-10-25(32-19-21)23-4-2-3-5-24(23)31/h2-7,10-11,18-19,22H,8-9,12-17H2,1H3,(H,33,37)(H,34,38) SJWCZWWCJRTEGX-UHFFFAOYSA-N 300565 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 135 Protein Wnt-3a Human 84.8 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300565&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459964 381749346 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575182 CN6CCN(C5(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC4CC4)CC5)CC6 InChI=1S/C30H32FN5O3/c1-35-14-16-36(17-15-35)30(12-13-30)29(38)34-26-18-20(6-11-27(26)39-22-8-9-22)28(37)33-21-7-10-25(32-19-21)23-4-2-3-5-24(23)31/h2-7,10-11,18-19,22H,8-9,12-17H2,1H3,(H,33,37)(H,34,38) SJWCZWWCJRTEGX-UHFFFAOYSA-N 300565 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 135 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300565&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459964 381749346 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575183 O=C(Nc2ccc(c1ccccc1F)nc2)c7ccc(OC3CC3)c(NC(=O)C6(N5CCN(C4CC4)CC5)CC6)c7 InChI=1S/C32H34FN5O3/c33-26-4-2-1-3-25(26)27-11-6-22(20-34-27)35-30(39)21-5-12-29(41-24-9-10-24)28(19-21)36-31(40)32(13-14-32)38-17-15-37(16-18-38)23-7-8-23/h1-6,11-12,19-20,23-24H,7-10,13-18H2,(H,35,39)(H,36,40) WUXIYFKQIOIKPO-UHFFFAOYSA-N 300566 4-(cyclopropyloxy)-3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]benzamide::US10130633, Example 136 Protein Wnt-3a Human 21.4 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300566&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459704 381749347 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575184 O=C(Nc2ccc(c1ccccc1F)nc2)c7ccc(OC3CC3)c(NC(=O)C6(N5CCN(C4CC4)CC5)CC6)c7 InChI=1S/C32H34FN5O3/c33-26-4-2-1-3-25(26)27-11-6-22(20-34-27)35-30(39)21-5-12-29(41-24-9-10-24)28(19-21)36-31(40)32(13-14-32)38-17-15-37(16-18-38)23-7-8-23/h1-6,11-12,19-20,23-24H,7-10,13-18H2,(H,35,39)(H,36,40) WUXIYFKQIOIKPO-UHFFFAOYSA-N 300566 4-(cyclopropyloxy)-3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]benzamide::US10130633, Example 136 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300566&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459704 381749347 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575185 CC4CN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)CCN4C InChI=1S/C27H27F4N5O3/c1-17-15-36(12-11-35(17)2)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) IBSFTHPGPUBNAB-UHFFFAOYSA-N 300567 3-{[(3,4-dimethylpiperazin-1-yl)acetyl]amino}-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 137 Protein Wnt-3a Human 272 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300567 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300567&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460430 381749348 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575186 CC4CN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)CCN4C InChI=1S/C27H27F4N5O3/c1-17-15-36(12-11-35(17)2)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) IBSFTHPGPUBNAB-UHFFFAOYSA-N 300567 3-{[(3,4-dimethylpiperazin-1-yl)acetyl]amino}-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 137 Protein Wnt-3a Human 20000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300567 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300567&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460430 381749348 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575187 CSc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O3S/c1-34-23-9-6-17(14-22(23)29-24(31)16-30-10-12-33-13-11-30)25(32)28-18-7-8-21(27-15-18)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) CTAZMMSEIFTRNQ-UHFFFAOYSA-N 300568 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(methylsulfanyl)-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 138 Protein Wnt-3a Human 150 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300568&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460280 381749349 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575188 CSc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O3S/c1-34-23-9-6-17(14-22(23)29-24(31)16-30-10-12-33-13-11-30)25(32)28-18-7-8-21(27-15-18)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) CTAZMMSEIFTRNQ-UHFFFAOYSA-N 300568 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(methylsulfanyl)-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 138 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300568&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460280 381749349 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575189 CS(=O)(=O)c3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O5S/c1-36(33,34)23-9-6-17(14-22(23)29-24(31)16-30-10-12-35-13-11-30)25(32)28-18-7-8-21(27-15-18)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) OOYNAYAQMMGGNZ-UHFFFAOYSA-N 300569 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(methylsulfonyl)-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 139 Protein Wnt-3a Human 500 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300569 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300569&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608486 381749350 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575190 CS(=O)(=O)c3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O5S/c1-36(33,34)23-9-6-17(14-22(23)29-24(31)16-30-10-12-35-13-11-30)25(32)28-18-7-8-21(27-15-18)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) OOYNAYAQMMGGNZ-UHFFFAOYSA-N 300569 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(methylsulfonyl)-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 139 Protein Wnt-3a Human 25000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300569 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300569&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608486 381749350 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575191 CN(C)C5(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC4CC4)CC5 InChI=1S/C27H27FN4O3/c1-32(2)27(13-14-27)26(34)31-23-15-17(7-12-24(23)35-19-9-10-19)25(33)30-18-8-11-22(29-16-18)20-5-3-4-6-21(20)28/h3-8,11-12,15-16,19H,9-10,13-14H2,1-2H3,(H,30,33)(H,31,34) MSJLUQKNNPKZAZ-UHFFFAOYSA-N 300570 4-(cyclopropyloxy)-3-({[1-(dimethylamino)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]benzamide::US10130633, Example 140 Protein Wnt-3a Human 293 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300570&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608441 381749351 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575192 CN(C)C5(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC4CC4)CC5 InChI=1S/C27H27FN4O3/c1-32(2)27(13-14-27)26(34)31-23-15-17(7-12-24(23)35-19-9-10-19)25(33)30-18-8-11-22(29-16-18)20-5-3-4-6-21(20)28/h3-8,11-12,15-16,19H,9-10,13-14H2,1-2H3,(H,30,33)(H,31,34) MSJLUQKNNPKZAZ-UHFFFAOYSA-N 300570 4-(cyclopropyloxy)-3-({[1-(dimethylamino)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]benzamide::US10130633, Example 140 Protein Wnt-3a Human 10000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300570 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300570&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608441 381749351 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575193 O=C(Cn1cccn1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC5CC5 InChI=1S/C26H22FN5O3/c27-21-5-2-1-4-20(21)22-10-7-18(15-28-22)30-26(34)17-6-11-24(35-19-8-9-19)23(14-17)31-25(33)16-32-13-3-12-29-32/h1-7,10-15,19H,8-9,16H2,(H,30,34)(H,31,33) FQLIWGPZAVDQMC-UHFFFAOYSA-N 300571 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(1H-pyrazol-1-ylacetyl)amino]benzamide::US10130633, Example 141 Protein Wnt-3a Human 680 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300571 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300571&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461944 381749352 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575194 O=C(Cn1cccn1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC5CC5 InChI=1S/C26H22FN5O3/c27-21-5-2-1-4-20(21)22-10-7-18(15-28-22)30-26(34)17-6-11-24(35-19-8-9-19)23(14-17)31-25(33)16-32-13-3-12-29-32/h1-7,10-15,19H,8-9,16H2,(H,30,34)(H,31,33) FQLIWGPZAVDQMC-UHFFFAOYSA-N 300571 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(1H-pyrazol-1-ylacetyl)amino]benzamide::US10130633, Example 141 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300571 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300571&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461944 381749352 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575195 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3C(C)(C)C)N4CCOCC4 InChI=1S/C29H33FN4O3/c1-19(34-13-15-37-16-14-34)27(35)33-26-17-20(9-11-23(26)29(2,3)4)28(36)32-21-10-12-25(31-18-21)22-7-5-6-8-24(22)30/h5-12,17-19H,13-16H2,1-4H3,(H,32,36)(H,33,35) NEIXOCGOICECLN-UHFFFAOYSA-N 300572 4-tert-butyl-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}benzamide::US10130633, Example 142 Protein Wnt-3a Human 118 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300572 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300572&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459269 381749353 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575196 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3C(C)(C)C)N4CCOCC4 InChI=1S/C29H33FN4O3/c1-19(34-13-15-37-16-14-34)27(35)33-26-17-20(9-11-23(26)29(2,3)4)28(36)32-21-10-12-25(31-18-21)22-7-5-6-8-24(22)30/h5-12,17-19H,13-16H2,1-4H3,(H,32,36)(H,33,35) NEIXOCGOICECLN-UHFFFAOYSA-N 300572 4-tert-butyl-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}benzamide::US10130633, Example 142 Protein Wnt-3a Human 7150 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300572 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300572&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459269 381749353 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575197 CC(C(=O)Nc3cc(C(=O)Nc2ncc(c1ccccc1)s2)ccc3C(C)(C)C)N4CCOCC4 InChI=1S/C27H32N4O3S/c1-18(31-12-14-34-15-13-31)24(32)29-22-16-20(10-11-21(22)27(2,3)4)25(33)30-26-28-17-23(35-26)19-8-6-5-7-9-19/h5-11,16-18H,12-15H2,1-4H3,(H,29,32)(H,28,30,33) NLLKUPSXLVBHLL-UHFFFAOYSA-N 300573 4-tert-butyl-3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3-thiazol-2-yl)benzamide::US10130633, Example 143 Protein Wnt-3a Human 204 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300573 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300573&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608529 381749354 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575198 CC(C(=O)Nc3cc(C(=O)Nc2ncc(c1ccccc1)s2)ccc3C(C)(C)C)N4CCOCC4 InChI=1S/C27H32N4O3S/c1-18(31-12-14-34-15-13-31)24(32)29-22-16-20(10-11-21(22)27(2,3)4)25(33)30-26-28-17-23(35-26)19-8-6-5-7-9-19/h5-11,16-18H,12-15H2,1-4H3,(H,29,32)(H,28,30,33) NLLKUPSXLVBHLL-UHFFFAOYSA-N 300573 4-tert-butyl-3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3-thiazol-2-yl)benzamide::US10130633, Example 143 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300573 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300573&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608529 381749354 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575199 Cc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)(F)F)c(NC(=O)CN2CCN(C)CC2)c3)s4 InChI=1S/C24H25F3N6O3S/c1-15-5-3-4-6-17(15)22-30-31-23(37-22)29-21(35)16-7-8-19(36-24(25,26)27)18(13-16)28-20(34)14-33-11-9-32(2)10-12-33/h3-8,13H,9-12,14H2,1-2H3,(H,28,34)(H,29,31,35) QAORLMPTNPIBLC-UHFFFAOYSA-N 300574 N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 144 Protein Wnt-3a Human 195 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300574 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300574&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463165 381749355 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575200 Cc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)(F)F)c(NC(=O)CN2CCN(C)CC2)c3)s4 InChI=1S/C24H25F3N6O3S/c1-15-5-3-4-6-17(15)22-30-31-23(37-22)29-21(35)16-7-8-19(36-24(25,26)27)18(13-16)28-20(34)14-33-11-9-32(2)10-12-33/h3-8,13H,9-12,14H2,1-2H3,(H,28,34)(H,29,31,35) QAORLMPTNPIBLC-UHFFFAOYSA-N 300574 N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 144 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300574 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300574&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463165 381749355 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575201 Cc4cccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCN(C)CC1)c2)s3)c4 InChI=1S/C24H25F3N6O3S/c1-15-4-3-5-17(12-15)22-30-31-23(37-22)29-21(35)16-6-7-19(36-24(25,26)27)18(13-16)28-20(34)14-33-10-8-32(2)9-11-33/h3-7,12-13H,8-11,14H2,1-2H3,(H,28,34)(H,29,31,35) QGEXAONIEHTYHE-UHFFFAOYSA-N 300575 N-[5-(3-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 145 Protein Wnt-3a Human 152 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300575 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300575&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462967 381749356 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575202 Cc4cccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCN(C)CC1)c2)s3)c4 InChI=1S/C24H25F3N6O3S/c1-15-4-3-5-17(12-15)22-30-31-23(37-22)29-21(35)16-6-7-19(36-24(25,26)27)18(13-16)28-20(34)14-33-10-8-32(2)9-11-33/h3-7,12-13H,8-11,14H2,1-2H3,(H,28,34)(H,29,31,35) QGEXAONIEHTYHE-UHFFFAOYSA-N 300575 N-[5-(3-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 145 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300575 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300575&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462967 381749356 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575203 COc4cccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCN(C)CC1)c2)s3)c4 InChI=1S/C24H25F3N6O4S/c1-32-8-10-33(11-9-32)14-20(34)28-18-13-15(6-7-19(18)37-24(25,26)27)21(35)29-23-31-30-22(38-23)16-4-3-5-17(12-16)36-2/h3-7,12-13H,8-11,14H2,1-2H3,(H,28,34)(H,29,31,35) PSVJGXBBZREOLY-UHFFFAOYSA-N 300576 N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 146 Protein Wnt-3a Human 365 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300576 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300576&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462369 381749357 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575204 COc4cccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCN(C)CC1)c2)s3)c4 InChI=1S/C24H25F3N6O4S/c1-32-8-10-33(11-9-32)14-20(34)28-18-13-15(6-7-19(18)37-24(25,26)27)21(35)29-23-31-30-22(38-23)16-4-3-5-17(12-16)36-2/h3-7,12-13H,8-11,14H2,1-2H3,(H,28,34)(H,29,31,35) PSVJGXBBZREOLY-UHFFFAOYSA-N 300576 N-[5-(3-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 146 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300576 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300576&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462369 381749357 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575205 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccc(Cl)cc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22ClF3N6O3S/c1-32-8-10-33(11-9-32)13-19(34)28-17-12-15(4-7-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)14-2-5-16(24)6-3-14/h2-7,12H,8-11,13H2,1H3,(H,28,34)(H,29,31,35) QDGMCVODFZGVON-UHFFFAOYSA-N 300577 N-[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 147 Protein Wnt-3a Human 2200 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300577 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300577&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463153 381749358 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575206 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccc(Cl)cc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22ClF3N6O3S/c1-32-8-10-33(11-9-32)13-19(34)28-17-12-15(4-7-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)14-2-5-16(24)6-3-14/h2-7,12H,8-11,13H2,1H3,(H,28,34)(H,29,31,35) QDGMCVODFZGVON-UHFFFAOYSA-N 300577 N-[5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 147 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300577 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300577&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463153 381749358 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575207 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1Cl)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22ClF3N6O3S/c1-32-8-10-33(11-9-32)13-19(34)28-17-12-14(6-7-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-4-2-3-5-16(15)24/h2-7,12H,8-11,13H2,1H3,(H,28,34)(H,29,31,35) SMRXMWVWWPBBLI-UHFFFAOYSA-N 300578 N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 148 Protein Wnt-3a Human 205 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300578 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300578&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462705 381749359 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575208 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1Cl)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22ClF3N6O3S/c1-32-8-10-33(11-9-32)13-19(34)28-17-12-14(6-7-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-4-2-3-5-16(15)24/h2-7,12H,8-11,13H2,1H3,(H,28,34)(H,29,31,35) SMRXMWVWWPBBLI-UHFFFAOYSA-N 300578 N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 148 Protein Wnt-3a Human 36500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300578 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300578&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462705 381749359 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575209 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccc(F)cc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22F4N6O3S/c1-32-8-10-33(11-9-32)13-19(34)28-17-12-15(4-7-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)14-2-5-16(24)6-3-14/h2-7,12H,8-11,13H2,1H3,(H,28,34)(H,29,31,35) DOTXZOHERWZHQT-UHFFFAOYSA-N 300579 N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 149 Protein Wnt-3a Human 704 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300579 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300579&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462274 381749360 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575210 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccc(F)cc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22F4N6O3S/c1-32-8-10-33(11-9-32)13-19(34)28-17-12-15(4-7-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)14-2-5-16(24)6-3-14/h2-7,12H,8-11,13H2,1H3,(H,28,34)(H,29,31,35) DOTXZOHERWZHQT-UHFFFAOYSA-N 300579 N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 149 Protein Wnt-3a Human 47500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300579 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300579&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462274 381749360 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575211 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1F)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22F4N6O3S/c1-32-8-10-33(11-9-32)13-19(34)28-17-12-14(6-7-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-4-2-3-5-16(15)24/h2-7,12H,8-11,13H2,1H3,(H,28,34)(H,29,31,35) CIBFIVGNIUACHL-UHFFFAOYSA-N 300580 N-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 150 Protein Wnt-3a Human 76.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300580 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300580&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463046 381749361 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575212 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1F)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22F4N6O3S/c1-32-8-10-33(11-9-32)13-19(34)28-17-12-14(6-7-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-4-2-3-5-16(15)24/h2-7,12H,8-11,13H2,1H3,(H,28,34)(H,29,31,35) CIBFIVGNIUACHL-UHFFFAOYSA-N 300580 N-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 150 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300580 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300580&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463046 381749361 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575213 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(Cl)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22ClF3N6O3S/c1-32-7-9-33(10-8-32)13-19(34)28-17-12-14(5-6-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-3-2-4-16(24)11-15/h2-6,11-12H,7-10,13H2,1H3,(H,28,34)(H,29,31,35) DZKLRJPRYPLYLJ-UHFFFAOYSA-N 300581 N-[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 151 Protein Wnt-3a Human 71.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300581 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300581&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462425 381749362 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575214 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(Cl)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22ClF3N6O3S/c1-32-7-9-33(10-8-32)13-19(34)28-17-12-14(5-6-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-3-2-4-16(24)11-15/h2-6,11-12H,7-10,13H2,1H3,(H,28,34)(H,29,31,35) DZKLRJPRYPLYLJ-UHFFFAOYSA-N 300581 N-[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 151 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300581 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300581&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462425 381749362 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575215 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(F)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22F4N6O3S/c1-32-7-9-33(10-8-32)13-19(34)28-17-12-14(5-6-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-3-2-4-16(24)11-15/h2-6,11-12H,7-10,13H2,1H3,(H,28,34)(H,29,31,35) AVIAJJJEFUNBGD-UHFFFAOYSA-N 300582 N-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 152 Protein Wnt-3a Human 200 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300582 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300582&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461463 381749363 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575216 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(F)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22F4N6O3S/c1-32-7-9-33(10-8-32)13-19(34)28-17-12-14(5-6-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-3-2-4-16(24)11-15/h2-6,11-12H,7-10,13H2,1H3,(H,28,34)(H,29,31,35) AVIAJJJEFUNBGD-UHFFFAOYSA-N 300582 N-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 152 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300582 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300582&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461463 381749363 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575217 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2cccc(F)c2)s3)ccc4OC(F)(F)F InChI=1S/C22H19F4N5O4S/c23-15-3-1-2-14(10-15)20-29-30-21(36-20)28-19(33)13-4-5-17(35-22(24,25)26)16(11-13)27-18(32)12-31-6-8-34-9-7-31/h1-5,10-11H,6-9,12H2,(H,27,32)(H,28,30,33) PDQYHEFHNJFXIC-UHFFFAOYSA-N 300583 N-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 153 Protein Wnt-3a Human 132 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300583 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300583&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461686 381749364 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575218 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2cccc(F)c2)s3)ccc4OC(F)(F)F InChI=1S/C22H19F4N5O4S/c23-15-3-1-2-14(10-15)20-29-30-21(36-20)28-19(33)13-4-5-17(35-22(24,25)26)16(11-13)27-18(32)12-31-6-8-34-9-7-31/h1-5,10-11H,6-9,12H2,(H,27,32)(H,28,30,33) PDQYHEFHNJFXIC-UHFFFAOYSA-N 300583 N-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 153 Protein Wnt-3a Human 30000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300583 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300583&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461686 381749364 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575219 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2cccc(Cl)c2)s3)ccc4OC(F)(F)F InChI=1S/C22H19ClF3N5O4S/c23-15-3-1-2-14(10-15)20-29-30-21(36-20)28-19(33)13-4-5-17(35-22(24,25)26)16(11-13)27-18(32)12-31-6-8-34-9-7-31/h1-5,10-11H,6-9,12H2,(H,27,32)(H,28,30,33) DVXSXOMNXWNTCQ-UHFFFAOYSA-N 300584 N-[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 154 Protein Wnt-3a Human 420 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300584 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300584&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462377 381749365 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575220 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2cccc(Cl)c2)s3)ccc4OC(F)(F)F InChI=1S/C22H19ClF3N5O4S/c23-15-3-1-2-14(10-15)20-29-30-21(36-20)28-19(33)13-4-5-17(35-22(24,25)26)16(11-13)27-18(32)12-31-6-8-34-9-7-31/h1-5,10-11H,6-9,12H2,(H,27,32)(H,28,30,33) DVXSXOMNXWNTCQ-UHFFFAOYSA-N 300584 N-[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 154 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300584 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300584&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462377 381749365 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575221 COCCNC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C26H31N7O4S/c1-32-11-13-33(14-12-32)17-22(34)28-21-16-19(8-9-20(21)24(36)27-10-15-37-2)23(35)29-26-31-30-25(38-26)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,36)(H,28,34)(H,29,31,35) JRYRRBBOVUYPIB-UHFFFAOYSA-N 300585 N1-(2-methoxyethyl)-2-{[(4-methylpiperazin-1-yl)acetyl]amino}-N4-(5-phenyl-1,3,4-thiadiazol-2-yl)terephthalamide::US10130633, Example 155 Protein Wnt-3a Human 592 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300585 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300585&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462985 381749366 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575222 COCCNC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C26H31N7O4S/c1-32-11-13-33(14-12-32)17-22(34)28-21-16-19(8-9-20(21)24(36)27-10-15-37-2)23(35)29-26-31-30-25(38-26)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,36)(H,28,34)(H,29,31,35) JRYRRBBOVUYPIB-UHFFFAOYSA-N 300585 N1-(2-methoxyethyl)-2-{[(4-methylpiperazin-1-yl)acetyl]amino}-N4-(5-phenyl-1,3,4-thiadiazol-2-yl)terephthalamide::US10130633, Example 155 Protein Wnt-3a Human 32500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300585 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300585&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462985 381749366 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575223 COCCNC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H28N6O5S/c1-35-12-9-26-23(34)19-8-7-18(15-20(19)27-21(32)16-31-10-13-36-14-11-31)22(33)28-25-30-29-24(37-25)17-5-3-2-4-6-17/h2-8,15H,9-14,16H2,1H3,(H,26,34)(H,27,32)(H,28,30,33) WMQPZCFVANWPCP-UHFFFAOYSA-N 300586 N1-(2-methoxyethyl)-2-[(morpholin-4-ylacetyl)amino]-N4-(5-phenyl-1,3,4-thiadiazol-2-yl)terephthalamide::US10130633, Example 156 Protein Wnt-3a Human 542 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300586 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300586&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463144 381749367 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575224 COCCNC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H28N6O5S/c1-35-12-9-26-23(34)19-8-7-18(15-20(19)27-21(32)16-31-10-13-36-14-11-31)22(33)28-25-30-29-24(37-25)17-5-3-2-4-6-17/h2-8,15H,9-14,16H2,1H3,(H,26,34)(H,27,32)(H,28,30,33) WMQPZCFVANWPCP-UHFFFAOYSA-N 300586 N1-(2-methoxyethyl)-2-[(morpholin-4-ylacetyl)amino]-N4-(5-phenyl-1,3,4-thiadiazol-2-yl)terephthalamide::US10130633, Example 156 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300586 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300586&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463144 381749367 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575225 Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCN(C)CC4)CC5 InChI=1S/C25H28N6O2S/c1-17-8-9-19(21(32)27-24-29-28-22(34-24)18-6-4-3-5-7-18)16-20(17)26-23(33)25(10-11-25)31-14-12-30(2)13-15-31/h3-9,16H,10-15H2,1-2H3,(H,26,33)(H,27,29,32) IIVRXASASXHWOI-UHFFFAOYSA-N 300587 4-methyl-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide hydrochloride (1:1)::US10130633, Example 157 Protein Wnt-3a Human 96.6 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300587 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300587&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462828 381749368 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575226 Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCN(C)CC4)CC5 InChI=1S/C25H28N6O2S/c1-17-8-9-19(21(32)27-24-29-28-22(34-24)18-6-4-3-5-7-18)16-20(17)26-23(33)25(10-11-25)31-14-12-30(2)13-15-31/h3-9,16H,10-15H2,1-2H3,(H,26,33)(H,27,29,32) IIVRXASASXHWOI-UHFFFAOYSA-N 300587 4-methyl-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide hydrochloride (1:1)::US10130633, Example 157 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300587 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300587&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462828 381749368 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575227 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)cn2)ccc3OC(F)(F)F)CC4 InChI=1S/C26H26F3N5O3/c1-33-11-13-34(14-12-33)17-24(35)31-21-15-19(7-9-22(21)37-26(27,28)29)25(36)32-23-10-8-20(16-30-23)18-5-3-2-4-6-18/h2-10,15-16H,11-14,17H2,1H3,(H,31,35)(H,30,32,36) RXFARYKWAYLJON-UHFFFAOYSA-N 300588 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 158 Protein Wnt-3a Human 73.6 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300588 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300588&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459849 381749369 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575228 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)cn2)ccc3OC(F)(F)F)CC4 InChI=1S/C26H26F3N5O3/c1-33-11-13-34(14-12-33)17-24(35)31-21-15-19(7-9-22(21)37-26(27,28)29)25(36)32-23-10-8-20(16-30-23)18-5-3-2-4-6-18/h2-10,15-16H,11-14,17H2,1H3,(H,31,35)(H,30,32,36) RXFARYKWAYLJON-UHFFFAOYSA-N 300588 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 158 Protein Wnt-3a Human 21800 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300588 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300588&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459849 381749369 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575229 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC3CC3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C26H27N5O4S/c32-22(28-25-30-29-23(36-25)17-4-2-1-3-5-17)18-6-9-21(35-19-7-8-19)20(16-18)27-24(33)26(10-11-26)31-12-14-34-15-13-31/h1-6,9,16,19H,7-8,10-15H2,(H,27,33)(H,28,30,32) WZBAQYZHNIQOIY-UHFFFAOYSA-N 300589 4-(cyclopropyloxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 159 Protein Wnt-3a Human 41.4 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300589 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300589&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462159 381749370 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575230 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC3CC3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C26H27N5O4S/c32-22(28-25-30-29-23(36-25)17-4-2-1-3-5-17)18-6-9-21(35-19-7-8-19)20(16-18)27-24(33)26(10-11-26)31-12-14-34-15-13-31/h1-6,9,16,19H,7-8,10-15H2,(H,27,33)(H,28,30,32) WZBAQYZHNIQOIY-UHFFFAOYSA-N 300589 4-(cyclopropyloxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 159 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300589 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300589&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462159 381749370 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575231 CC4CN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CCN4C InChI=1S/C24H25F3N6O3S/c1-15-13-33(11-10-32(15)2)14-20(34)28-18-12-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,12,15H,10-11,13-14H2,1-2H3,(H,28,34)(H,29,31,35) RVJQAQPBSFCKFZ-UHFFFAOYSA-N 300590 3-{[(3,4-dimethylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 160 Protein Wnt-3a Human 948 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300590 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300590&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463514 381749371 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575232 CC4CN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CCN4C InChI=1S/C24H25F3N6O3S/c1-15-13-33(11-10-32(15)2)14-20(34)28-18-12-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,12,15H,10-11,13-14H2,1-2H3,(H,28,34)(H,29,31,35) RVJQAQPBSFCKFZ-UHFFFAOYSA-N 300590 3-{[(3,4-dimethylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 160 Protein Wnt-3a Human 28000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300590 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300590&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463514 381749371 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575233 C[C@@H]1CN(C)CCN1CC(=O)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C27H27F4N5O3/c1-17-15-35(2)11-12-36(17)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) LNUKHOVUQVDDMA-UHFFFAOYSA-N 300591 3-({[(2R)-2,4-dimethylpiperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 161 Protein Wnt-3a Human 325 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300591 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300591&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608525 381749372 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575234 C[C@@H]1CN(C)CCN1CC(=O)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C27H27F4N5O3/c1-17-15-35(2)11-12-36(17)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) LNUKHOVUQVDDMA-UHFFFAOYSA-N 300591 3-({[(2R)-2,4-dimethylpiperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 161 Protein Wnt-3a Human 10000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300591 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300591&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608525 381749372 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575235 C[C@H]1CN(C)CCN1CC(=O)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C27H27F4N5O3/c1-17-15-35(2)11-12-36(17)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) LNUKHOVUQVDDMA-UHFFFAOYSA-N 300592 3-({[(2S)-2,4-dimethylpiperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 162 Protein Wnt-3a Human 85.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300592 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300592&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459913 381749373 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575236 C[C@H]1CN(C)CCN1CC(=O)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C27H27F4N5O3/c1-17-15-35(2)11-12-36(17)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) LNUKHOVUQVDDMA-UHFFFAOYSA-N 300592 3-({[(2S)-2,4-dimethylpiperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 162 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300592 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300592&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459913 381749373 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575237 C[C@H]4CN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)CCN4C InChI=1S/C27H27F4N5O3/c1-17-15-36(12-11-35(17)2)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) IBSFTHPGPUBNAB-UHFFFAOYSA-N 300593 3-({[(3S)-3,4-dimethylpiperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 163 Protein Wnt-3a Human 57.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300593 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300593&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460141 381749374 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575238 C[C@H]4CN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)CCN4C InChI=1S/C27H27F4N5O3/c1-17-15-36(12-11-35(17)2)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) IBSFTHPGPUBNAB-UHFFFAOYSA-N 300593 3-({[(3S)-3,4-dimethylpiperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 163 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300593 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300593&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460141 381749374 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575239 C[C@@H]4CN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)CCN4C InChI=1S/C27H27F4N5O3/c1-17-15-36(12-11-35(17)2)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) IBSFTHPGPUBNAB-UHFFFAOYSA-N 300594 3-({[(3R)-3,4-dimethylpiperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 164 Protein Wnt-3a Human 220 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300594 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300594&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459093 381749375 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575240 C[C@@H]4CN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)CCN4C InChI=1S/C27H27F4N5O3/c1-17-15-36(12-11-35(17)2)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) IBSFTHPGPUBNAB-UHFFFAOYSA-N 300594 3-({[(3R)-3,4-dimethylpiperazin-1-yl]acetyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 164 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300594 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300594&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459093 381749375 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575241 CC1CN(C)CCN1CC(=O)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C27H27F4N5O3/c1-17-15-35(2)11-12-36(17)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) LNUKHOVUQVDDMA-UHFFFAOYSA-N 300595 3-{[(2,4-dimethylpiperazin-1-yl)acetyl]amino}-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 165 Protein Wnt-3a Human 51.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300595 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300595&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459670 381749376 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575242 CC1CN(C)CCN1CC(=O)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F InChI=1S/C27H27F4N5O3/c1-17-15-35(2)11-12-36(17)16-25(37)34-23-13-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-14-19)20-5-3-4-6-21(20)28/h3-10,13-14,17H,11-12,15-16H2,1-2H3,(H,33,38)(H,34,37) LNUKHOVUQVDDMA-UHFFFAOYSA-N 300595 3-{[(2,4-dimethylpiperazin-1-yl)acetyl]amino}-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 165 Protein Wnt-3a Human 7200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300595 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300595&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459670 381749376 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575243 CN1C5CCC1CN(CC(=O)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F)C5 InChI=1S/C28H27F4N5O3/c1-36-19-8-9-20(36)15-37(14-19)16-26(38)35-24-12-17(6-11-25(24)40-28(30,31)32)27(39)34-18-7-10-23(33-13-18)21-4-2-3-5-22(21)29/h2-7,10-13,19-20H,8-9,14-16H2,1H3,(H,34,39)(H,35,38) BUMLUVXLIAMEJB-UHFFFAOYSA-N 300596 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(8-methyl-3,8-diazabicyclo[3.2.1]oct-3-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 166 Protein Wnt-3a Human 148 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300596&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459639 381749377 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575244 CN1C5CCC1CN(CC(=O)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC(F)(F)F)C5 InChI=1S/C28H27F4N5O3/c1-36-19-8-9-20(36)15-37(14-19)16-26(38)35-24-12-17(6-11-25(24)40-28(30,31)32)27(39)34-18-7-10-23(33-13-18)21-4-2-3-5-22(21)29/h2-7,10-13,19-20H,8-9,14-16H2,1H3,(H,34,39)(H,35,38) BUMLUVXLIAMEJB-UHFFFAOYSA-N 300596 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(8-methyl-3,8-diazabicyclo[3.2.1]oct-3-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 166 Protein Wnt-3a Human 3900 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300596&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459639 381749377 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575245 CC1CN(C)CCN1CC(=O)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C24H25F3N6O3S/c1-15-13-32(2)10-11-33(15)14-20(34)28-18-12-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,12,15H,10-11,13-14H2,1-2H3,(H,28,34)(H,29,31,35) SJKNFORWJWODFL-UHFFFAOYSA-N 300597 3-{[(2,4-dimethylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 167 Protein Wnt-3a Human 685 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300597&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608488 381749378 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575246 CC1CN(C)CCN1CC(=O)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C24H25F3N6O3S/c1-15-13-32(2)10-11-33(15)14-20(34)28-18-12-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,12,15H,10-11,13-14H2,1-2H3,(H,28,34)(H,29,31,35) SJKNFORWJWODFL-UHFFFAOYSA-N 300597 3-{[(2,4-dimethylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 167 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300597&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608488 381749378 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575247 CN4CCCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H25F3N6O3S/c1-32-10-5-11-33(13-12-32)15-20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-3-2-4-7-16/h2-4,6-9,14H,5,10-13,15H2,1H3,(H,28,34)(H,29,31,35) ZSRCWTPZLLQYCM-UHFFFAOYSA-N 300598 3-{[(4-methyl-1,4-diazepan-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 168 Protein Wnt-3a Human 1080 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300598&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462720 381749379 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575248 CN4CCCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H25F3N6O3S/c1-32-10-5-11-33(13-12-32)15-20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-3-2-4-7-16/h2-4,6-9,14H,5,10-13,15H2,1H3,(H,28,34)(H,29,31,35) ZSRCWTPZLLQYCM-UHFFFAOYSA-N 300598 3-{[(4-methyl-1,4-diazepan-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 168 Protein Wnt-3a Human 12000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300598&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462720 381749379 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575249 O=C(CN1CCCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C23H22F3N5O4S/c24-23(25,26)35-18-8-7-16(13-17(18)27-19(32)14-31-9-4-11-34-12-10-31)20(33)28-22-30-29-21(36-22)15-5-2-1-3-6-15/h1-3,5-8,13H,4,9-12,14H2,(H,27,32)(H,28,30,33) RAIVJJCRJLZDCI-UHFFFAOYSA-N 300599 3-[(1,4-oxazepan-4-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 169 Protein Wnt-3a Human 66.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300599&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462616 381749380 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575250 O=C(CN1CCCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C23H22F3N5O4S/c24-23(25,26)35-18-8-7-16(13-17(18)27-19(32)14-31-9-4-11-34-12-10-31)20(33)28-22-30-29-21(36-22)15-5-2-1-3-6-15/h1-3,5-8,13H,4,9-12,14H2,(H,27,32)(H,28,30,33) RAIVJJCRJLZDCI-UHFFFAOYSA-N 300599 3-[(1,4-oxazepan-4-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 169 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300599&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462616 381749380 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575251 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OC5CC5 InChI=1S/C24H25N5O4S/c30-21(15-29-10-12-32-13-11-29)25-19-14-17(6-9-20(19)33-18-7-8-18)22(31)26-24-28-27-23(34-24)16-4-2-1-3-5-16/h1-6,9,14,18H,7-8,10-13,15H2,(H,25,30)(H,26,28,31) UVOXPKOPPZKZBN-UHFFFAOYSA-N 300600 4-(cyclopropyloxy)-3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 170 Protein Wnt-3a Human 118 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300600&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462496 381749381 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575252 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OC5CC5 InChI=1S/C24H25N5O4S/c30-21(15-29-10-12-32-13-11-29)25-19-14-17(6-9-20(19)33-18-7-8-18)22(31)26-24-28-27-23(34-24)16-4-2-1-3-5-16/h1-6,9,14,18H,7-8,10-13,15H2,(H,25,30)(H,26,28,31) UVOXPKOPPZKZBN-UHFFFAOYSA-N 300600 4-(cyclopropyloxy)-3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 170 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300600&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462496 381749381 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575253 CN6CCN(C5(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC4CC4)CC5)CC6 InChI=1S/C27H30N6O3S/c1-32-13-15-33(16-14-32)27(11-12-27)25(35)28-21-17-19(7-10-22(21)36-20-8-9-20)23(34)29-26-31-30-24(37-26)18-5-3-2-4-6-18/h2-7,10,17,20H,8-9,11-16H2,1H3,(H,28,35)(H,29,31,34) VSEUYWCFGOXRCB-UHFFFAOYSA-N 300601 4-(cyclopropyloxy)-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 171 Protein Wnt-3a Human 102 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300601&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293018 381749382 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575254 CN6CCN(C5(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC4CC4)CC5)CC6 InChI=1S/C27H30N6O3S/c1-32-13-15-33(16-14-32)27(11-12-27)25(35)28-21-17-19(7-10-22(21)36-20-8-9-20)23(34)29-26-31-30-24(37-26)18-5-3-2-4-6-18/h2-7,10,17,20H,8-9,11-16H2,1H3,(H,28,35)(H,29,31,34) VSEUYWCFGOXRCB-UHFFFAOYSA-N 300601 4-(cyclopropyloxy)-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 171 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300601&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293018 381749382 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575255 CCN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H25F3N6O3S/c1-2-32-10-12-33(13-11-32)15-20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14H,2,10-13,15H2,1H3,(H,28,34)(H,29,31,35) BPALRZPDYSCQMA-UHFFFAOYSA-N 300602 3-{[(4-ethylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 172 Protein Wnt-3a Human 855 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300602&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462890 381749383 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575256 CCN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H25F3N6O3S/c1-2-32-10-12-33(13-11-32)15-20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14H,2,10-13,15H2,1H3,(H,28,34)(H,29,31,35) BPALRZPDYSCQMA-UHFFFAOYSA-N 300602 3-{[(4-ethylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 172 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300602&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462890 381749383 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575257 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3Cl)CC4 InChI=1S/C22H23ClN6O2S/c1-28-9-11-29(12-10-28)14-19(30)24-18-13-16(7-8-17(18)23)20(31)25-22-27-26-21(32-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,24,30)(H,25,27,31) IXDRMRQJBIPTLB-UHFFFAOYSA-N 300603 4-chloro-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 173 Protein Wnt-3a Human 520 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300603 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300603&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461696 381749384 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575258 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3Cl)CC4 InChI=1S/C22H23ClN6O2S/c1-28-9-11-29(12-10-28)14-19(30)24-18-13-16(7-8-17(18)23)20(31)25-22-27-26-21(32-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,24,30)(H,25,27,31) IXDRMRQJBIPTLB-UHFFFAOYSA-N 300603 4-chloro-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 173 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300603 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300603&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461696 381749384 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575259 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3C#N)CC4 InChI=1S/C23H23N7O2S/c1-29-9-11-30(12-10-29)15-20(31)25-19-13-17(7-8-18(19)14-24)21(32)26-23-28-27-22(33-23)16-5-3-2-4-6-16/h2-8,13H,9-12,15H2,1H3,(H,25,31)(H,26,28,32) VWIDLKSSNAOYJK-UHFFFAOYSA-N 300604 4-cyano-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 174 Protein Wnt-3a Human 3800 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300604&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463138 381749385 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575260 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3C#N)CC4 InChI=1S/C23H23N7O2S/c1-29-9-11-30(12-10-29)15-20(31)25-19-13-17(7-8-18(19)14-24)21(32)26-23-28-27-22(33-23)16-5-3-2-4-6-16/h2-8,13H,9-12,15H2,1H3,(H,25,31)(H,26,28,32) VWIDLKSSNAOYJK-UHFFFAOYSA-N 300604 4-cyano-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 174 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300604&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463138 381749385 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575261 Cc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)F)c(NC(=O)CN2CCN(C)CC2)c3)s4 InChI=1S/C24H26F2N6O3S/c1-15-5-3-4-6-17(15)22-29-30-24(36-22)28-21(34)16-7-8-19(35-23(25)26)18(13-16)27-20(33)14-32-11-9-31(2)10-12-32/h3-8,13,23H,9-12,14H2,1-2H3,(H,27,33)(H,28,30,34) IAYMTGIVHBMYGA-UHFFFAOYSA-N 300605 4-(difluoromethoxy)-N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}benzamide::US10130633, Example 175 Protein Wnt-3a Human 215 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300605&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462352 381749386 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575262 Cc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)F)c(NC(=O)CN2CCN(C)CC2)c3)s4 InChI=1S/C24H26F2N6O3S/c1-15-5-3-4-6-17(15)22-29-30-24(36-22)28-21(34)16-7-8-19(35-23(25)26)18(13-16)27-20(33)14-32-11-9-31(2)10-12-32/h3-8,13,23H,9-12,14H2,1-2H3,(H,27,33)(H,28,30,34) IAYMTGIVHBMYGA-UHFFFAOYSA-N 300605 4-(difluoromethoxy)-N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}benzamide::US10130633, Example 175 Protein Wnt-3a Human 7100 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300605&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462352 381749386 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575263 COCc3ccc(C(=O)Nc2nnc(c1ccccc1C)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C24H27N5O4S/c1-16-5-3-4-6-19(16)23-27-28-24(34-23)26-22(31)17-7-8-18(15-32-2)20(13-17)25-21(30)14-29-9-11-33-12-10-29/h3-8,13H,9-12,14-15H2,1-2H3,(H,25,30)(H,26,28,31) JNWOTSDRFZKFLM-UHFFFAOYSA-N 300606 4-(methoxymethyl)-N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 176 Protein Wnt-3a Human 315 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300606&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461596 381749387 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575264 COCc3ccc(C(=O)Nc2nnc(c1ccccc1C)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C24H27N5O4S/c1-16-5-3-4-6-19(16)23-27-28-24(34-23)26-22(31)17-7-8-18(15-32-2)20(13-17)25-21(30)14-29-9-11-33-12-10-29/h3-8,13H,9-12,14-15H2,1-2H3,(H,25,30)(H,26,28,31) JNWOTSDRFZKFLM-UHFFFAOYSA-N 300606 4-(methoxymethyl)-N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 176 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300606&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461596 381749387 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575265 COCc3ccc(C(=O)Nc2nnc(c1ccccc1C)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C25H30N6O3S/c1-17-6-4-5-7-20(17)24-28-29-25(35-24)27-23(33)18-8-9-19(16-34-3)21(14-18)26-22(32)15-31-12-10-30(2)11-13-31/h4-9,14H,10-13,15-16H2,1-3H3,(H,26,32)(H,27,29,33) MIVIGGIWTKLWDA-UHFFFAOYSA-N 300607 4-(methoxymethyl)-N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}benzamide hydrochloride (1:1)::US10130633, Example 177 Protein Wnt-3a Human 460 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300607&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462714 381749388 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575266 COCc3ccc(C(=O)Nc2nnc(c1ccccc1C)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C25H30N6O3S/c1-17-6-4-5-7-20(17)24-28-29-25(35-24)27-23(33)18-8-9-19(16-34-3)21(14-18)26-22(32)15-31-12-10-30(2)11-13-31/h4-9,14H,10-13,15-16H2,1-3H3,(H,26,32)(H,27,29,33) MIVIGGIWTKLWDA-UHFFFAOYSA-N 300607 4-(methoxymethyl)-N-[5-(2-methylphenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}benzamide hydrochloride (1:1)::US10130633, Example 177 Protein Wnt-3a Human 35000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300607&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462714 381749388 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575267 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-10-16(2-7-25(24)41-28(31,32)33)27(39)35-20-3-6-23(34-12-20)17-8-18(29)11-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) CPGFVPCOIQDIEE-UHFFFAOYSA-N 300608 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 215::US10130633, Example 178 Protein Wnt-3a Human 42.4 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300608&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608509 381749389 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575268 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-10-16(2-7-25(24)41-28(31,32)33)27(39)35-20-3-6-23(34-12-20)17-8-18(29)11-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) CPGFVPCOIQDIEE-UHFFFAOYSA-N 300608 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 215::US10130633, Example 178 Protein Wnt-3a Human 3800 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300608&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608509 381749389 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575269 CN(C)C1(CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C25H22F4N4O3/c1-33(2)24(11-12-24)23(35)32-20-13-15(7-10-21(20)36-25(27,28)29)22(34)31-16-8-9-19(30-14-16)17-5-3-4-6-18(17)26/h3-10,13-14H,11-12H2,1-2H3,(H,31,34)(H,32,35) YDPJEULZEGJWCD-UHFFFAOYSA-N 300609 3-({[1- (dimethylamino)cyclopropyl] carbonyl}amino)-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethoxy)benzamide::US10130633, Example 179 Protein Wnt-3a Human 362 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300609 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300609&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460031 381749390 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575270 CN(C)C1(CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C25H22F4N4O3/c1-33(2)24(11-12-24)23(35)32-20-13-15(7-10-21(20)36-25(27,28)29)22(34)31-16-8-9-19(30-14-16)17-5-3-4-6-18(17)26/h3-10,13-14H,11-12H2,1-2H3,(H,31,34)(H,32,35) YDPJEULZEGJWCD-UHFFFAOYSA-N 300609 3-({[1- (dimethylamino)cyclopropyl] carbonyl}amino)-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethoxy)benzamide::US10130633, Example 179 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300609 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300609&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460031 381749390 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575271 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 |r| InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-8-15(2-5-24(23)40-27(30,31)32)26(38)34-19-3-4-22(33-11-19)16-6-17(28)9-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) JSAIVQYMVQPPGL-UHFFFAOYSA-N 300610 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- ({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 181::US10130633, Example 180 Protein Wnt-3a Human 148 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300610 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300610&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608510 381749391 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575272 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 |r| InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-8-15(2-5-24(23)40-27(30,31)32)26(38)34-19-3-4-22(33-11-19)16-6-17(28)9-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) JSAIVQYMVQPPGL-UHFFFAOYSA-N 300610 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- ({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 181::US10130633, Example 180 Protein Wnt-3a Human 9800 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300610 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300610&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608510 381749391 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575273 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 |r| InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-8-15(2-5-24(23)40-27(30,31)32)26(38)34-19-3-4-22(33-11-19)16-6-17(28)9-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) JSAIVQYMVQPPGL-UHFFFAOYSA-N 300610 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- ({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 181::US10130633, Example 180 Protein Wnt-3a Human 53.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300610 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300610&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608510 381749391 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575274 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 |r| InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-8-15(2-5-24(23)40-27(30,31)32)26(38)34-19-3-4-22(33-11-19)16-6-17(28)9-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) JSAIVQYMVQPPGL-UHFFFAOYSA-N 300610 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- ({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 181::US10130633, Example 180 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300610 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300610&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608510 381749391 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575275 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-18(5-8-23(22)38-26(28,29)30)25(36)32-20-6-7-21(31-15-20)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) CPGGPSNHWZNRFF-UHFFFAOYSA-N 300612 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 183::US10130633, Example 182 Protein Wnt-3a Human 288 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300612 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300612&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292059 381749392 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575276 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-18(5-8-23(22)38-26(28,29)30)25(36)32-20-6-7-21(31-15-20)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) CPGGPSNHWZNRFF-UHFFFAOYSA-N 300612 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 183::US10130633, Example 182 Protein Wnt-3a Human 44000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300612 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300612&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292059 381749392 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575277 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-18(5-8-23(22)38-26(28,29)30)25(36)32-20-6-7-21(31-15-20)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) CPGGPSNHWZNRFF-UHFFFAOYSA-N 300612 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 183::US10130633, Example 182 Protein Wnt-3a Human 29.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300612 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300612&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292059 381749392 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575278 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-18(5-8-23(22)38-26(28,29)30)25(36)32-20-6-7-21(31-15-20)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) CPGGPSNHWZNRFF-UHFFFAOYSA-N 300612 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 183::US10130633, Example 182 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300612 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300612&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292059 381749392 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575279 O=C(CN1C[C@@H]2C[C@H]1CO2)Nc5cc(NC(=O)c4ccc(c3cc(F)cc(F)c3)nc4)ccc5OC(F)(F)F InChI=1S/C26H21F5N4O4/c27-16-5-15(6-17(28)7-16)21-3-1-14(10-32-21)25(37)33-18-2-4-23(39-26(29,30)31)22(8-18)34-24(36)12-35-11-20-9-19(35)13-38-20/h1-8,10,19-20H,9,11-13H2,(H,33,37)(H,34,36) PQQAFFMNOCRFGS-UHFFFAOYSA-N 300614 6-(3,5-difluorophenyl)-N-[3- {[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- ylacetyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 184 Protein Wnt-3a Human 196 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300614 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300614&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122513692 381749393 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575280 O=C(CN1C[C@@H]2C[C@H]1CO2)Nc5cc(NC(=O)c4ccc(c3cc(F)cc(F)c3)nc4)ccc5OC(F)(F)F InChI=1S/C26H21F5N4O4/c27-16-5-15(6-17(28)7-16)21-3-1-14(10-32-21)25(37)33-18-2-4-23(39-26(29,30)31)22(8-18)34-24(36)12-35-11-20-9-19(35)13-38-20/h1-8,10,19-20H,9,11-13H2,(H,33,37)(H,34,36) PQQAFFMNOCRFGS-UHFFFAOYSA-N 300614 6-(3,5-difluorophenyl)-N-[3- {[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- ylacetyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 184 Protein Wnt-3a Human 11000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300614 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300614&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122513692 381749393 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575281 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F |r| InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-9-19(3-5-24(23)40-27(30,31)32)34-26(38)15-2-4-22(33-11-15)16-6-17(28)8-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) YGCKEZVKGKFJRJ-UHFFFAOYSA-N 300615 6-(3,5-difluorophenyl)-N-[3- ({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 217::US10130633, Example 185 Protein Wnt-3a Human 160 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300615 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300615&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608497 381749394 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575282 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F |r| InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-9-19(3-5-24(23)40-27(30,31)32)34-26(38)15-2-4-22(33-11-15)16-6-17(28)8-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) YGCKEZVKGKFJRJ-UHFFFAOYSA-N 300615 6-(3,5-difluorophenyl)-N-[3- ({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 217::US10130633, Example 185 Protein Wnt-3a Human 10000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300615 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300615&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608497 381749394 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575283 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-11-20(3-7-25(24)41-28(31,32)33)35-27(39)16-2-6-23(34-12-16)17-8-18(29)10-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) ORGZGXHJAVTURH-UHFFFAOYSA-N 300616 US10130633, Example 218::6-(3,5-difluorophenyl)-N-[3-{[2- (8-oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 186 Protein Wnt-3a Human 95.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300616 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300616&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458876 381749395 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575284 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-11-20(3-7-25(24)41-28(31,32)33)35-27(39)16-2-6-23(34-12-16)17-8-18(29)10-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) ORGZGXHJAVTURH-UHFFFAOYSA-N 300616 US10130633, Example 218::6-(3,5-difluorophenyl)-N-[3-{[2- (8-oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 186 Protein Wnt-3a Human 5400 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300616 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300616&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458876 381749395 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575285 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-13-20(3-5-23(22)39-26(29,30)31)33-25(37)16-2-4-21(32-14-16)17-10-18(27)12-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) KHTVKLOEOYGTGS-UHFFFAOYSA-N 300617 US10130633, Example 187::6-(3,5-difluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::BDBM300633 Protein Wnt-3a Human 175 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300617 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300617&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459456 381749396 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575286 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-13-20(3-5-23(22)39-26(29,30)31)33-25(37)16-2-4-21(32-14-16)17-10-18(27)12-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) KHTVKLOEOYGTGS-UHFFFAOYSA-N 300617 US10130633, Example 187::6-(3,5-difluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::BDBM300633 Protein Wnt-3a Human 42000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300617 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300617&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459456 381749396 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575287 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-20(6-10-25(24)40-28(30,31)32)34-27(38)18-5-9-23(33-13-18)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) LATTXWCIZLGUND-UHFFFAOYSA-N 300618 US10130633, Example 220::6-(3-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 188 Protein Wnt-3a Human 120 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300618 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300618&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459596 381749397 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575288 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-20(6-10-25(24)40-28(30,31)32)34-27(38)18-5-9-23(33-13-18)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) LATTXWCIZLGUND-UHFFFAOYSA-N 300618 US10130633, Example 220::6-(3-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 188 Protein Wnt-3a Human 5500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300618 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300618&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459596 381749397 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575289 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-20(6-8-23(22)38-26(28,29)30)32-25(36)18-5-7-21(31-15-18)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) QPPPKBFFQKDCMX-UHFFFAOYSA-N 300619 6-(3-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 190::US10130633, Example 189 Protein Wnt-3a Human 138 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300619 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300619&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90464913 381749398 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575290 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-20(6-8-23(22)38-26(28,29)30)32-25(36)18-5-7-21(31-15-18)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) QPPPKBFFQKDCMX-UHFFFAOYSA-N 300619 6-(3-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 190::US10130633, Example 189 Protein Wnt-3a Human 10000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300619 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300619&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90464913 381749398 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575291 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-20(6-8-23(22)38-26(28,29)30)32-25(36)18-5-7-21(31-15-18)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) QPPPKBFFQKDCMX-UHFFFAOYSA-N 300619 6-(3-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 190::US10130633, Example 189 Protein Wnt-3a Human 87.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300619 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300619&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90464913 381749398 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575292 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-20(6-8-23(22)38-26(28,29)30)32-25(36)18-5-7-21(31-15-18)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) QPPPKBFFQKDCMX-UHFFFAOYSA-N 300619 6-(3-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 190::US10130633, Example 189 Protein Wnt-3a Human 9500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300619 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300619&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90464913 381749398 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575293 FC(F)(F)Oc1ccc(cc1NC(=O)CN1CCOCC1)C(=O)Nc1nnc(o1)-c1ccccc1 InChI=1S/C22H20F3N5O5/c23-22(24,25)35-17-7-6-15(12-16(17)26-18(31)13-30-8-10-33-11-9-30)19(32)27-21-29-28-20(34-21)14-4-2-1-3-5-14/h1-7,12H,8-11,13H2,(H,26,31)(H,27,29,32) JQLQNWPQDNVZOR-UHFFFAOYSA-N 300621 3-[(morpholin-4- ylacetyl)amino]-N-(5-phenyl- 1,3,4-oxadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 191 Protein Wnt-3a Human 4100 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300621 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300621&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608472 381749399 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575294 FC(F)(F)Oc1ccc(cc1NC(=O)CN1CCOCC1)C(=O)Nc1nnc(o1)-c1ccccc1 InChI=1S/C22H20F3N5O5/c23-22(24,25)35-17-7-6-15(12-16(17)26-18(31)13-30-8-10-33-11-9-30)19(32)27-21-29-28-20(34-21)14-4-2-1-3-5-14/h1-7,12H,8-11,13H2,(H,26,31)(H,27,29,32) JQLQNWPQDNVZOR-UHFFFAOYSA-N 300621 3-[(morpholin-4- ylacetyl)amino]-N-(5-phenyl- 1,3,4-oxadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 191 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300621 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300621&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608472 381749399 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575295 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4C[C@@H]5C[C@H]4CO5 InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-17(5-8-24(23)39-27(29,30)31)26(37)33-19-6-7-22(32-12-19)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IVAPGQZOCYCUJU-UHFFFAOYSA-N 300622 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-({2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 192 Protein Wnt-3a Human 135 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300622 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300622&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608515 381749400 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575296 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4C[C@@H]5C[C@H]4CO5 InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-17(5-8-24(23)39-27(29,30)31)26(37)33-19-6-7-22(32-12-19)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IVAPGQZOCYCUJU-UHFFFAOYSA-N 300622 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-({2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 192 Protein Wnt-3a Human 12400 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300622 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300622&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608515 381749400 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575297 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F |r| InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-19(6-8-24(23)39-27(29,30)31)33-26(37)17-5-7-22(32-12-17)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IUQPGUXQWQGVHA-UHFFFAOYSA-N 300623 US10130633, Example 222::6-(3-fluorophenyl)-N-[3-({(2R*)- 2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 193 Protein Wnt-3a Human 148 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300623 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300623&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608476 381749401 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575298 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F |r| InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-19(6-8-24(23)39-27(29,30)31)33-26(37)17-5-7-22(32-12-17)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IUQPGUXQWQGVHA-UHFFFAOYSA-N 300623 US10130633, Example 222::6-(3-fluorophenyl)-N-[3-({(2R*)- 2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 193 Protein Wnt-3a Human 8800 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300623 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300623&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608476 381749401 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575299 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-10-16(2-7-25(24)41-28(31,32)33)27(39)35-20-3-6-23(34-12-20)17-8-18(29)11-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) CPGFVPCOIQDIEE-UHFFFAOYSA-N 300624 N-[6-(3,5-difluorophenyl) pyridin-3-yl]-3- {[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 194 Protein Wnt-3a Human 39.9 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300624 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300624&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608509 381749402 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575300 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-10-16(2-7-25(24)41-28(31,32)33)27(39)35-20-3-6-23(34-12-20)17-8-18(29)11-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) CPGFVPCOIQDIEE-UHFFFAOYSA-N 300624 N-[6-(3,5-difluorophenyl) pyridin-3-yl]-3- {[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 194 Protein Wnt-3a Human 35000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300624 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300624&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608509 381749402 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575301 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(O)cc1 InChI=1S/C26H25F3N4O5/c1-16(33-10-12-37-13-11-33)24(35)32-22-14-18(4-9-23(22)38-26(27,28)29)25(36)31-19-5-8-21(30-15-19)17-2-6-20(34)7-3-17/h2-9,14-16,34H,10-13H2,1H3,(H,31,36)(H,32,35) KCLNHRUVIHYPGS-UHFFFAOYSA-N 300625 N-[6-(4-hydroxyphenyl)pyridin- 3-yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 195 Protein Wnt-3a Human 222 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300625 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300625&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 136638946 381749403 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575302 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(O)cc1 InChI=1S/C26H25F3N4O5/c1-16(33-10-12-37-13-11-33)24(35)32-22-14-18(4-9-23(22)38-26(27,28)29)25(36)31-19-5-8-21(30-15-19)17-2-6-20(34)7-3-17/h2-9,14-16,34H,10-13H2,1H3,(H,31,36)(H,32,35) KCLNHRUVIHYPGS-UHFFFAOYSA-N 300625 N-[6-(4-hydroxyphenyl)pyridin- 3-yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 195 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300625 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300625&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 136638946 381749403 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575303 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N5CCN(C4CC4)CC5 InChI=1S/C29H29F4N5O3/c1-18(37-12-14-38(15-13-37)21-8-9-21)27(39)36-25-16-19(6-11-26(25)41-29(31,32)33)28(40)35-20-7-10-24(34-17-20)22-4-2-3-5-23(22)30/h2-7,10-11,16-18,21H,8-9,12-15H2,1H3,(H,35,40)(H,36,39) CKDUXLHDEQCHIL-UHFFFAOYSA-N 300626 3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amino}-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethoxy)benzamide::US10130633, Example 196 Protein Wnt-3a Human 143 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300626 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300626&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459015 381749404 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575304 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N5CCN(C4CC4)CC5 InChI=1S/C29H29F4N5O3/c1-18(37-12-14-38(15-13-37)21-8-9-21)27(39)36-25-16-19(6-11-26(25)41-29(31,32)33)28(40)35-20-7-10-24(34-17-20)22-4-2-3-5-23(22)30/h2-7,10-11,16-18,21H,8-9,12-15H2,1H3,(H,35,40)(H,36,39) CKDUXLHDEQCHIL-UHFFFAOYSA-N 300626 3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amino}-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethoxy)benzamide::US10130633, Example 196 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300626 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300626&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459015 381749404 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575305 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)CC4 InChI=1S/C26H25F4N5O3/c1-34-10-12-35(13-11-34)16-24(36)33-22-14-17(6-9-23(22)38-26(28,29)30)25(37)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-15H,10-13,16H2,1H3,(H,32,37)(H,33,36) LMDODSFONNSZHT-UHFFFAOYSA-N 300627 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[(4-methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 197 Protein Wnt-3a Human 1200 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300627 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300627&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459612 381749405 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575306 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)CC4 InChI=1S/C26H25F4N5O3/c1-34-10-12-35(13-11-34)16-24(36)33-22-14-17(6-9-23(22)38-26(28,29)30)25(37)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-15H,10-13,16H2,1H3,(H,32,37)(H,33,36) LMDODSFONNSZHT-UHFFFAOYSA-N 300627 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[(4-methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 197 Protein Wnt-3a Human 34000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300627 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300627&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459612 381749405 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575307 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4C[C@@H]5C[C@H]4CO5 InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-9-19(3-5-24(23)40-27(30,31)32)34-26(38)15-2-4-22(33-11-15)16-6-17(28)8-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) YGCKEZVKGKFJRJ-UHFFFAOYSA-N 300628 6-(3,5-difluorophenyl)-N-[3-({2- [(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 198 Protein Wnt-3a Human 144 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300628 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300628&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608497 381749406 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575308 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4C[C@@H]5C[C@H]4CO5 InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-9-19(3-5-24(23)40-27(30,31)32)34-26(38)15-2-4-22(33-11-15)16-6-17(28)8-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) YGCKEZVKGKFJRJ-UHFFFAOYSA-N 300628 6-(3,5-difluorophenyl)-N-[3-({2- [(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 198 Protein Wnt-3a Human 15000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300628 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300628&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608497 381749406 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575309 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4C[C@@H]5C[C@H]4CO5 InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-19(6-8-24(23)39-27(29,30)31)33-26(37)17-5-7-22(32-12-17)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IUQPGUXQWQGVHA-UHFFFAOYSA-N 300629 6-(3-fluorophenyl)-N-[3-({2- [(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 199 Protein Wnt-3a Human 71.7 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300629 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300629&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608476 381749407 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575310 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4C[C@@H]5C[C@H]4CO5 InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-19(6-8-24(23)39-27(29,30)31)33-26(37)17-5-7-22(32-12-17)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IUQPGUXQWQGVHA-UHFFFAOYSA-N 300629 6-(3-fluorophenyl)-N-[3-({2- [(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 199 Protein Wnt-3a Human 8800 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300629 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300629&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608476 381749407 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575311 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-20(6-10-25(24)40-28(30,31)32)34-27(38)18-5-9-23(33-13-18)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) LATTXWCIZLGUND-UHFFFAOYSA-N 300630 6-(3-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 200 Protein Wnt-3a Human 190 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300630 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300630&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459596 381749408 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575312 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-20(6-10-25(24)40-28(30,31)32)34-27(38)18-5-9-23(33-13-18)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) LATTXWCIZLGUND-UHFFFAOYSA-N 300630 6-(3-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 200 Protein Wnt-3a Human 6400 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300630 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300630&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459596 381749408 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575313 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-20(6-8-23(22)38-26(28,29)30)32-25(36)18-5-7-21(31-15-18)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) QPPPKBFFQKDCMX-UHFFFAOYSA-N 300631 6-(3-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 201 Protein Wnt-3a Human 106 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300631 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300631&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90464913 381749409 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575314 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-9-11-37-12-10-34)24(35)33-22-14-20(6-8-23(22)38-26(28,29)30)32-25(36)18-5-7-21(31-15-18)17-3-2-4-19(27)13-17/h2-8,13-16H,9-12H2,1H3,(H,32,36)(H,33,35) QPPPKBFFQKDCMX-UHFFFAOYSA-N 300631 6-(3-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 201 Protein Wnt-3a Human 28600 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300631 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300631&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90464913 381749409 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575315 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-11-20(3-7-25(24)41-28(31,32)33)35-27(39)16-2-6-23(34-12-16)17-8-18(29)10-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) ORGZGXHJAVTURH-UHFFFAOYSA-N 300632 6-(3,5-difluorophenyl)-N-[3-{[2- (8-oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 202 Protein Wnt-3a Human 200 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300632 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300632&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458876 381749410 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575316 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-11-20(3-7-25(24)41-28(31,32)33)35-27(39)16-2-6-23(34-12-16)17-8-18(29)10-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) ORGZGXHJAVTURH-UHFFFAOYSA-N 300632 6-(3,5-difluorophenyl)-N-[3-{[2- (8-oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 202 Protein Wnt-3a Human 5800 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300632 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300632&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458876 381749410 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575317 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-13-20(3-5-23(22)39-26(29,30)31)33-25(37)16-2-4-21(32-14-16)17-10-18(27)12-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) KHTVKLOEOYGTGS-UHFFFAOYSA-N 300617 US10130633, Example 187::6-(3,5-difluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::BDBM300633 Protein Wnt-3a Human 124 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300617 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300617&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459456 381749396 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575318 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-13-20(3-5-23(22)39-26(29,30)31)33-25(37)16-2-4-21(32-14-16)17-10-18(27)12-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) KHTVKLOEOYGTGS-UHFFFAOYSA-N 300617 US10130633, Example 187::6-(3,5-difluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::BDBM300633 Protein Wnt-3a Human 15200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300617 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300617&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459456 381749396 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575319 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2ccccc2F)ccc1OC(F)(F)F InChI=1S/C28H26F4N4O4/c1-16(36-14-19-8-9-20(15-36)39-19)26(37)35-24-12-18(7-11-25(24)40-28(30,31)32)34-27(38)17-6-10-23(33-13-17)21-4-2-3-5-22(21)29/h2-7,10-13,16,19-20H,8-9,14-15H2,1H3,(H,34,38)(H,35,37) LMVNIXQGKHQJFM-UHFFFAOYSA-N 300634 6-(2-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 205::US10130633, Example 204 Protein Wnt-3a Human 76.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300634 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300634&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460269 381749411 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575320 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2ccccc2F)ccc1OC(F)(F)F InChI=1S/C28H26F4N4O4/c1-16(36-14-19-8-9-20(15-36)39-19)26(37)35-24-12-18(7-11-25(24)40-28(30,31)32)34-27(38)17-6-10-23(33-13-17)21-4-2-3-5-22(21)29/h2-7,10-13,16,19-20H,8-9,14-15H2,1H3,(H,34,38)(H,35,37) LMVNIXQGKHQJFM-UHFFFAOYSA-N 300634 6-(2-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 205::US10130633, Example 204 Protein Wnt-3a Human 32800 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300634 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300634&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460269 381749411 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575321 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2ccccc2F)ccc1OC(F)(F)F InChI=1S/C28H26F4N4O4/c1-16(36-14-19-8-9-20(15-36)39-19)26(37)35-24-12-18(7-11-25(24)40-28(30,31)32)34-27(38)17-6-10-23(33-13-17)21-4-2-3-5-22(21)29/h2-7,10-13,16,19-20H,8-9,14-15H2,1H3,(H,34,38)(H,35,37) LMVNIXQGKHQJFM-UHFFFAOYSA-N 300634 6-(2-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 205::US10130633, Example 204 Protein Wnt-3a Human 20.2 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300634 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300634&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460269 381749411 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575322 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2ccccc2F)ccc1OC(F)(F)F InChI=1S/C28H26F4N4O4/c1-16(36-14-19-8-9-20(15-36)39-19)26(37)35-24-12-18(7-11-25(24)40-28(30,31)32)34-27(38)17-6-10-23(33-13-17)21-4-2-3-5-22(21)29/h2-7,10-13,16,19-20H,8-9,14-15H2,1H3,(H,34,38)(H,35,37) LMVNIXQGKHQJFM-UHFFFAOYSA-N 300634 6-(2-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 205::US10130633, Example 204 Protein Wnt-3a Human 18200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300634 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300634&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460269 381749411 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575323 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2ccccc2F)ccc1OC(F)(F)F InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(7-9-23(22)38-26(28,29)30)32-25(36)17-6-8-21(31-15-17)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) XFZOXFOCQJSZKQ-UHFFFAOYSA-N 300636 6-(2-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 224::US10130633, Example 206 Protein Wnt-3a Human 87.6 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300636 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300636&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458705 381749412 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575324 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2ccccc2F)ccc1OC(F)(F)F InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(7-9-23(22)38-26(28,29)30)32-25(36)17-6-8-21(31-15-17)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) XFZOXFOCQJSZKQ-UHFFFAOYSA-N 300636 6-(2-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 224::US10130633, Example 206 Protein Wnt-3a Human 36500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300636 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300636&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458705 381749412 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575325 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3C(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O3/c1-16(34-10-12-37-13-11-34)24(35)33-23-14-17(6-8-20(23)26(28,29)30)25(36)32-18-7-9-22(31-15-18)19-4-2-3-5-21(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) PFSXCOASGAJFDG-UHFFFAOYSA-N 300637 US10130633, Example 225::N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethyl)benzamide::US10130633, Example 207 Protein Wnt-3a Human 153 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300637 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300637&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458818 381749413 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575326 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3C(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O3/c1-16(34-10-12-37-13-11-34)24(35)33-23-14-17(6-8-20(23)26(28,29)30)25(36)32-18-7-9-22(31-15-18)19-4-2-3-5-21(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) PFSXCOASGAJFDG-UHFFFAOYSA-N 300637 US10130633, Example 225::N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethyl)benzamide::US10130633, Example 207 Protein Wnt-3a Human 8550 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300637 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300637&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458818 381749413 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575327 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H25F3N4O4/c1-17(33-11-13-36-14-12-33)24(34)32-22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-17H,11-14H2,1H3,(H,31,35)(H,32,34) FWSLMXRDOJIPST-UHFFFAOYSA-N 300440 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 208::US10130633, Example 10 Protein Wnt-3a Human 10.4 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300440&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293398 381749221 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575328 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H25F3N4O4/c1-17(33-11-13-36-14-12-33)24(34)32-22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-17H,11-14H2,1H3,(H,31,35)(H,32,34) FWSLMXRDOJIPST-UHFFFAOYSA-N 300440 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 208::US10130633, Example 10 Protein Wnt-3a Human 9700 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300440&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293398 381749221 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575329 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1 InChI=1S/C26H25F3N4O4/c1-17(33-11-13-36-14-12-33)24(34)32-22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-17H,11-14H2,1H3,(H,31,35)(H,32,34) FWSLMXRDOJIPST-UHFFFAOYSA-N 300639 3-{[2-(morpholin-4- yl)propanoyl]amino}-N-(6- phenylpyridin-3-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 209 Protein Wnt-3a Human 112 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300639 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300639&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293398 381749414 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575330 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1 InChI=1S/C26H25F3N4O4/c1-17(33-11-13-36-14-12-33)24(34)32-22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-17H,11-14H2,1H3,(H,31,35)(H,32,34) FWSLMXRDOJIPST-UHFFFAOYSA-N 300639 3-{[2-(morpholin-4- yl)propanoyl]amino}-N-(6- phenylpyridin-3-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 209 Protein Wnt-3a Human 11000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300639 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300639&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293398 381749414 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575331 CN1CCN(CC(=O)Nc2cc(ccc2C(F)(F)F)C(=O)Nc2ccc(nc2)-c2ccccc2F)CC1 InChI=1S/C26H25F4N5O2/c1-34-10-12-35(13-11-34)16-24(36)33-23-14-17(6-8-20(23)26(28,29)30)25(37)32-18-7-9-22(31-15-18)19-4-2-3-5-21(19)27/h2-9,14-15H,10-13,16H2,1H3,(H,32,37)(H,33,36) LEVIESVMAYMBRU-UHFFFAOYSA-N 300640 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[(4-methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethyl)benzamide::US10130633, Example 210 Protein Wnt-3a Human 152 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300640 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300640&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459864 381749415 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575332 CN1CCN(CC(=O)Nc2cc(ccc2C(F)(F)F)C(=O)Nc2ccc(nc2)-c2ccccc2F)CC1 InChI=1S/C26H25F4N5O2/c1-34-10-12-35(13-11-34)16-24(36)33-23-14-17(6-8-20(23)26(28,29)30)25(37)32-18-7-9-22(31-15-18)19-4-2-3-5-21(19)27/h2-9,14-15H,10-13,16H2,1H3,(H,32,37)(H,33,36) LEVIESVMAYMBRU-UHFFFAOYSA-N 300640 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[(4-methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethyl)benzamide::US10130633, Example 210 Protein Wnt-3a Human 29500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300640 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300640&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459864 381749415 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575333 CC(N1CCOCC1)C(=O)Nc1cc(ccc1C(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C26H24F4N4O3/c1-16(34-10-12-37-13-11-34)24(35)33-23-14-17(6-8-20(23)26(28,29)30)25(36)32-18-7-9-22(31-15-18)19-4-2-3-5-21(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) PFSXCOASGAJFDG-UHFFFAOYSA-N 300641 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethyl)benzamide::US10130633, Example 211 Protein Wnt-3a Human 40.2 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300641 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300641&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458818 381749416 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575334 CC(N1CCOCC1)C(=O)Nc1cc(ccc1C(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C26H24F4N4O3/c1-16(34-10-12-37-13-11-34)24(35)33-23-14-17(6-8-20(23)26(28,29)30)25(36)32-18-7-9-22(31-15-18)19-4-2-3-5-21(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) PFSXCOASGAJFDG-UHFFFAOYSA-N 300641 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethyl)benzamide::US10130633, Example 211 Protein Wnt-3a Human 24600 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300641 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300641&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458818 381749416 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575335 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H26F4N4O4/c1-16(36-14-19-8-9-20(15-36)39-19)26(37)35-24-12-18(7-11-25(24)40-28(30,31)32)34-27(38)17-6-10-23(33-13-17)21-4-2-3-5-22(21)29/h2-7,10-13,16,19-20H,8-9,14-15H2,1H3,(H,34,38)(H,35,37) LMVNIXQGKHQJFM-UHFFFAOYSA-N 300642 6-(2-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 212 Protein Wnt-3a Human 180 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300642 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300642&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460269 381749417 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575336 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H26F4N4O4/c1-16(36-14-19-8-9-20(15-36)39-19)26(37)35-24-12-18(7-11-25(24)40-28(30,31)32)34-27(38)17-6-10-23(33-13-17)21-4-2-3-5-22(21)29/h2-7,10-13,16,19-20H,8-9,14-15H2,1H3,(H,34,38)(H,35,37) LMVNIXQGKHQJFM-UHFFFAOYSA-N 300642 6-(2-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 212 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300642 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300642&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460269 381749417 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575337 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(7-9-23(22)38-26(28,29)30)32-25(36)17-6-8-21(31-15-17)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) XFZOXFOCQJSZKQ-UHFFFAOYSA-N 300643 6-(2-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 213 Protein Wnt-3a Human 140 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300643 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300643&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458705 381749418 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575338 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(7-9-23(22)38-26(28,29)30)32-25(36)17-6-8-21(31-15-17)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) XFZOXFOCQJSZKQ-UHFFFAOYSA-N 300643 6-(2-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 213 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300643 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300643&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458705 381749418 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575339 O=C(CN1C[C@@H]2C[C@H]1CO2)Nc5cc(C(=O)Nc4ccc(c3cc(F)cc(F)c3)nc4)ccc5OC(F)(F)F InChI=1S/C26H21F5N4O4/c27-16-5-15(6-17(28)8-16)21-3-2-18(10-32-21)33-25(37)14-1-4-23(39-26(29,30)31)22(7-14)34-24(36)12-35-11-20-9-19(35)13-38-20/h1-8,10,19-20H,9,11-13H2,(H,33,37)(H,34,36) UOYVIRAGJKUVFZ-UHFFFAOYSA-N 300644 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- ylacetyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 214 Protein Wnt-3a Human 375 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300644 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300644&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122513683 381749419 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575340 O=C(CN1C[C@@H]2C[C@H]1CO2)Nc5cc(C(=O)Nc4ccc(c3cc(F)cc(F)c3)nc4)ccc5OC(F)(F)F InChI=1S/C26H21F5N4O4/c27-16-5-15(6-17(28)8-16)21-3-2-18(10-32-21)33-25(37)14-1-4-23(39-26(29,30)31)22(7-14)34-24(36)12-35-11-20-9-19(35)13-38-20/h1-8,10,19-20H,9,11-13H2,(H,33,37)(H,34,36) UOYVIRAGJKUVFZ-UHFFFAOYSA-N 300644 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- ylacetyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 214 Protein Wnt-3a Human 6300 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300644 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300644&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122513683 381749419 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575341 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-10-16(2-7-25(24)41-28(31,32)33)27(39)35-20-3-6-23(34-12-20)17-8-18(29)11-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) CPGFVPCOIQDIEE-UHFFFAOYSA-N 300608 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 215::US10130633, Example 178 Protein Wnt-3a Human 245 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300608&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608509 381749389 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575342 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-10-16(2-7-25(24)41-28(31,32)33)27(39)35-20-3-6-23(34-12-20)17-8-18(29)11-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) CPGFVPCOIQDIEE-UHFFFAOYSA-N 300608 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 215::US10130633, Example 178 Protein Wnt-3a Human 3300 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300608&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608509 381749389 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575343 O=C(CN1CC2CCC(C1)O2)Nc5cc(NC(=O)c4ccc(c3cc(F)cc(F)c3)nc4)ccc5OC(F)(F)F InChI=1S/C27H23F5N4O4/c28-17-7-16(8-18(29)9-17)22-5-1-15(11-33-22)26(38)34-19-2-6-24(40-27(30,31)32)23(10-19)35-25(37)14-36-12-20-3-4-21(13-36)39-20/h1-2,5-11,20-21H,3-4,12-14H2,(H,34,38)(H,35,37) YISYDXQRWSOUMO-UHFFFAOYSA-N 300646 6-(3,5-difluorophenyl)-N-{3-[(8- oxa-3-azabicyclo[3.2.1]oct-3- ylacetyl)amino]-4- (trifluoromethoxy)phenyl} nicotinamide::US10130633, Example 216 Protein Wnt-3a Human 260 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300646 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300646&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459073 381749420 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575344 O=C(CN1CC2CCC(C1)O2)Nc5cc(NC(=O)c4ccc(c3cc(F)cc(F)c3)nc4)ccc5OC(F)(F)F InChI=1S/C27H23F5N4O4/c28-17-7-16(8-18(29)9-17)22-5-1-15(11-33-22)26(38)34-19-2-6-24(40-27(30,31)32)23(10-19)35-25(37)14-36-12-20-3-4-21(13-36)39-20/h1-2,5-11,20-21H,3-4,12-14H2,(H,34,38)(H,35,37) YISYDXQRWSOUMO-UHFFFAOYSA-N 300646 6-(3,5-difluorophenyl)-N-{3-[(8- oxa-3-azabicyclo[3.2.1]oct-3- ylacetyl)amino]-4- (trifluoromethoxy)phenyl} nicotinamide::US10130633, Example 216 Protein Wnt-3a Human 3600 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300646 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300646&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459073 381749420 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575345 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F |r| InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-9-19(3-5-24(23)40-27(30,31)32)34-26(38)15-2-4-22(33-11-15)16-6-17(28)8-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) YGCKEZVKGKFJRJ-UHFFFAOYSA-N 300615 6-(3,5-difluorophenyl)-N-[3- ({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 217::US10130633, Example 185 Protein Wnt-3a Human 438 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300615 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300615&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608497 381749394 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575346 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F |r| InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-9-19(3-5-24(23)40-27(30,31)32)34-26(38)15-2-4-22(33-11-15)16-6-17(28)8-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) YGCKEZVKGKFJRJ-UHFFFAOYSA-N 300615 6-(3,5-difluorophenyl)-N-[3- ({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 217::US10130633, Example 185 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300615 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300615&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608497 381749394 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575347 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-11-20(3-7-25(24)41-28(31,32)33)35-27(39)16-2-6-23(34-12-16)17-8-18(29)10-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) ORGZGXHJAVTURH-UHFFFAOYSA-N 300616 US10130633, Example 218::6-(3,5-difluorophenyl)-N-[3-{[2- (8-oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 186 Protein Wnt-3a Human 330 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300616 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300616&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458876 381749395 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575348 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cc(F)cc(F)c2)ccc1OC(F)(F)F InChI=1S/C28H25F5N4O4/c1-15(37-13-21-4-5-22(14-37)40-21)26(38)36-24-11-20(3-7-25(24)41-28(31,32)33)35-27(39)16-2-6-23(34-12-16)17-8-18(29)10-19(30)9-17/h2-3,6-12,15,21-22H,4-5,13-14H2,1H3,(H,35,39)(H,36,38) ORGZGXHJAVTURH-UHFFFAOYSA-N 300616 US10130633, Example 218::6-(3,5-difluorophenyl)-N-[3-{[2- (8-oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 186 Protein Wnt-3a Human 15000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300616 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300616&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458876 381749395 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575349 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-13-20(3-5-23(22)39-26(29,30)31)33-25(37)16-2-4-21(32-14-16)17-10-18(27)12-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) KHTVKLOEOYGTGS-UHFFFAOYSA-N 300649 6-(3,5-difluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 219 Protein Wnt-3a Human 245 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300649 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300649&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459456 381749421 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575350 CC(C(=O)Nc3cc(NC(=O)c2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-13-20(3-5-23(22)39-26(29,30)31)33-25(37)16-2-4-21(32-14-16)17-10-18(27)12-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) KHTVKLOEOYGTGS-UHFFFAOYSA-N 300649 6-(3,5-difluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 219 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300649 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300649&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459456 381749421 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575351 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-20(6-10-25(24)40-28(30,31)32)34-27(38)18-5-9-23(33-13-18)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) LATTXWCIZLGUND-UHFFFAOYSA-N 300618 US10130633, Example 220::6-(3-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 188 Protein Wnt-3a Human 375 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300618 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300618&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459596 381749397 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575352 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-20(6-10-25(24)40-28(30,31)32)34-27(38)18-5-9-23(33-13-18)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) LATTXWCIZLGUND-UHFFFAOYSA-N 300618 US10130633, Example 220::6-(3-fluorophenyl)-N-[3-{[2-(8- oxa-3-azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 188 Protein Wnt-3a Human 13000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300618 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300618&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459596 381749397 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575353 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-12-16(2-5-23(22)39-26(29,30)31)25(37)33-20-3-4-21(32-14-20)17-10-18(27)13-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) GYGINCUNIMDWPT-UHFFFAOYSA-N 300651 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 221 Protein Wnt-3a Human 235 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300651 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300651&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608469 381749422 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575354 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-12-16(2-5-23(22)39-26(29,30)31)25(37)33-20-3-4-21(32-14-20)17-10-18(27)13-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) GYGINCUNIMDWPT-UHFFFAOYSA-N 300651 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 221 Protein Wnt-3a Human 12200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300651 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300651&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608469 381749422 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575355 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F |r| InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-19(6-8-24(23)39-27(29,30)31)33-26(37)17-5-7-22(32-12-17)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IUQPGUXQWQGVHA-UHFFFAOYSA-N 300623 US10130633, Example 222::6-(3-fluorophenyl)-N-[3-({(2R*)- 2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 193 Protein Wnt-3a Human 263 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300623 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300623&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608476 381749401 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575356 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)ccc1OC(F)(F)F |r| InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-19(6-8-24(23)39-27(29,30)31)33-26(37)17-5-7-22(32-12-17)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IUQPGUXQWQGVHA-UHFFFAOYSA-N 300623 US10130633, Example 222::6-(3-fluorophenyl)-N-[3-({(2R*)- 2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 193 Protein Wnt-3a Human 15200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300623 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300623&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608476 381749401 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575357 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4C[C@@H]5C[C@H]4CO5 InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-8-15(2-5-24(23)40-27(30,31)32)26(38)34-19-3-4-22(33-11-19)16-6-17(28)9-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) JSAIVQYMVQPPGL-UHFFFAOYSA-N 300653 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- ({2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 223 Protein Wnt-3a Human 238 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300653 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300653&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608510 381749423 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575358 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cc(F)cc(F)c1)nc2)ccc3OC(F)(F)F)N4C[C@@H]5C[C@H]4CO5 InChI=1S/C27H23F5N4O4/c1-14(36-12-21-10-20(36)13-39-21)25(37)35-23-8-15(2-5-24(23)40-27(30,31)32)26(38)34-19-3-4-22(33-11-19)16-6-17(28)9-18(29)7-16/h2-9,11,14,20-21H,10,12-13H2,1H3,(H,34,38)(H,35,37) JSAIVQYMVQPPGL-UHFFFAOYSA-N 300653 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- ({2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 223 Protein Wnt-3a Human 17100 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300653 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300653&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608510 381749423 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575359 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2ccccc2F)ccc1OC(F)(F)F InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(7-9-23(22)38-26(28,29)30)32-25(36)17-6-8-21(31-15-17)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) XFZOXFOCQJSZKQ-UHFFFAOYSA-N 300636 6-(2-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 224::US10130633, Example 206 Protein Wnt-3a Human 382 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300636 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300636&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458705 381749412 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575360 CC(N1CCOCC1)C(=O)Nc1cc(NC(=O)c2ccc(nc2)-c2ccccc2F)ccc1OC(F)(F)F InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(7-9-23(22)38-26(28,29)30)32-25(36)17-6-8-21(31-15-17)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) XFZOXFOCQJSZKQ-UHFFFAOYSA-N 300636 6-(2-fluorophenyl)-N-[3-{[2- (morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl] nicotinamide::US10130633, Example 224::US10130633, Example 206 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300636 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300636&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458705 381749412 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575361 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3C(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O3/c1-16(34-10-12-37-13-11-34)24(35)33-23-14-17(6-8-20(23)26(28,29)30)25(36)32-18-7-9-22(31-15-18)19-4-2-3-5-21(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) PFSXCOASGAJFDG-UHFFFAOYSA-N 300637 US10130633, Example 225::N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethyl)benzamide::US10130633, Example 207 Protein Wnt-3a Human 237 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300637 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300637&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458818 381749413 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575362 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3C(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O3/c1-16(34-10-12-37-13-11-34)24(35)33-23-14-17(6-8-20(23)26(28,29)30)25(36)32-18-7-9-22(31-15-18)19-4-2-3-5-21(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) PFSXCOASGAJFDG-UHFFFAOYSA-N 300637 US10130633, Example 225::N-[6-(2-fluorophenyl)pyridin-3- yl]-3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethyl)benzamide::US10130633, Example 207 Protein Wnt-3a Human 11200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300637 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300637&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458818 381749413 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575363 Fc1ccccc1-c1ccc(NC(=O)c2ccc(c(NC(=O)CN3CC4CCC(C3)O4)c2)C(F)(F)F)cn1 InChI=1S/C27H24F4N4O3/c28-22-4-2-1-3-20(22)23-10-6-17(12-32-23)33-26(37)16-5-9-21(27(29,30)31)24(11-16)34-25(36)15-35-13-18-7-8-19(14-35)38-18/h1-6,9-12,18-19H,7-8,13-15H2,(H,33,37)(H,34,36) JZTUOJLYMZQFMZ-UHFFFAOYSA-N 300656 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-[(8-oxa-3- azabicyclo[3.2.1]oct-3- ylacetyl)amino]-4- (trifluoromethyl)benzamide::US10130633, Example 226 Protein Wnt-3a Human 245 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300656 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300656&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459147 381749424 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575364 Fc1ccccc1-c1ccc(NC(=O)c2ccc(c(NC(=O)CN3CC4CCC(C3)O4)c2)C(F)(F)F)cn1 InChI=1S/C27H24F4N4O3/c28-22-4-2-1-3-20(22)23-10-6-17(12-32-23)33-26(37)16-5-9-21(27(29,30)31)24(11-16)34-25(36)15-35-13-18-7-8-19(14-35)38-18/h1-6,9-12,18-19H,7-8,13-15H2,(H,33,37)(H,34,36) JZTUOJLYMZQFMZ-UHFFFAOYSA-N 300656 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-[(8-oxa-3- azabicyclo[3.2.1]oct-3- ylacetyl)amino]-4- (trifluoromethyl)benzamide::US10130633, Example 226 Protein Wnt-3a Human 6500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300656 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300656&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459147 381749424 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575365 Fc1ccccc1-c1ccc(NC(=O)c2ccc(c(NC(=O)CN3CCN(CC3)C3CC3)c2)C(F)(F)F)cn1 InChI=1S/C28H27F4N5O2/c29-23-4-2-1-3-21(23)24-10-6-19(16-33-24)34-27(39)18-5-9-22(28(30,31)32)25(15-18)35-26(38)17-36-11-13-37(14-12-36)20-7-8-20/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,34,39)(H,35,38) KPPSFOKJNKIGSC-UHFFFAOYSA-N 300657 3-{[(4-cyclopropylpiperazin-1- yl)acetyl]amino}-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethyl)benzamide::US10130633, Example 227 Protein Wnt-3a Human 245 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300657 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300657&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458983 381749425 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575366 Fc1ccccc1-c1ccc(NC(=O)c2ccc(c(NC(=O)CN3CCN(CC3)C3CC3)c2)C(F)(F)F)cn1 InChI=1S/C28H27F4N5O2/c29-23-4-2-1-3-21(23)24-10-6-19(16-33-24)34-27(39)18-5-9-22(28(30,31)32)25(15-18)35-26(38)17-36-11-13-37(14-12-36)20-7-8-20/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,34,39)(H,35,38) KPPSFOKJNKIGSC-UHFFFAOYSA-N 300657 3-{[(4-cyclopropylpiperazin-1- yl)acetyl]amino}-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethyl)benzamide::US10130633, Example 227 Protein Wnt-3a Human 10200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300657 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300657&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458983 381749425 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575367 CN(C(=O)CN1CCOCC1)c1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1 InChI=1S/C26H25F3N4O4/c1-32(24(34)17-33-11-13-36-14-12-33)22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-16H,11-14,17H2,1H3,(H,31,35) NTFFMNYOEUPKQU-UHFFFAOYSA-N 300658 3-[methyl(morpholin-4- ylacetyl)amino]-N-(6- phenylpyridin-3-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 228 Protein Wnt-3a Human 2870 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300658 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300658&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608467 381749426 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575368 CN(C(=O)CN1CCOCC1)c1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1 InChI=1S/C26H25F3N4O4/c1-32(24(34)17-33-11-13-36-14-12-33)22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-16H,11-14,17H2,1H3,(H,31,35) NTFFMNYOEUPKQU-UHFFFAOYSA-N 300658 3-[methyl(morpholin-4- ylacetyl)amino]-N-(6- phenylpyridin-3-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 228 Protein Wnt-3a Human 29000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300658 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300658&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608467 381749426 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575369 COc3ccc(NC(=O)c2ccc(c1ccc(F)cc1)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O4/c1-33-23-9-7-20(14-22(23)29-24(31)16-30-10-12-34-13-11-30)28-25(32)18-4-8-21(27-15-18)17-2-5-19(26)6-3-17/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) BHVKNAHHCBACKA-UHFFFAOYSA-N 300659 6-(4-fluorophenyl)-N-{4- methoxy-3-[(morpholin-4- ylacetyl)amino]phenyl} nicotinamide::US10130633, Example 229 Protein Wnt-3a Human 2300 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300659 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300659&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90464932 381749427 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575370 COc3ccc(NC(=O)c2ccc(c1ccc(F)cc1)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O4/c1-33-23-9-7-20(14-22(23)29-24(31)16-30-10-12-34-13-11-30)28-25(32)18-4-8-21(27-15-18)17-2-5-19(26)6-3-17/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) BHVKNAHHCBACKA-UHFFFAOYSA-N 300659 6-(4-fluorophenyl)-N-{4- methoxy-3-[(morpholin-4- ylacetyl)amino]phenyl} nicotinamide::US10130633, Example 229 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300659 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300659&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90464932 381749427 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575371 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)N4CCN(C)CC4 InChI=1S/C25H30N6O4S2/c1-17(31-13-11-30(2)12-14-31)22(32)26-21-15-19(9-10-20(21)16-37(3,34)35)23(33)27-25-29-28-24(36-25)18-7-5-4-6-8-18/h4-10,15,17H,11-14,16H2,1-3H3,(H,26,32)(H,27,29,33) TUXONIDNAJFNRA-UHFFFAOYSA-N 300660 3-{[2-(4-methylpiperazin-1- yl)propanoyl]amino}-4- [(methylsulfonyl)methyl]-N-(5- phenyl-1,3,4-thiadiazol-2- yl)benzamide trifluoroacetate (1:1)::US10130633, Example 230 Protein Wnt-3a Human 720 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300660 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300660&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292834 381749428 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575372 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)N4CCN(C)CC4 InChI=1S/C25H30N6O4S2/c1-17(31-13-11-30(2)12-14-31)22(32)26-21-15-19(9-10-20(21)16-37(3,34)35)23(33)27-25-29-28-24(36-25)18-7-5-4-6-8-18/h4-10,15,17H,11-14,16H2,1-3H3,(H,26,32)(H,27,29,33) TUXONIDNAJFNRA-UHFFFAOYSA-N 300660 3-{[2-(4-methylpiperazin-1- yl)propanoyl]amino}-4- [(methylsulfonyl)methyl]-N-(5- phenyl-1,3,4-thiadiazol-2- yl)benzamide trifluoroacetate (1:1)::US10130633, Example 230 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300660 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300660&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292834 381749428 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575373 CC(N1CCN(C)CC1)C(=O)Nc1cc(ccc1CS(C)(=O)=O)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C25H30N6O4S2/c1-17(31-13-11-30(2)12-14-31)22(32)26-21-15-19(9-10-20(21)16-37(3,34)35)23(33)27-25-29-28-24(36-25)18-7-5-4-6-8-18/h4-10,15,17H,11-14,16H2,1-3H3,(H,26,32)(H,27,29,33) TUXONIDNAJFNRA-UHFFFAOYSA-N 300661 3-{[2-(4-methylpiperazin-1- yl)propanoyl]amino}-4- [(methylsulfonyl)methyl]-N-(5- phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 232::US10130633, Example 231 Protein Wnt-3a Human 1020 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300661 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300661&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292834 381749429 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575374 CC(N1CCN(C)CC1)C(=O)Nc1cc(ccc1CS(C)(=O)=O)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C25H30N6O4S2/c1-17(31-13-11-30(2)12-14-31)22(32)26-21-15-19(9-10-20(21)16-37(3,34)35)23(33)27-25-29-28-24(36-25)18-7-5-4-6-8-18/h4-10,15,17H,11-14,16H2,1-3H3,(H,26,32)(H,27,29,33) TUXONIDNAJFNRA-UHFFFAOYSA-N 300661 3-{[2-(4-methylpiperazin-1- yl)propanoyl]amino}-4- [(methylsulfonyl)methyl]-N-(5- phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 232::US10130633, Example 231 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300661 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300661&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292834 381749429 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575375 CC(N1CCN(C)CC1)C(=O)Nc1cc(ccc1CS(C)(=O)=O)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C25H30N6O4S2/c1-17(31-13-11-30(2)12-14-31)22(32)26-21-15-19(9-10-20(21)16-37(3,34)35)23(33)27-25-29-28-24(36-25)18-7-5-4-6-8-18/h4-10,15,17H,11-14,16H2,1-3H3,(H,26,32)(H,27,29,33) TUXONIDNAJFNRA-UHFFFAOYSA-N 300661 3-{[2-(4-methylpiperazin-1- yl)propanoyl]amino}-4- [(methylsulfonyl)methyl]-N-(5- phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 232::US10130633, Example 231 Protein Wnt-3a Human 2200 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300661 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300661&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292834 381749429 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575376 CC(N1CCN(C)CC1)C(=O)Nc1cc(ccc1CS(C)(=O)=O)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C25H30N6O4S2/c1-17(31-13-11-30(2)12-14-31)22(32)26-21-15-19(9-10-20(21)16-37(3,34)35)23(33)27-25-29-28-24(36-25)18-7-5-4-6-8-18/h4-10,15,17H,11-14,16H2,1-3H3,(H,26,32)(H,27,29,33) TUXONIDNAJFNRA-UHFFFAOYSA-N 300661 3-{[2-(4-methylpiperazin-1- yl)propanoyl]amino}-4- [(methylsulfonyl)methyl]-N-(5- phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 232::US10130633, Example 231 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300661 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300661&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292834 381749429 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575377 Fc1ccccc1-c1ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN3CCN(CC(F)(F)F)CC3)c2)cn1 InChI=1S/C27H24F7N5O3/c28-20-4-2-1-3-19(20)21-7-6-18(14-35-21)36-25(41)17-5-8-23(42-27(32,33)34)22(13-17)37-24(40)15-38-9-11-39(12-10-38)16-26(29,30)31/h1-8,13-14H,9-12,15-16H2,(H,36,41)(H,37,40) JXJVCGNQKUAUGB-UHFFFAOYSA-N 300663 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-({[4-(2,2,2- trifluoroethyl)piperazin-1- yl]acetyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 233 Protein Wnt-3a Human 985 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300663 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300663&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459712 381749430 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575378 Fc1ccccc1-c1ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN3CCN(CC(F)(F)F)CC3)c2)cn1 InChI=1S/C27H24F7N5O3/c28-20-4-2-1-3-19(20)21-7-6-18(14-35-21)36-25(41)17-5-8-23(42-27(32,33)34)22(13-17)37-24(40)15-38-9-11-39(12-10-38)16-26(29,30)31/h1-8,13-14H,9-12,15-16H2,(H,36,41)(H,37,40) JXJVCGNQKUAUGB-UHFFFAOYSA-N 300663 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-({[4-(2,2,2- trifluoroethyl)piperazin-1- yl]acetyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 233 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300663 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300663&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459712 381749430 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575379 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N5CCN(C4CC4)CC5 InChI=1S/C26H27F3N6O3S/c1-16(34-11-13-35(14-12-34)19-8-9-19)22(36)30-20-15-18(7-10-21(20)38-26(27,28)29)23(37)31-25-33-32-24(39-25)17-5-3-2-4-6-17/h2-7,10,15-16,19H,8-9,11-14H2,1H3,(H,30,36)(H,31,33,37) XUKFUAOFRUUZPD-UHFFFAOYSA-N 300664 3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amino}-N-(5- phenyl-1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 234 Protein Wnt-3a Human 635 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300664 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300664&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462275 381749431 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575380 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N5CCN(C4CC4)CC5 InChI=1S/C26H27F3N6O3S/c1-16(34-11-13-35(14-12-34)19-8-9-19)22(36)30-20-15-18(7-10-21(20)38-26(27,28)29)23(37)31-25-33-32-24(39-25)17-5-3-2-4-6-17/h2-7,10,15-16,19H,8-9,11-14H2,1H3,(H,30,36)(H,31,33,37) XUKFUAOFRUUZPD-UHFFFAOYSA-N 300664 3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amino}-N-(5- phenyl-1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 234 Protein Wnt-3a Human 40500 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300664 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300664&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462275 381749431 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575381 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C23H25N5O5S2/c1-35(31,32)15-18-8-7-17(13-19(18)24-20(29)14-28-9-11-33-12-10-28)21(30)25-23-27-26-22(34-23)16-5-3-2-4-6-16/h2-8,13H,9-12,14-15H2,1H3,(H,24,29)(H,25,27,30) LWANVTRQRKFEOL-UHFFFAOYSA-N 300665 4-[(methylsulfonyl)methyl]-3- [(morpholin-4-ylacetyl)amino]- N-(5-phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 235 Protein Wnt-3a Human 1310 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300665 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300665&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461315 381749432 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575382 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCOCC4 InChI=1S/C23H25N5O5S2/c1-35(31,32)15-18-8-7-17(13-19(18)24-20(29)14-28-9-11-33-12-10-28)21(30)25-23-27-26-22(34-23)16-5-3-2-4-6-16/h2-8,13H,9-12,14-15H2,1H3,(H,24,29)(H,25,27,30) LWANVTRQRKFEOL-UHFFFAOYSA-N 300665 4-[(methylsulfonyl)methyl]-3- [(morpholin-4-ylacetyl)amino]- N-(5-phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 235 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300665 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300665&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461315 381749432 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575383 CN1CCN(CC1)C1(CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C28H27F4N5O3/c1-36-12-14-37(15-13-36)27(10-11-27)26(39)35-23-16-18(6-9-24(23)40-28(30,31)32)25(38)34-19-7-8-22(33-17-19)20-4-2-3-5-21(20)29/h2-9,16-17H,10-15H2,1H3,(H,34,38)(H,35,39) WFSAVABYAYRKQZ-UHFFFAOYSA-N 300666 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-({[1-(4-methylpiperazin-1- yl)cyclopropyl]carbonyl}amino)- 4-(trifluoromethoxy)benzamide::US10130633, Example 236 Protein Wnt-3a Human 276 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300666 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300666&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460545 381749433 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575384 CN1CCN(CC1)C1(CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C28H27F4N5O3/c1-36-12-14-37(15-13-36)27(10-11-27)26(39)35-23-16-18(6-9-24(23)40-28(30,31)32)25(38)34-19-7-8-22(33-17-19)20-4-2-3-5-21(20)29/h2-9,16-17H,10-15H2,1H3,(H,34,38)(H,35,39) WFSAVABYAYRKQZ-UHFFFAOYSA-N 300666 N-[6-(2-fluorophenyl)pyridin-3- yl]-3-({[1-(4-methylpiperazin-1- yl)cyclopropyl]carbonyl}amino)- 4-(trifluoromethoxy)benzamide::US10130633, Example 236 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300666 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300666&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460545 381749433 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575385 FC(F)Oc1ccc(cc1NC(=O)CN1CCOCC1)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C25H23F3N4O4/c26-19-4-2-1-3-18(19)20-7-6-17(14-29-20)30-24(34)16-5-8-22(36-25(27)28)21(13-16)31-23(33)15-32-9-11-35-12-10-32/h1-8,13-14,25H,9-12,15H2,(H,30,34)(H,31,33) LSALXJYHGMAXJO-UHFFFAOYSA-N 300667 4-(difluoromethoxy)-N-[6-(2- fluorophenyl)pyridin-3-yl]-3- [(morpholin-4- ylacetyl)amino]benzamide::US10130633, Example 237 Protein Wnt-3a Human 139 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300667 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300667&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460273 381749434 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575386 FC(F)Oc1ccc(cc1NC(=O)CN1CCOCC1)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C25H23F3N4O4/c26-19-4-2-1-3-18(19)20-7-6-17(14-29-20)30-24(34)16-5-8-22(36-25(27)28)21(13-16)31-23(33)15-32-9-11-35-12-10-32/h1-8,13-14,25H,9-12,15H2,(H,30,34)(H,31,33) LSALXJYHGMAXJO-UHFFFAOYSA-N 300667 4-(difluoromethoxy)-N-[6-(2- fluorophenyl)pyridin-3-yl]-3- [(morpholin-4- ylacetyl)amino]benzamide::US10130633, Example 237 Protein Wnt-3a Human 13000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300667 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300667&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460273 381749434 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575387 O=C(Cc1ccccn1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC5CC5 InChI=1S/C28H23FN4O3/c29-23-7-2-1-6-22(23)24-12-9-20(17-31-24)32-28(35)18-8-13-26(36-21-10-11-21)25(15-18)33-27(34)16-19-5-3-4-14-30-19/h1-9,12-15,17,21H,10-11,16H2,(H,32,35)(H,33,34) DUZAUOIWOXFULL-UHFFFAOYSA-N 300668 4-(cyclopropyloxy)-N-[6-(2- fluorophenyl)pyridin-3-yl]-3- [(pyridin-2- ylacetyl)amino]benzamide::US10130633, Example 238 Protein Wnt-3a Human 1750 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300668 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300668&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460272 381749435 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575388 O=C(Cc1ccccn1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC5CC5 InChI=1S/C28H23FN4O3/c29-23-7-2-1-6-22(23)24-12-9-20(17-31-24)32-28(35)18-8-13-26(36-21-10-11-21)25(15-18)33-27(34)16-19-5-3-4-14-30-19/h1-9,12-15,17,21H,10-11,16H2,(H,32,35)(H,33,34) DUZAUOIWOXFULL-UHFFFAOYSA-N 300668 4-(cyclopropyloxy)-N-[6-(2- fluorophenyl)pyridin-3-yl]-3- [(pyridin-2- ylacetyl)amino]benzamide::US10130633, Example 238 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300668 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300668&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460272 381749435 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575389 FC(F)Oc1ccc(cc1NC(=O)CN1CCOCC1)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C22H21F2N5O4S/c23-21(24)33-17-7-6-15(12-16(17)25-18(30)13-29-8-10-32-11-9-29)19(31)26-22-28-27-20(34-22)14-4-2-1-3-5-14/h1-7,12,21H,8-11,13H2,(H,25,30)(H,26,28,31) XERYACSULAQUIR-UHFFFAOYSA-N 300669 4-(difluoromethoxy)-3- [(morpholin-4-ylacetyl)amino]- N-(5-phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 239 Protein Wnt-3a Human 2890 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300669 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300669&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608478 381749436 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575390 FC(F)Oc1ccc(cc1NC(=O)CN1CCOCC1)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C22H21F2N5O4S/c23-21(24)33-17-7-6-15(12-16(17)25-18(30)13-29-8-10-32-11-9-29)19(31)26-22-28-27-20(34-22)14-4-2-1-3-5-14/h1-7,12,21H,8-11,13H2,(H,25,30)(H,26,28,31) XERYACSULAQUIR-UHFFFAOYSA-N 300669 4-(difluoromethoxy)-3- [(morpholin-4-ylacetyl)amino]- N-(5-phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 239 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300669 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300669&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608478 381749436 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575391 FC(F)(F)Oc1ccc(cc1NC(=O)CN1CC2CCC(C1)O2)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C24H22F3N5O4S/c25-24(26,27)36-19-9-6-15(21(34)29-23-31-30-22(37-23)14-4-2-1-3-5-14)10-18(19)28-20(33)13-32-11-16-7-8-17(12-32)35-16/h1-6,9-10,16-17H,7-8,11-13H2,(H,28,33)(H,29,31,34) DGXDRGBUZVPAJV-UHFFFAOYSA-N 300670 3-[(8-oxa-3- azabicyclo[3.2.1]oct-3- ylacetyl)amino]-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 240 Protein Wnt-3a Human 1180 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300670 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300670&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461655 381749437 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575392 FC(F)(F)Oc1ccc(cc1NC(=O)CN1CC2CCC(C1)O2)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C24H22F3N5O4S/c25-24(26,27)36-19-9-6-15(21(34)29-23-31-30-22(37-23)14-4-2-1-3-5-14)10-18(19)28-20(33)13-32-11-16-7-8-17(12-32)35-16/h1-6,9-10,16-17H,7-8,11-13H2,(H,28,33)(H,29,31,34) DGXDRGBUZVPAJV-UHFFFAOYSA-N 300670 3-[(8-oxa-3- azabicyclo[3.2.1]oct-3- ylacetyl)amino]-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 240 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300670 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300670&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461655 381749437 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575393 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O4S/c1-14(31-9-11-34-12-10-31)19(32)27-17-13-16(7-8-18(17)35-23(24,25)26)20(33)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) NZNXXRYDQGCBFK-UHFFFAOYSA-N 300671 3-{[2-(morpholin-4- yl)propanoyl]amino}-N-(5- phenyl-1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 242::US10130633, Example 241 Protein Wnt-3a Human 1820 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300671&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291647 381749438 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575394 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O4S/c1-14(31-9-11-34-12-10-31)19(32)27-17-13-16(7-8-18(17)35-23(24,25)26)20(33)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) NZNXXRYDQGCBFK-UHFFFAOYSA-N 300671 3-{[2-(morpholin-4- yl)propanoyl]amino}-N-(5- phenyl-1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 242::US10130633, Example 241 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300671&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291647 381749438 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575395 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O4S/c1-14(31-9-11-34-12-10-31)19(32)27-17-13-16(7-8-18(17)35-23(24,25)26)20(33)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) NZNXXRYDQGCBFK-UHFFFAOYSA-N 300671 3-{[2-(morpholin-4- yl)propanoyl]amino}-N-(5- phenyl-1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 242::US10130633, Example 241 Protein Wnt-3a Human 753 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300671&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291647 381749438 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575396 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O4S/c1-14(31-9-11-34-12-10-31)19(32)27-17-13-16(7-8-18(17)35-23(24,25)26)20(33)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) NZNXXRYDQGCBFK-UHFFFAOYSA-N 300671 3-{[2-(morpholin-4- yl)propanoyl]amino}-N-(5- phenyl-1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 242::US10130633, Example 241 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300671&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291647 381749438 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575397 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 |r| InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-17(5-8-24(23)39-27(29,30)31)26(37)33-19-6-7-22(32-12-19)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IVAPGQZOCYCUJU-UHFFFAOYSA-N 300673 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 244::US10130633, Example 243 Protein Wnt-3a Human 28.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300673&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608515 381749439 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575398 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 |r| InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-17(5-8-24(23)39-27(29,30)31)26(37)33-19-6-7-22(32-12-19)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IVAPGQZOCYCUJU-UHFFFAOYSA-N 300673 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 244::US10130633, Example 243 Protein Wnt-3a Human 7700 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300673&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608515 381749439 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575399 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 |r| InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-17(5-8-24(23)39-27(29,30)31)26(37)33-19-6-7-22(32-12-19)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IVAPGQZOCYCUJU-UHFFFAOYSA-N 300673 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 244::US10130633, Example 243 Protein Wnt-3a Human 120 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300673&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608515 381749439 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575400 CC(N1C[C@@H]2C[C@H]1CO2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 |r| InChI=1S/C27H24F4N4O4/c1-15(35-13-21-11-20(35)14-38-21)25(36)34-23-10-17(5-8-24(23)39-27(29,30)31)26(37)33-19-6-7-22(32-12-19)16-3-2-4-18(28)9-16/h2-10,12,15,20-21H,11,13-14H2,1H3,(H,33,37)(H,34,36) IVAPGQZOCYCUJU-UHFFFAOYSA-N 300673 N-[6-(3-fluorophenyl)pyridin-3- yl]-3-({(2R*)-2-[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- yl]propanoyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 244::US10130633, Example 243 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300673&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608515 381749439 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575401 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-12-16(2-5-23(22)39-26(29,30)31)25(37)33-20-3-4-21(32-14-20)17-10-18(27)13-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) GYGINCUNIMDWPT-UHFFFAOYSA-N 300675 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 246::US10130633, Example 245 Protein Wnt-3a Human 7.85 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300675&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608469 381749440 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575402 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-12-16(2-5-23(22)39-26(29,30)31)25(37)33-20-3-4-21(32-14-20)17-10-18(27)13-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) GYGINCUNIMDWPT-UHFFFAOYSA-N 300675 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 246::US10130633, Example 245 Protein Wnt-3a Human 5200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300675&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608469 381749440 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575403 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-12-16(2-5-23(22)39-26(29,30)31)25(37)33-20-3-4-21(32-14-20)17-10-18(27)13-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) GYGINCUNIMDWPT-UHFFFAOYSA-N 300675 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 246::US10130633, Example 245 Protein Wnt-3a Human 47.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300675&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608469 381749440 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575404 CC(N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C26H23F5N4O4/c1-15(35-6-8-38-9-7-35)24(36)34-22-12-16(2-5-23(22)39-26(29,30)31)25(37)33-20-3-4-21(32-14-20)17-10-18(27)13-19(28)11-17/h2-5,10-15H,6-9H2,1H3,(H,33,37)(H,34,36) GYGINCUNIMDWPT-UHFFFAOYSA-N 300675 N-[6-(3,5- difluorophenyl)pyridin-3-yl]-3- {[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 246::US10130633, Example 245 Protein Wnt-3a Human 27800 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300675&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608469 381749440 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575405 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-18(5-10-25(24)40-28(30,31)32)27(38)34-20-6-9-23(33-13-20)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) XTYSNFAOAGFDBE-UHFFFAOYSA-N 300677 US10130633, Example 248::N-[6-(3-fluorophenyl)pyridin-3- yl]-3-{[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 247 Protein Wnt-3a Human 11.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300677&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292060 381749441 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575406 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-18(5-10-25(24)40-28(30,31)32)27(38)34-20-6-9-23(33-13-20)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) XTYSNFAOAGFDBE-UHFFFAOYSA-N 300677 US10130633, Example 248::N-[6-(3-fluorophenyl)pyridin-3- yl]-3-{[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 247 Protein Wnt-3a Human 7200 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300677&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292060 381749441 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575407 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-18(5-10-25(24)40-28(30,31)32)27(38)34-20-6-9-23(33-13-20)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) XTYSNFAOAGFDBE-UHFFFAOYSA-N 300677 US10130633, Example 248::N-[6-(3-fluorophenyl)pyridin-3- yl]-3-{[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 247 Protein Wnt-3a Human 340 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300677&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292060 381749441 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575408 CC(N1CC2CCC(C1)O2)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cccc(F)c1 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-18(5-10-25(24)40-28(30,31)32)27(38)34-20-6-9-23(33-13-20)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) XTYSNFAOAGFDBE-UHFFFAOYSA-N 300677 US10130633, Example 248::N-[6-(3-fluorophenyl)pyridin-3- yl]-3-{[2-(8-oxa-3- azabicyclo[3.2.1]oct-3- yl)propanoyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 247 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300677&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292060 381749441 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575409 CC(N1CCN(CC1)C1CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C29H29F4N5O3/c1-18(37-12-14-38(15-13-37)21-8-9-21)27(39)36-25-16-19(6-11-26(25)41-29(31,32)33)28(40)35-20-7-10-24(34-17-20)22-4-2-3-5-23(22)30/h2-7,10-11,16-18,21H,8-9,12-15H2,1H3,(H,35,40)(H,36,39) CKDUXLHDEQCHIL-UHFFFAOYSA-N 300679 3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amino}-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethoxy)benzamide::US10130633, Example 250::US10130633, Example 249 Protein Wnt-3a Human 198 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300679&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459015 381749442 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575410 CC(N1CCN(CC1)C1CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C29H29F4N5O3/c1-18(37-12-14-38(15-13-37)21-8-9-21)27(39)36-25-16-19(6-11-26(25)41-29(31,32)33)28(40)35-20-7-10-24(34-17-20)22-4-2-3-5-23(22)30/h2-7,10-11,16-18,21H,8-9,12-15H2,1H3,(H,35,40)(H,36,39) CKDUXLHDEQCHIL-UHFFFAOYSA-N 300679 3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amino}-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethoxy)benzamide::US10130633, Example 250::US10130633, Example 249 Protein Wnt-3a Human 38000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300679&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459015 381749442 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575411 CC(N1CCN(CC1)C1CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C29H29F4N5O3/c1-18(37-12-14-38(15-13-37)21-8-9-21)27(39)36-25-16-19(6-11-26(25)41-29(31,32)33)28(40)35-20-7-10-24(34-17-20)22-4-2-3-5-23(22)30/h2-7,10-11,16-18,21H,8-9,12-15H2,1H3,(H,35,40)(H,36,39) CKDUXLHDEQCHIL-UHFFFAOYSA-N 300679 3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amino}-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethoxy)benzamide::US10130633, Example 250::US10130633, Example 249 Protein Wnt-3a Human 192 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300679&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459015 381749442 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575412 CC(N1CCN(CC1)C1CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F InChI=1S/C29H29F4N5O3/c1-18(37-12-14-38(15-13-37)21-8-9-21)27(39)36-25-16-19(6-11-26(25)41-29(31,32)33)28(40)35-20-7-10-24(34-17-20)22-4-2-3-5-23(22)30/h2-7,10-11,16-18,21H,8-9,12-15H2,1H3,(H,35,40)(H,36,39) CKDUXLHDEQCHIL-UHFFFAOYSA-N 300679 3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amino}-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethoxy)benzamide::US10130633, Example 250::US10130633, Example 249 Protein Wnt-3a Human 31000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300679&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459015 381749442 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575413 CN(C)C1(CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C25H21F5N4O3/c1-34(2)24(7-8-24)23(36)33-20-11-14(3-6-21(20)37-25(28,29)30)22(35)32-18-4-5-19(31-13-18)15-9-16(26)12-17(27)10-15/h3-6,9-13H,7-8H2,1-2H3,(H,32,35)(H,33,36) XHTGZKKVCCWCPM-UHFFFAOYSA-N 300681 N-[6-(3,5-difluorophenyl) pyridin-3-yl]-3-({[1- (dimethylamino)cyclopropyl] carbonyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 251 Protein Wnt-3a Human 220 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300681 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300681&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459338 381749443 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575414 CN(C)C1(CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1cc(F)cc(F)c1 InChI=1S/C25H21F5N4O3/c1-34(2)24(7-8-24)23(36)33-20-11-14(3-6-21(20)37-25(28,29)30)22(35)32-18-4-5-19(31-13-18)15-9-16(26)12-17(27)10-15/h3-6,9-13H,7-8H2,1-2H3,(H,32,35)(H,33,36) XHTGZKKVCCWCPM-UHFFFAOYSA-N 300681 N-[6-(3,5-difluorophenyl) pyridin-3-yl]-3-({[1- (dimethylamino)cyclopropyl] carbonyl}amino)-4- (trifluoromethoxy)benzamide::US10130633, Example 251 Protein Wnt-3a Human 16000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300681 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300681&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459338 381749443 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575415 FC(F)(F)Oc1ccc(NC(=O)c2cnc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)29-20(31)14-30-8-10-33-11-9-30)28-21(32)19-13-27-22(35-19)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,32)(H,29,31) HVTXCROPHVCWDI-UHFFFAOYSA-N 300682 N-{3-[(morpholin-4- ylacetyl)amino]-4- (trifluoromethoxy)phenyl}-2- phenyl-1,3-thiazole-5- carboxamide::US10130633, Example 252 Protein Wnt-3a Human 2300 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300682 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300682&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608495 381749444 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575416 FC(F)(F)Oc1ccc(NC(=O)c2cnc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)29-20(31)14-30-8-10-33-11-9-30)28-21(32)19-13-27-22(35-19)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,32)(H,29,31) HVTXCROPHVCWDI-UHFFFAOYSA-N 300682 N-{3-[(morpholin-4- ylacetyl)amino]-4- (trifluoromethoxy)phenyl}-2- phenyl-1,3-thiazole-5- carboxamide::US10130633, Example 252 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300682 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300682&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608495 381749444 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575417 Brc1ccc(cc1NC(=O)CN1CCN(CC1)C1CC1)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C24H25BrN6O2S/c25-19-9-6-17(22(33)27-24-29-28-23(34-24)16-4-2-1-3-5-16)14-20(19)26-21(32)15-30-10-12-31(13-11-30)18-7-8-18/h1-6,9,14,18H,7-8,10-13,15H2,(H,26,32)(H,27,29,33) WCDZUSIBEQNATE-UHFFFAOYSA-N 300683 4-bromo-3-{[(4- cyclopropylpiperazin-1- yl)acetyl]amino}-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 253 Protein Wnt-3a Human 4040 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300683 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300683&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608496 381749445 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575418 Brc1ccc(cc1NC(=O)CN1CCN(CC1)C1CC1)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C24H25BrN6O2S/c25-19-9-6-17(22(33)27-24-29-28-23(34-24)16-4-2-1-3-5-16)14-20(19)26-21(32)15-30-10-12-31(13-11-30)18-7-8-18/h1-6,9,14,18H,7-8,10-13,15H2,(H,26,32)(H,27,29,33) WCDZUSIBEQNATE-UHFFFAOYSA-N 300683 4-bromo-3-{[(4- cyclopropylpiperazin-1- yl)acetyl]amino}-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 253 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300683 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300683&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608496 381749445 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575419 FC(F)(F)Oc1ccc(cc1NC(=O)CN1C[C@@H]2C[C@H]1CO2)C(=O)Nc1nnc(s1)-c1ccccc1 |r| InChI=1S/C23H20F3N5O4S/c24-23(25,26)35-18-7-6-14(8-17(18)27-19(32)11-31-10-16-9-15(31)12-34-16)20(33)28-22-30-29-21(36-22)13-4-2-1-3-5-13/h1-8,15-16H,9-12H2,(H,27,32)(H,28,30,33) GYSOZGKEEMIXBQ-UHFFFAOYSA-N 300684 3-{[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- ylacetyl]amino}-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 254 Protein Wnt-3a Human 4340 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300684 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300684&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608498 381749446 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575420 FC(F)(F)Oc1ccc(cc1NC(=O)CN1C[C@@H]2C[C@H]1CO2)C(=O)Nc1nnc(s1)-c1ccccc1 |r| InChI=1S/C23H20F3N5O4S/c24-23(25,26)35-18-7-6-14(8-17(18)27-19(32)11-31-10-16-9-15(31)12-34-16)20(33)28-22-30-29-21(36-22)13-4-2-1-3-5-13/h1-8,15-16H,9-12H2,(H,27,32)(H,28,30,33) GYSOZGKEEMIXBQ-UHFFFAOYSA-N 300684 3-{[(1S,4S)-2-oxa-5- azabicyclo[2.2.1]hept-5- ylacetyl]amino}-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 254 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300684 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300684&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608498 381749446 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575421 CC(C(=O)Nc3cc(NC(=O)c2cnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C24H23F3N4O4S/c1-15(31-9-11-34-12-10-31)21(32)30-18-13-17(7-8-19(18)35-24(25,26)27)29-22(33)20-14-28-23(36-20)16-5-3-2-4-6-16/h2-8,13-15H,9-12H2,1H3,(H,29,33)(H,30,32) MYUPVEBIIYJUOI-UHFFFAOYSA-N 300685 N-[3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl]-2- phenyl-1,3-thiazole-5- carboxamide::US10130633, Example 255 Protein Wnt-3a Human 2100 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300685 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300685&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608474 381749447 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575422 CC(C(=O)Nc3cc(NC(=O)c2cnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C24H23F3N4O4S/c1-15(31-9-11-34-12-10-31)21(32)30-18-13-17(7-8-19(18)35-24(25,26)27)29-22(33)20-14-28-23(36-20)16-5-3-2-4-6-16/h2-8,13-15H,9-12H2,1H3,(H,29,33)(H,30,32) MYUPVEBIIYJUOI-UHFFFAOYSA-N 300685 N-[3-{[2-(morpholin-4- yl)propanoyl]amino}-4- (trifluoromethoxy)phenyl]-2- phenyl-1,3-thiazole-5- carboxamide::US10130633, Example 255 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300685 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300685&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608474 381749447 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575423 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H28N4O4/c1-34-24-10-8-21(17-23(24)30-26(33)27(11-12-27)31-13-15-35-16-14-31)29-25(32)20-7-9-22(28-18-20)19-5-3-2-4-6-19/h2-10,17-18H,11-16H2,1H3,(H,29,32)(H,30,33) WPBHNIQFIGOLKX-UHFFFAOYSA-N 300686 N-[4-methoxy-3-({[1- (morpholin-4- yl)cyclopropyl]carbonyl}amino) phenyl]-6-phenylnicotinamide::US10130633, Example 256 Protein Wnt-3a Human 240 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300686 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300686&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608477 381749448 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575424 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H28N4O4/c1-34-24-10-8-21(17-23(24)30-26(33)27(11-12-27)31-13-15-35-16-14-31)29-25(32)20-7-9-22(28-18-20)19-5-3-2-4-6-19/h2-10,17-18H,11-16H2,1H3,(H,29,32)(H,30,33) WPBHNIQFIGOLKX-UHFFFAOYSA-N 300686 N-[4-methoxy-3-({[1- (morpholin-4- yl)cyclopropyl]carbonyl}amino) phenyl]-6-phenylnicotinamide::US10130633, Example 256 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300686 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300686&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608477 381749448 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575425 Cc1ccccc1c5nnc(NC(=O)c4ccc(OC(F)(F)F)c(NC(=O)C3(N2CCOCC2)CC3)c4)s5 InChI=1S/C25H24F3N5O4S/c1-15-4-2-3-5-17(15)21-31-32-23(38-21)30-20(34)16-6-7-19(37-25(26,27)28)18(14-16)29-22(35)24(8-9-24)33-10-12-36-13-11-33/h2-7,14H,8-13H2,1H3,(H,29,35)(H,30,32,34) LDKPLJLMCJBGFA-UHFFFAOYSA-N 300687 N-[5-(2-methylphenyl)-1,3,4- thiadiazol-2-yl]-3-({[1- (morpholin-4- yl)cyclopropyl]carbonyl}amino)- 4-(trifluoromethoxy)benzamide::US10130633, Example 257 Protein Wnt-3a Human 17.0 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300687 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300687&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608470 381749449 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575426 Cc1ccccc1c5nnc(NC(=O)c4ccc(OC(F)(F)F)c(NC(=O)C3(N2CCOCC2)CC3)c4)s5 InChI=1S/C25H24F3N5O4S/c1-15-4-2-3-5-17(15)21-31-32-23(38-21)30-20(34)16-6-7-19(37-25(26,27)28)18(14-16)29-22(35)24(8-9-24)33-10-12-36-13-11-33/h2-7,14H,8-13H2,1H3,(H,29,35)(H,30,32,34) LDKPLJLMCJBGFA-UHFFFAOYSA-N 300687 N-[5-(2-methylphenyl)-1,3,4- thiadiazol-2-yl]-3-({[1- (morpholin-4- yl)cyclopropyl]carbonyl}amino)- 4-(trifluoromethoxy)benzamide::US10130633, Example 257 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300687 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300687&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608470 381749449 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575427 COCc3ccc(C(=O)Nc2nnc(c1ccccc1C)s2)cc3NC(=O)C5(N4CCN(C)CC4)CC5 InChI=1S/C27H32N6O3S/c1-18-6-4-5-7-21(18)24-30-31-26(37-24)29-23(34)19-8-9-20(17-36-3)22(16-19)28-25(35)27(10-11-27)33-14-12-32(2)13-15-33/h4-9,16H,10-15,17H2,1-3H3,(H,28,35)(H,29,31,34) BWPANBDMTCMGJL-UHFFFAOYSA-N 300688 4-(methoxymethyl)-N-[5-(2- methylphenyl)-1,3,4-thiadiazol- 2-yl]-3-({[1-(4-methylpiperazin- 1-yl)cyclopropyl]carbonyl} amino)benzamide trifluoroacetate (1:1)::US10130633, Example 258 Protein Wnt-3a Human 45.5 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300688 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300688&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608473 381749450 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575428 COCc3ccc(C(=O)Nc2nnc(c1ccccc1C)s2)cc3NC(=O)C5(N4CCN(C)CC4)CC5 InChI=1S/C27H32N6O3S/c1-18-6-4-5-7-21(18)24-30-31-26(37-24)29-23(34)19-8-9-20(17-36-3)22(16-19)28-25(35)27(10-11-27)33-14-12-32(2)13-15-33/h4-9,16H,10-15,17H2,1-3H3,(H,28,35)(H,29,31,34) BWPANBDMTCMGJL-UHFFFAOYSA-N 300688 4-(methoxymethyl)-N-[5-(2- methylphenyl)-1,3,4-thiadiazol- 2-yl]-3-({[1-(4-methylpiperazin- 1-yl)cyclopropyl]carbonyl} amino)benzamide trifluoroacetate (1:1)::US10130633, Example 258 Protein Wnt-3a Human 24000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300688 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300688&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608473 381749450 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575429 CN5CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OCC4CC4)CC5 InChI=1S/C26H30N6O3S/c1-31-11-13-32(14-12-31)16-23(33)27-21-15-20(9-10-22(21)35-17-18-7-8-18)24(34)28-26-30-29-25(36-26)19-5-3-2-4-6-19/h2-6,9-10,15,18H,7-8,11-14,16-17H2,1H3,(H,27,33)(H,28,30,34) XCOJBBCUQXYUCJ-UHFFFAOYSA-N 300689 4-(cyclopropylmethoxy)-3-{[(4- methylpiperazin-1- yl)acetyl]amino}-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 259 Protein Wnt-3a Human 119 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300689 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300689&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608479 381749451 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575430 CN5CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OCC4CC4)CC5 InChI=1S/C26H30N6O3S/c1-31-11-13-32(14-12-31)16-23(33)27-21-15-20(9-10-22(21)35-17-18-7-8-18)24(34)28-26-30-29-25(36-26)19-5-3-2-4-6-19/h2-6,9-10,15,18H,7-8,11-14,16-17H2,1H3,(H,27,33)(H,28,30,34) XCOJBBCUQXYUCJ-UHFFFAOYSA-N 300689 4-(cyclopropylmethoxy)-3-{[(4- methylpiperazin-1- yl)acetyl]amino}-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 259 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300689 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300689&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608479 381749451 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575431 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O3S/c1-15(33-12-10-32(2)11-13-33)20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) QWBOSJFOAGJZPT-UHFFFAOYSA-N 300488 US10130633, Example 260::3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 273::US10130633, Example 58 Protein Wnt-3a Human 123 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300488&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291851 381749269 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575432 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O3S/c1-15(33-12-10-32(2)11-13-33)20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) QWBOSJFOAGJZPT-UHFFFAOYSA-N 300488 US10130633, Example 260::3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 273::US10130633, Example 58 Protein Wnt-3a Human 9800 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300488&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291851 381749269 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575433 COCCN(C)C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H24F3N5O4S/c1-32(12-13-35-2)23(10-11-23)21(34)28-17-14-16(8-9-18(17)36-24(25,26)27)19(33)29-22-31-30-20(37-22)15-6-4-3-5-7-15/h3-9,14H,10-13H2,1-2H3,(H,28,34)(H,29,31,33) ILWSOKXNXAMLLM-UHFFFAOYSA-N 300691 3-[({1-[(2- methoxyethyl)(methyl)amino] cyclopropyl}carbonyl)amino]-N- (5-phenyl-1,3,4-thiadiazol-2-yl)- 4-(trifluoromethoxy)benzamide::US10130633, Example 261 Protein Wnt-3a Human 150 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300691 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300691&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122513700 381749452 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575434 COCCN(C)C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H24F3N5O4S/c1-32(12-13-35-2)23(10-11-23)21(34)28-17-14-16(8-9-18(17)36-24(25,26)27)19(33)29-22-31-30-20(37-22)15-6-4-3-5-7-15/h3-9,14H,10-13H2,1-2H3,(H,28,34)(H,29,31,33) ILWSOKXNXAMLLM-UHFFFAOYSA-N 300691 3-[({1-[(2- methoxyethyl)(methyl)amino] cyclopropyl}carbonyl)amino]-N- (5-phenyl-1,3,4-thiadiazol-2-yl)- 4-(trifluoromethoxy)benzamide::US10130633, Example 261 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300691 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300691&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122513700 381749452 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575435 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(Cl)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C26H27ClN6O2S/c27-20-9-6-18(22(34)29-25-31-30-23(36-25)17-4-2-1-3-5-17)16-21(20)28-24(35)26(10-11-26)33-14-12-32(13-15-33)19-7-8-19/h1-6,9,16,19H,7-8,10-15H2,(H,28,35)(H,29,31,34) LGZNBISZCZHCLR-UHFFFAOYSA-N 300692 4-chloro-3-({[1-(4- cyclopropylpiperazin-1- yl)cyclopropyl]carbonyl}amino)- N-(5-phenyl-1,3,4-thiadiazol-2- yl)benzamide trifluoroacetate (1:1)::US10130633, Example 262 Protein Wnt-3a Human 195 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300692 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300692&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462384 381749453 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575436 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(Cl)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C26H27ClN6O2S/c27-20-9-6-18(22(34)29-25-31-30-23(36-25)17-4-2-1-3-5-17)16-21(20)28-24(35)26(10-11-26)33-14-12-32(13-15-33)19-7-8-19/h1-6,9,16,19H,7-8,10-15H2,(H,28,35)(H,29,31,34) LGZNBISZCZHCLR-UHFFFAOYSA-N 300692 4-chloro-3-({[1-(4- cyclopropylpiperazin-1- yl)cyclopropyl]carbonyl}amino)- N-(5-phenyl-1,3,4-thiadiazol-2- yl)benzamide trifluoroacetate (1:1)::US10130633, Example 262 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300692 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300692&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462384 381749453 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575437 Nc4ccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCOCC1)c2)s3)cc4 InChI=1S/C22H21F3N6O4S/c23-22(24,25)35-17-6-3-14(11-16(17)27-18(32)12-31-7-9-34-10-8-31)19(33)28-21-30-29-20(36-21)13-1-4-15(26)5-2-13/h1-6,11H,7-10,12,26H2,(H,27,32)(H,28,30,33) QBJVQCDGFNFWQP-UHFFFAOYSA-N 300693 N-[5-(4-aminophenyl)-1,3,4- thiadiazol-2-yl]-3-[(morpholin- 4-ylacetyl)amino]-4- (trifluoromethoxy)benzamide::US10130633, Example 263 Protein Wnt-3a Human 250 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300693 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300693&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462118 381749454 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575438 Nc4ccc(c3nnc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCOCC1)c2)s3)cc4 InChI=1S/C22H21F3N6O4S/c23-22(24,25)35-17-6-3-14(11-16(17)27-18(32)12-31-7-9-34-10-8-31)19(33)28-21-30-29-20(36-21)13-1-4-15(26)5-2-13/h1-6,11H,7-10,12,26H2,(H,27,32)(H,28,30,33) QBJVQCDGFNFWQP-UHFFFAOYSA-N 300693 N-[5-(4-aminophenyl)-1,3,4- thiadiazol-2-yl]-3-[(morpholin- 4-ylacetyl)amino]-4- (trifluoromethoxy)benzamide::US10130633, Example 263 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300693 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300693&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462118 381749454 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575439 Cc1ccccc1c5nnc(NC(=O)c4ccc(OC2CC2)c(NC(=O)CN3CCN(C)CC3)c4)s5 InChI=1S/C26H30N6O3S/c1-17-5-3-4-6-20(17)25-29-30-26(36-25)28-24(34)18-7-10-22(35-19-8-9-19)21(15-18)27-23(33)16-32-13-11-31(2)12-14-32/h3-7,10,15,19H,8-9,11-14,16H2,1-2H3,(H,27,33)(H,28,30,34) OTVIQSCDOOZODQ-UHFFFAOYSA-N 300694 4-(cyclopropyloxy)-N-[5-(2- methylphenyl)-1,3,4-thiadiazol- 2-yl]-3-{[(4-methylpiperazin-1- yl)acetyl]amino}benzamide::US10130633, Example 264 Protein Wnt-3a Human 255 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300694&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608521 381749455 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575440 Cc1ccccc1c5nnc(NC(=O)c4ccc(OC2CC2)c(NC(=O)CN3CCN(C)CC3)c4)s5 InChI=1S/C26H30N6O3S/c1-17-5-3-4-6-20(17)25-29-30-26(36-25)28-24(34)18-7-10-22(35-19-8-9-19)21(15-18)27-23(33)16-32-13-11-31(2)12-14-32/h3-7,10,15,19H,8-9,11-14,16H2,1-2H3,(H,27,33)(H,28,30,34) OTVIQSCDOOZODQ-UHFFFAOYSA-N 300694 4-(cyclopropyloxy)-N-[5-(2- methylphenyl)-1,3,4-thiadiazol- 2-yl]-3-{[(4-methylpiperazin-1- yl)acetyl]amino}benzamide::US10130633, Example 264 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300694&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608521 381749455 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575441 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OCC6CC6 InChI=1S/C28H32N6O3S/c35-25(17-33-12-14-34(15-13-33)22-9-10-22)29-23-16-21(8-11-24(23)37-18-19-6-7-19)26(36)30-28-32-31-27(38-28)20-4-2-1-3-5-20/h1-5,8,11,16,19,22H,6-7,9-10,12-15,17-18H2,(H,29,35)(H,30,32,36) YNZGNMMGIWDCAW-UHFFFAOYSA-N 300695 4-(cyclopropylmethoxy)-3-{[(4- cyclopropylpiperazin-1- yl)acetyl]amino}-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 265 Protein Wnt-3a Human 320 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300695&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608519 381749456 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575442 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OCC6CC6 InChI=1S/C28H32N6O3S/c35-25(17-33-12-14-34(15-13-33)22-9-10-22)29-23-16-21(8-11-24(23)37-18-19-6-7-19)26(36)30-28-32-31-27(38-28)20-4-2-1-3-5-20/h1-5,8,11,16,19,22H,6-7,9-10,12-15,17-18H2,(H,29,35)(H,30,32,36) YNZGNMMGIWDCAW-UHFFFAOYSA-N 300695 4-(cyclopropylmethoxy)-3-{[(4- cyclopropylpiperazin-1- yl)acetyl]amino}-N-(5-phenyl- 1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 265 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300695&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608519 381749456 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575443 Cc1ccccc1c5nnc(NC(=O)c4ccc(OC2CC2)c(NC(=O)CN3CCOCC3)c4)s5 InChI=1S/C25H27N5O4S/c1-16-4-2-3-5-19(16)24-28-29-25(35-24)27-23(32)17-6-9-21(34-18-7-8-18)20(14-17)26-22(31)15-30-10-12-33-13-11-30/h2-6,9,14,18H,7-8,10-13,15H2,1H3,(H,26,31)(H,27,29,32) DGGUJILSDNTKBA-UHFFFAOYSA-N 300696 4-(cyclopropyloxy)-N-[5-(2- methylphenyl)-1,3,4-thiadiazol- 2-yl]-3-[(morpholin-4- ylacetyl)amino]benzamide::US10130633, Example 266 Protein Wnt-3a Human 345 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300696 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300696&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462401 381749457 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575444 Cc1ccccc1c5nnc(NC(=O)c4ccc(OC2CC2)c(NC(=O)CN3CCOCC3)c4)s5 InChI=1S/C25H27N5O4S/c1-16-4-2-3-5-19(16)24-28-29-25(35-24)27-23(32)17-6-9-21(34-18-7-8-18)20(14-17)26-22(31)15-30-10-12-33-13-11-30/h2-6,9,14,18H,7-8,10-13,15H2,1H3,(H,26,31)(H,27,29,32) DGGUJILSDNTKBA-UHFFFAOYSA-N 300696 4-(cyclopropyloxy)-N-[5-(2- methylphenyl)-1,3,4-thiadiazol- 2-yl]-3-[(morpholin-4- ylacetyl)amino]benzamide::US10130633, Example 266 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300696 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300696&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462401 381749457 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575445 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(C#N)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H22F3N7O3S/c1-33-7-9-34(10-8-33)14-20(35)29-18-12-16(5-6-19(18)37-24(25,26)27)21(36)30-23-32-31-22(38-23)17-4-2-3-15(11-17)13-28/h2-6,11-12H,7-10,14H2,1H3,(H,29,35)(H,30,32,36) PTZVQYLAEACEBD-UHFFFAOYSA-N 300697 N-[5-(3-cyanophenyl)-1,3,4- thiadiazol-2-yl]-3-{[(4- methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 267 Protein Wnt-3a Human 365 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300697&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608523 381749458 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575446 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(C#N)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H22F3N7O3S/c1-33-7-9-34(10-8-33)14-20(35)29-18-12-16(5-6-19(18)37-24(25,26)27)21(36)30-23-32-31-22(38-23)17-4-2-3-15(11-17)13-28/h2-6,11-12H,7-10,14H2,1H3,(H,29,35)(H,30,32,36) PTZVQYLAEACEBD-UHFFFAOYSA-N 300697 N-[5-(3-cyanophenyl)-1,3,4- thiadiazol-2-yl]-3-{[(4- methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethoxy)benzamide::US10130633, Example 267 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300697&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608523 381749458 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575447 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OCC5CC5 InChI=1S/C25H27N5O4S/c31-22(15-30-10-12-33-13-11-30)26-20-14-19(8-9-21(20)34-16-17-6-7-17)23(32)27-25-29-28-24(35-25)18-4-2-1-3-5-18/h1-5,8-9,14,17H,6-7,10-13,15-16H2,(H,26,31)(H,27,29,32) ZLHADKIBBRAPRP-UHFFFAOYSA-N 300698 4-(cyclopropylmethoxy)-3- [(morpholin-4-ylacetyl)amino]- N-(5-phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 268 Protein Wnt-3a Human 365 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300698&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462831 381749459 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575448 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3nnc(c2ccccc2)s3)ccc4OCC5CC5 InChI=1S/C25H27N5O4S/c31-22(15-30-10-12-33-13-11-30)26-20-14-19(8-9-21(20)34-16-17-6-7-17)23(32)27-25-29-28-24(35-25)18-4-2-1-3-5-18/h1-5,8-9,14,17H,6-7,10-13,15-16H2,(H,26,31)(H,27,29,32) ZLHADKIBBRAPRP-UHFFFAOYSA-N 300698 4-(cyclopropylmethoxy)-3- [(morpholin-4-ylacetyl)amino]- N-(5-phenyl-1,3,4-thiadiazol-2- yl)benzamide::US10130633, Example 268 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300698&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462831 381749459 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575449 CCc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c3)s4 InChI=1S/C24H24F3N5O4S/c1-2-15-5-3-4-6-17(15)22-30-31-23(37-22)29-21(34)16-7-8-19(36-24(25,26)27)18(13-16)28-20(33)14-32-9-11-35-12-10-32/h3-8,13H,2,9-12,14H2,1H3,(H,28,33)(H,29,31,34) GJTMRWOJGHNSEC-UHFFFAOYSA-N 300699 N-[5-(2-ethylphenyl)-1,3,4- thiadiazol-2-yl]-3-[(morpholin- 4-ylacetyl)amino]-4- (trifluoromethoxy)benzamide::US10130633, Example 269 Protein Wnt-3a Human 375 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300699 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300699&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462151 381749460 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575450 CCc1ccccc1c4nnc(NC(=O)c3ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c3)s4 InChI=1S/C24H24F3N5O4S/c1-2-15-5-3-4-6-17(15)22-30-31-23(37-22)29-21(34)16-7-8-19(36-24(25,26)27)18(13-16)28-20(33)14-32-9-11-35-12-10-32/h3-8,13H,2,9-12,14H2,1H3,(H,28,33)(H,29,31,34) GJTMRWOJGHNSEC-UHFFFAOYSA-N 300699 N-[5-(2-ethylphenyl)-1,3,4- thiadiazol-2-yl]-3-[(morpholin- 4-ylacetyl)amino]-4- (trifluoromethoxy)benzamide::US10130633, Example 269 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300699 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300699&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462151 381749460 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575451 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1C(F)(F)F)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H22F6N6O3S/c1-35-8-10-36(11-9-35)13-19(37)31-17-12-14(6-7-18(17)39-24(28,29)30)20(38)32-22-34-33-21(40-22)15-4-2-3-5-16(15)23(25,26)27/h2-7,12H,8-11,13H2,1H3,(H,31,37)(H,32,34,38) ZHIHVAKRBQMXJL-UHFFFAOYSA-N 300700 3-{[(4-methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethoxy)-N-{5-[2- (trifluoromethyl)phenyl]-1,3,4- thiadiazol-2-yl}benzamide::US10130633, Example 270 Protein Wnt-3a Human 390 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300700&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608480 381749461 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575452 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1C(F)(F)F)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H22F6N6O3S/c1-35-8-10-36(11-9-35)13-19(37)31-17-12-14(6-7-18(17)39-24(28,29)30)20(38)32-22-34-33-21(40-22)15-4-2-3-5-16(15)23(25,26)27/h2-7,12H,8-11,13H2,1H3,(H,31,37)(H,32,34,38) ZHIHVAKRBQMXJL-UHFFFAOYSA-N 300700 3-{[(4-methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethoxy)-N-{5-[2- (trifluoromethyl)phenyl]-1,3,4- thiadiazol-2-yl}benzamide::US10130633, Example 270 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300700&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608480 381749461 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575453 Cc1ccccc1c5nnc(NC(=O)c4ccc(OC(F)(F)F)c(NC(=O)C3(N2CCN(C)CC2)CC3)c4)s5 InChI=1S/C26H27F3N6O3S/c1-16-5-3-4-6-18(16)22-32-33-24(39-22)31-21(36)17-7-8-20(38-26(27,28)29)19(15-17)30-23(37)25(9-10-25)35-13-11-34(2)12-14-35/h3-8,15H,9-14H2,1-2H3,(H,30,37)(H,31,33,36) LDWZCLCNZVXTKQ-UHFFFAOYSA-N 300701 N-[5-(2-methylphenyl)-1,3,4- thiadiazol-2-yl]-3-({[1-(4- methylpiperazin-1- yl)cyclopropyl]carbonyl}amino)- 4-(trifluoromethoxy)benzamide::US10130633, Example 271 Protein Wnt-3a Human 480 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300701&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463063 381749462 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575454 Cc1ccccc1c5nnc(NC(=O)c4ccc(OC(F)(F)F)c(NC(=O)C3(N2CCN(C)CC2)CC3)c4)s5 InChI=1S/C26H27F3N6O3S/c1-16-5-3-4-6-18(16)22-32-33-24(39-22)31-21(36)17-7-8-20(38-26(27,28)29)19(15-17)30-23(37)25(9-10-25)35-13-11-34(2)12-14-35/h3-8,15H,9-14H2,1-2H3,(H,30,37)(H,31,33,36) LDWZCLCNZVXTKQ-UHFFFAOYSA-N 300701 N-[5-(2-methylphenyl)-1,3,4- thiadiazol-2-yl]-3-({[1-(4- methylpiperazin-1- yl)cyclopropyl]carbonyl}amino)- 4-(trifluoromethoxy)benzamide::US10130633, Example 271 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300701&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90463063 381749462 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575455 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(C(F)(F)F)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H22F6N6O3S/c1-35-7-9-36(10-8-35)13-19(37)31-17-12-14(5-6-18(17)39-24(28,29)30)20(38)32-22-34-33-21(40-22)15-3-2-4-16(11-15)23(25,26)27/h2-6,11-12H,7-10,13H2,1H3,(H,31,37)(H,32,34,38) XEFHDBUDMDTZFF-UHFFFAOYSA-N 300702 3-{[(4-methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethoxy)-N-{5-[3- (trifluoromethyl)phenyl]-1,3,4- thiadiazol-2-yl}benzamide::US10130633, Example 272 Protein Wnt-3a Human 545 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300702&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608481 381749463 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575456 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(C(F)(F)F)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C24H22F6N6O3S/c1-35-7-9-36(10-8-35)13-19(37)31-17-12-14(5-6-18(17)39-24(28,29)30)20(38)32-22-34-33-21(40-22)15-3-2-4-16(11-15)23(25,26)27/h2-6,11-12H,7-10,13H2,1H3,(H,31,37)(H,32,34,38) XEFHDBUDMDTZFF-UHFFFAOYSA-N 300702 3-{[(4-methylpiperazin-1- yl)acetyl]amino}-4- (trifluoromethoxy)-N-{5-[3- (trifluoromethyl)phenyl]-1,3,4- thiadiazol-2-yl}benzamide::US10130633, Example 272 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300702&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608481 381749463 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575457 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O3S/c1-15(33-12-10-32(2)11-13-33)20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) QWBOSJFOAGJZPT-UHFFFAOYSA-N 300488 US10130633, Example 260::3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 273::US10130633, Example 58 Protein Wnt-3a Human 930 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300488&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291851 381749269 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575458 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O3S/c1-15(33-12-10-32(2)11-13-33)20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) QWBOSJFOAGJZPT-UHFFFAOYSA-N 300488 US10130633, Example 260::3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 273::US10130633, Example 58 Protein Wnt-3a Human 27000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300488&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291851 381749269 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575459 CC[C@H](C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C25H27F3N6O3S/c1-3-19(34-13-11-33(2)12-14-34)22(36)29-18-15-17(9-10-20(18)37-25(26,27)28)21(35)30-24-32-31-23(38-24)16-7-5-4-6-8-16/h4-10,15,19H,3,11-14H2,1-2H3,(H,29,36)(H,30,32,35) GQPGHJVYVOMEFU-UHFFFAOYSA-N 300704 3-{[(2R)-2-(4-methylpiperazin-1- yl)butanoyl]amino}-N-(5- phenyl-1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 274 Protein Wnt-3a Human 3020 US Patent 10.7270/Q2FN188G aid1796054 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300704&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608490 381749464 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575460 CC[C@H](C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C25H27F3N6O3S/c1-3-19(34-13-11-33(2)12-14-34)22(36)29-18-15-17(9-10-20(18)37-25(26,27)28)21(35)30-24-32-31-23(38-24)16-7-5-4-6-8-16/h4-10,15,19H,3,11-14H2,1-2H3,(H,29,36)(H,30,32,35) GQPGHJVYVOMEFU-UHFFFAOYSA-N 300704 3-{[(2R)-2-(4-methylpiperazin-1- yl)butanoyl]amino}-N-(5- phenyl-1,3,4-thiadiazol-2-yl)-4- (trifluoromethoxy)benzamide::US10130633, Example 274 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796055 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300704&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608490 381749464 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575463 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O4/c1-33-23-9-6-17(14-22(23)29-24(31)16-30-10-12-34-13-11-30)25(32)28-18-7-8-21(27-15-18)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) SBSHXXHJRFEVEN-UHFFFAOYSA-N 300431 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 1 Protein Wnt-3a Human 3300 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300431&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293210 381749212 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575464 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CCOCC4 InChI=1S/C25H25FN4O4/c1-33-23-9-6-17(14-22(23)29-24(31)16-30-10-12-34-13-11-30)25(32)28-18-7-8-21(27-15-18)19-4-2-3-5-20(19)26/h2-9,14-15H,10-13,16H2,1H3,(H,28,32)(H,29,31) SBSHXXHJRFEVEN-UHFFFAOYSA-N 300431 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 1 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300431&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293210 381749212 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575465 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CC5CCC(C4)O5 InChI=1S/C27H27FN4O4/c1-35-25-11-6-17(12-24(25)31-26(33)16-32-14-19-8-9-20(15-32)36-19)27(34)30-18-7-10-23(29-13-18)21-4-2-3-5-22(21)28/h2-7,10-13,19-20H,8-9,14-16H2,1H3,(H,30,34)(H,31,33) XSNUAYHLXKXWHA-UHFFFAOYSA-N 300432 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]benzamide::US10130633, Example 2 Protein Wnt-3a Human 120 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300432&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293211 381749213 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575466 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)CN4CC5CCC(C4)O5 InChI=1S/C27H27FN4O4/c1-35-25-11-6-17(12-24(25)31-26(33)16-32-14-19-8-9-20(15-32)36-19)27(34)30-18-7-10-23(29-13-18)21-4-2-3-5-22(21)28/h2-7,10-13,19-20H,8-9,14-16H2,1H3,(H,30,34)(H,31,33) XSNUAYHLXKXWHA-UHFFFAOYSA-N 300432 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]benzamide::US10130633, Example 2 Protein Wnt-3a Human 6900 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300432&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293211 381749213 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575467 O=C(CN1CC2CCC(C1)O2)Nc5cc(C(=O)Nc4ccc(c3ccccc3F)nc4)ccc5OC(F)(F)F InChI=1S/C27H24F4N4O4/c28-21-4-2-1-3-20(21)22-9-6-17(12-32-22)33-26(37)16-5-10-24(39-27(29,30)31)23(11-16)34-25(36)15-35-13-18-7-8-19(14-35)38-18/h1-6,9-12,18-19H,7-8,13-15H2,(H,33,37)(H,34,36) QUECETJBQMLUHM-UHFFFAOYSA-N 300436 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 6 Protein Wnt-3a Human 13.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300436&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293213 381749217 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575468 O=C(CN1CC2CCC(C1)O2)Nc5cc(C(=O)Nc4ccc(c3ccccc3F)nc4)ccc5OC(F)(F)F InChI=1S/C27H24F4N4O4/c28-21-4-2-1-3-20(21)22-9-6-17(12-32-22)33-26(37)16-5-10-24(39-27(29,30)31)23(11-16)34-25(36)15-35-13-18-7-8-19(14-35)38-18/h1-6,9-12,18-19H,7-8,13-15H2,(H,33,37)(H,34,36) QUECETJBQMLUHM-UHFFFAOYSA-N 300436 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(8-oxa-3-azabicyclo[3.2.1]oct-3-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 6 Protein Wnt-3a Human 2800 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300436&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293213 381749217 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575469 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300437 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 7 Protein Wnt-3a Human 38.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300437&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293397 381749218 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575470 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300437 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 7 Protein Wnt-3a Human 7400 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300437&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293397 381749218 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575471 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300438 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 8 Protein Wnt-3a Human 130 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300438&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459788 381749219 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575472 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300438 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 8 Protein Wnt-3a Human 8100 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300438&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459788 381749219 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575473 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300439 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 9 Protein Wnt-3a Human 9.00 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300439&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459954 381749220 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575474 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C26H24F4N4O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-17(6-9-23(22)38-26(28,29)30)25(36)32-18-7-8-21(31-15-18)19-4-2-3-5-20(19)27/h2-9,14-16H,10-13H2,1H3,(H,32,36)(H,33,35) HFPJXXWOFQHZSR-UHFFFAOYSA-N 300439 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 9 Protein Wnt-3a Human 8200 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300439&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459954 381749220 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575475 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H25F3N4O4/c1-17(33-11-13-36-14-12-33)24(34)32-22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-17H,11-14H2,1H3,(H,31,35)(H,32,34) FWSLMXRDOJIPST-UHFFFAOYSA-N 300440 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 208::US10130633, Example 10 Protein Wnt-3a Human 92.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300440&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293398 381749221 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575476 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H25F3N4O4/c1-17(33-11-13-36-14-12-33)24(34)32-22-15-19(7-10-23(22)37-26(27,28)29)25(35)31-20-8-9-21(30-16-20)18-5-3-2-4-6-18/h2-10,15-17H,11-14H2,1H3,(H,31,35)(H,32,34) FWSLMXRDOJIPST-UHFFFAOYSA-N 300440 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 208::US10130633, Example 10 Protein Wnt-3a Human 19000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300440&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293398 381749221 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575477 CC(C)(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C27H26F4N4O4/c1-26(2,35-11-13-38-14-12-35)25(37)34-22-15-17(7-10-23(22)39-27(29,30)31)24(36)33-18-8-9-21(32-16-18)19-5-3-4-6-20(19)28/h3-10,15-16H,11-14H2,1-2H3,(H,33,36)(H,34,37) IAVWNBZQCNIJPT-UHFFFAOYSA-N 300441 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-methyl-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 11 Protein Wnt-3a Human 700 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300441&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459548 381749222 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575478 CC(C)(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C27H26F4N4O4/c1-26(2,35-11-13-38-14-12-35)25(37)34-22-15-17(7-10-23(22)39-27(29,30)31)24(36)33-18-8-9-21(32-16-18)19-5-3-4-6-20(19)28/h3-10,15-16H,11-14H2,1-2H3,(H,33,36)(H,34,37) IAVWNBZQCNIJPT-UHFFFAOYSA-N 300441 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-methyl-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 11 Protein Wnt-3a Human 8100 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300441&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459548 381749222 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575479 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ncc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)28-20(31)14-30-8-10-33-11-9-30)21(32)29-22-27-13-19(35-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,31)(H,27,29,32) SVMPHFGGFLOGKM-UHFFFAOYSA-N 300444 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 14 Protein Wnt-3a Human 550 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300444&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293021 381749225 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575480 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ncc(c2ccccc2)s3)ccc4OC(F)(F)F InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)28-20(31)14-30-8-10-33-11-9-30)21(32)29-22-27-13-19(35-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,31)(H,27,29,32) SVMPHFGGFLOGKM-UHFFFAOYSA-N 300444 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 14 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300444&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293021 381749225 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575481 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)nc3)ccc4OC(F)(F)F InChI=1S/C25H23F3N4O4/c26-25(27,28)36-22-9-6-18(14-21(22)31-23(33)16-32-10-12-35-13-11-32)24(34)30-19-7-8-20(29-15-19)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) PLVWMVVYKNZXLO-UHFFFAOYSA-N 300445 3-[(morpholin-4-ylacetyl)amino]-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 15 Protein Wnt-3a Human 48.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300445&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293209 381749226 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575482 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)nc3)ccc4OC(F)(F)F InChI=1S/C25H23F3N4O4/c26-25(27,28)36-22-9-6-18(14-21(22)31-23(33)16-32-10-12-35-13-11-32)24(34)30-19-7-8-20(29-15-19)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) PLVWMVVYKNZXLO-UHFFFAOYSA-N 300445 3-[(morpholin-4-ylacetyl)amino]-N-(6-phenylpyridin-3-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 15 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300445&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293209 381749226 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575483 FC(F)(F)Oc1ccc(NC(=O)c2ncc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)29-20(31)14-30-8-10-33-11-9-30)28-21(32)22-27-13-19(35-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,32)(H,29,31) XODAASDFJSXPKD-UHFFFAOYSA-N 300446 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1,3-thiazole-2-carboxamide::US10130633, Example 16 Protein Wnt-3a Human 92.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300446&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293399 381749227 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575484 FC(F)(F)Oc1ccc(NC(=O)c2ncc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H21F3N4O4S/c24-23(25,26)34-18-7-6-16(12-17(18)29-20(31)14-30-8-10-33-11-9-30)28-21(32)22-27-13-19(35-22)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,28,32)(H,29,31) XODAASDFJSXPKD-UHFFFAOYSA-N 300446 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1,3-thiazole-2-carboxamide::US10130633, Example 16 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300446&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293399 381749227 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575485 FC(F)(F)Oc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H22F3N3O4S/c25-24(26,27)34-19-7-6-17(14-18(19)29-22(31)15-30-10-12-33-13-11-30)28-23(32)21-9-8-20(35-21)16-4-2-1-3-5-16/h1-9,14H,10-13,15H2,(H,28,32)(H,29,31) JZIIDZNSPCRDLE-UHFFFAOYSA-N 300447 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 17 Protein Wnt-3a Human 33.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300447&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293588 381749228 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575486 FC(F)(F)Oc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H22F3N3O4S/c25-24(26,27)34-19-7-6-17(14-18(19)29-22(31)15-30-10-12-33-13-11-30)28-23(32)21-9-8-20(35-21)16-4-2-1-3-5-16/h1-9,14H,10-13,15H2,(H,28,32)(H,29,31) JZIIDZNSPCRDLE-UHFFFAOYSA-N 300447 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 17 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300447&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293588 381749228 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575487 CC(C)(C)c1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C27H31N3O3S/c1-27(2,3)21-10-9-20(17-22(21)29-25(31)18-30-13-15-33-16-14-30)28-26(32)24-12-11-23(34-24)19-7-5-4-6-8-19/h4-12,17H,13-16,18H2,1-3H3,(H,28,32)(H,29,31) BCIZWNGRDUPVKI-UHFFFAOYSA-N 300449 N-{4-tert-butyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 19 Protein Wnt-3a Human 990 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300449&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293400 381749230 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575488 CC(C)(C)c1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C27H31N3O3S/c1-27(2,3)21-10-9-20(17-22(21)29-25(31)18-30-13-15-33-16-14-30)28-26(32)24-12-11-23(34-24)19-7-5-4-6-8-19/h4-12,17H,13-16,18H2,1-3H3,(H,28,32)(H,29,31) BCIZWNGRDUPVKI-UHFFFAOYSA-N 300449 N-{4-tert-butyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 19 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300449&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293400 381749230 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575489 COc1ccc(NC(=O)c2ncc(o2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H24N4O5/c1-30-19-8-7-17(13-18(19)26-21(28)15-27-9-11-31-12-10-27)25-22(29)23-24-14-20(32-23)16-5-3-2-4-6-16/h2-8,13-14H,9-12,15H2,1H3,(H,25,29)(H,26,28) MVMRWWRDURQEGG-UHFFFAOYSA-N 300450 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1,3-oxazole-2-carboxamide::US10130633, Example 20 Protein Wnt-3a Human 2200 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300450&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293586 381749231 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575490 COc1ccc(NC(=O)c2ncc(o2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H24N4O5/c1-30-19-8-7-17(13-18(19)26-21(28)15-27-9-11-31-12-10-27)25-22(29)23-24-14-20(32-23)16-5-3-2-4-6-16/h2-8,13-14H,9-12,15H2,1H3,(H,25,29)(H,26,28) MVMRWWRDURQEGG-UHFFFAOYSA-N 300450 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1,3-oxazole-2-carboxamide::US10130633, Example 20 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300450&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293586 381749231 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575491 Clc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H22ClN3O3S/c24-18-7-6-17(14-19(18)26-22(28)15-27-10-12-30-13-11-27)25-23(29)21-9-8-20(31-21)16-4-2-1-3-5-16/h1-9,14H,10-13,15H2,(H,25,29)(H,26,28) INKOFQFGQJTKKN-UHFFFAOYSA-N 300451 N-{4-chloro-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 21 Protein Wnt-3a Human 140 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300451&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293585 381749232 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575492 Clc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H22ClN3O3S/c24-18-7-6-17(14-19(18)26-22(28)15-27-10-12-30-13-11-27)25-23(29)21-9-8-20(31-21)16-4-2-1-3-5-16/h1-9,14H,10-13,15H2,(H,25,29)(H,26,28) INKOFQFGQJTKKN-UHFFFAOYSA-N 300451 N-{4-chloro-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 21 Protein Wnt-3a Human 5800 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300451&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293585 381749232 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575493 Cc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H25N3O3S/c1-17-7-8-19(15-20(17)26-23(28)16-27-11-13-30-14-12-27)25-24(29)22-10-9-21(31-22)18-5-3-2-4-6-18/h2-10,15H,11-14,16H2,1H3,(H,25,29)(H,26,28) RCFXBGWEFKEYKH-UHFFFAOYSA-N 300452 N-{4-methyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 22 Protein Wnt-3a Human 1100 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300452&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293401 381749233 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575494 Cc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H25N3O3S/c1-17-7-8-19(15-20(17)26-23(28)16-27-11-13-30-14-12-27)25-24(29)22-10-9-21(31-22)18-5-3-2-4-6-18/h2-10,15H,11-14,16H2,1H3,(H,25,29)(H,26,28) RCFXBGWEFKEYKH-UHFFFAOYSA-N 300452 N-{4-methyl-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 22 Protein Wnt-3a Human 24000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300452&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293401 381749233 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575495 COc1ccc(NC(=O)c2ccc([nH]2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H26N4O4/c1-31-22-10-7-18(15-21(22)27-23(29)16-28-11-13-32-14-12-28)25-24(30)20-9-8-19(26-20)17-5-3-2-4-6-17/h2-10,15,26H,11-14,16H2,1H3,(H,25,30)(H,27,29) YSYRMCKCULKEPJ-UHFFFAOYSA-N 300454 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1H-pyrrole-2-carboxamide::US10130633, Example 24 Protein Wnt-3a Human 650 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300454&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293590 381749235 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575496 COc1ccc(NC(=O)c2ccc([nH]2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H26N4O4/c1-31-22-10-7-18(15-21(22)27-23(29)16-28-11-13-32-14-12-28)25-24(30)20-9-8-19(26-20)17-5-3-2-4-6-17/h2-10,15,26H,11-14,16H2,1H3,(H,25,30)(H,27,29) YSYRMCKCULKEPJ-UHFFFAOYSA-N 300454 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenyl-1H-pyrrole-2-carboxamide::US10130633, Example 24 Protein Wnt-3a Human 17000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300454&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293590 381749235 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575497 COc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H25N3O4S/c1-30-20-8-7-18(15-19(20)26-23(28)16-27-11-13-31-14-12-27)25-24(29)22-10-9-21(32-22)17-5-3-2-4-6-17/h2-10,15H,11-14,16H2,1H3,(H,25,29)(H,26,28) XEPLIBHQDIWXCP-UHFFFAOYSA-N 300455 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 25 Protein Wnt-3a Human 90.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300455&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293781 381749236 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575498 COc1ccc(NC(=O)c2ccc(s2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C24H25N3O4S/c1-30-20-8-7-18(15-19(20)26-23(28)16-27-11-13-31-14-12-27)25-24(29)22-10-9-21(32-22)17-5-3-2-4-6-17/h2-10,15H,11-14,16H2,1H3,(H,25,29)(H,26,28) XEPLIBHQDIWXCP-UHFFFAOYSA-N 300455 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-phenylthiophene-2-carboxamide::US10130633, Example 25 Protein Wnt-3a Human 10000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300455&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293781 381749236 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575499 Fc1cccc(c1F)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-18-3-1-2-17(23(18)27)19-6-4-15(13-31-19)24(36)32-16-5-7-21(38-25(28,29)30)20(12-16)33-22(35)14-34-8-10-37-11-9-34/h1-7,12-13H,8-11,14H2,(H,32,36)(H,33,35) ADMFSAXASSRTEU-UHFFFAOYSA-N 300456 6-(2,3-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 26 Protein Wnt-3a Human 350 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300456&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293782 381749237 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575500 Fc1cccc(c1F)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-18-3-1-2-17(23(18)27)19-6-4-15(13-31-19)24(36)32-16-5-7-21(38-25(28,29)30)20(12-16)33-22(35)14-34-8-10-37-11-9-34/h1-7,12-13H,8-11,14H2,(H,32,36)(H,33,35) ADMFSAXASSRTEU-UHFFFAOYSA-N 300456 6-(2,3-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 26 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300456&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293782 381749237 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575501 Fc1cc(F)cc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-17-9-16(10-18(27)11-17)20-3-1-15(13-31-20)24(36)32-19-2-4-22(38-25(28,29)30)21(12-19)33-23(35)14-34-5-7-37-8-6-34/h1-4,9-13H,5-8,14H2,(H,32,36)(H,33,35) DSQGNQYHKXRLFE-UHFFFAOYSA-N 300457 6-(3,5-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 27 Protein Wnt-3a Human 1000 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300457&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293783 381749238 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575502 Fc1cc(F)cc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H21F5N4O4/c26-17-9-16(10-18(27)11-17)20-3-1-15(13-31-20)24(36)32-19-2-4-22(38-25(28,29)30)21(12-19)33-23(35)14-34-5-7-37-8-6-34/h1-4,9-13H,5-8,14H2,(H,32,36)(H,33,35) DSQGNQYHKXRLFE-UHFFFAOYSA-N 300457 6-(3,5-difluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 27 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300457&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293783 381749238 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575503 Fc1cccc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H22F4N4O4/c26-18-3-1-2-16(12-18)20-6-4-17(14-30-20)24(35)31-19-5-7-22(37-25(27,28)29)21(13-19)32-23(34)15-33-8-10-36-11-9-33/h1-7,12-14H,8-11,15H2,(H,31,35)(H,32,34) FIXTUTUYLQVSOC-UHFFFAOYSA-N 300458 6-(3-fluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 28 Protein Wnt-3a Human 800 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300458&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293784 381749239 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575504 Fc1cccc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H22F4N4O4/c26-18-3-1-2-16(12-18)20-6-4-17(14-30-20)24(35)31-19-5-7-22(37-25(27,28)29)21(13-19)32-23(34)15-33-8-10-36-11-9-33/h1-7,12-14H,8-11,15H2,(H,31,35)(H,32,34) FIXTUTUYLQVSOC-UHFFFAOYSA-N 300458 6-(3-fluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 28 Protein Wnt-3a Human 20000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300458&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293784 381749239 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575505 Fc1ccccc1-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H22F4N4O4/c26-19-4-2-1-3-18(19)20-7-5-16(14-30-20)24(35)31-17-6-8-22(37-25(27,28)29)21(13-17)32-23(34)15-33-9-11-36-12-10-33/h1-8,13-14H,9-12,15H2,(H,31,35)(H,32,34) LMEAJULYWCIHIQ-UHFFFAOYSA-N 300460 6-(2-fluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 30 Protein Wnt-3a Human 1400 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300460 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300460&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293968 381749241 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575506 Fc1ccccc1-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H22F4N4O4/c26-19-4-2-1-3-18(19)20-7-5-16(14-30-20)24(35)31-17-6-8-22(37-25(27,28)29)21(13-17)32-23(34)15-33-9-11-36-12-10-33/h1-8,13-14H,9-12,15H2,(H,31,35)(H,32,34) LMEAJULYWCIHIQ-UHFFFAOYSA-N 300460 6-(2-fluorophenyl)-N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}nicotinamide::US10130633, Example 30 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300460 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300460&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293968 381749241 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575507 COc1ccc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H25FN4O4/c1-33-23-8-6-20(14-22(23)29-24(31)16-30-9-11-34-12-10-30)28-25(32)18-5-7-21(27-15-18)17-3-2-4-19(26)13-17/h2-8,13-15H,9-12,16H2,1H3,(H,28,32)(H,29,31) ASXQKWUUHVJUIZ-UHFFFAOYSA-N 300462 6-(3-fluorophenyl)-N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}nicotinamide::US10130633, Example 32 Protein Wnt-3a Human 260 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300462&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293970 381749243 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575508 COc1ccc(NC(=O)c2ccc(nc2)-c2cccc(F)c2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H25FN4O4/c1-33-23-8-6-20(14-22(23)29-24(31)16-30-9-11-34-12-10-30)28-25(32)18-5-7-21(27-15-18)17-3-2-4-19(26)13-17/h2-8,13-15H,9-12,16H2,1H3,(H,28,32)(H,29,31) ASXQKWUUHVJUIZ-UHFFFAOYSA-N 300462 6-(3-fluorophenyl)-N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}nicotinamide::US10130633, Example 32 Protein Wnt-3a Human 4000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300462&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293970 381749243 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575509 FC(F)(F)Oc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H23F3N4O4/c26-25(27,28)36-22-9-7-19(14-21(22)31-23(33)16-32-10-12-35-13-11-32)30-24(34)18-6-8-20(29-15-18)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) SOMPCIKDNUVLIX-UHFFFAOYSA-N 300463 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-6-phenylnicotinamide::US10130633, Example 33 Protein Wnt-3a Human 370 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300463&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293971 381749244 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575510 FC(F)(F)Oc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C25H23F3N4O4/c26-25(27,28)36-22-9-7-19(14-21(22)31-23(33)16-32-10-12-35-13-11-32)30-24(34)18-6-8-20(29-15-18)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,34)(H,31,33) SOMPCIKDNUVLIX-UHFFFAOYSA-N 300463 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-6-phenylnicotinamide::US10130633, Example 33 Protein Wnt-3a Human 7400 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300463&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293971 381749244 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575511 COc1ccc(cc1)-c1ccc(s1)C(=O)Nc1ccc(OC)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H27N3O5S/c1-31-19-6-3-17(4-7-19)22-9-10-23(34-22)25(30)26-18-5-8-21(32-2)20(15-18)27-24(29)16-28-11-13-33-14-12-28/h3-10,15H,11-14,16H2,1-2H3,(H,26,30)(H,27,29) VUUXDGFUVGYIJN-UHFFFAOYSA-N 300465 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-(4-methoxyphenyl)thiophene-2-carboxamide::US10130633, Example 35 Protein Wnt-3a Human 910 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300465&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294150 381749246 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575512 COc1ccc(cc1)-c1ccc(s1)C(=O)Nc1ccc(OC)c(NC(=O)CN2CCOCC2)c1 InChI=1S/C25H27N3O5S/c1-31-19-6-3-17(4-7-19)22-9-10-23(34-22)25(30)26-18-5-8-21(32-2)20(15-18)27-24(29)16-28-11-13-33-14-12-28/h3-10,15H,11-14,16H2,1-2H3,(H,26,30)(H,27,29) VUUXDGFUVGYIJN-UHFFFAOYSA-N 300465 N-{4-methoxy-3-[(morpholin-4-ylacetyl)amino]phenyl}-5-(4-methoxyphenyl)thiophene-2-carboxamide::US10130633, Example 35 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300465&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294150 381749246 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575513 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(OC(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H23F2N5O4S/c25-22(26)35-18-7-6-16(19(32)28-23-30-29-20(36-23)15-4-2-1-3-5-15)14-17(18)27-21(33)24(8-9-24)31-10-12-34-13-11-31/h1-7,14,22H,8-13H2,(H,27,33)(H,28,30,32) CJUIOOKKKHRBDW-UHFFFAOYSA-N 300467 4-(difluoromethoxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 37 Protein Wnt-3a Human 280 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300467&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294152 381749248 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575514 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(OC(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H23F2N5O4S/c25-22(26)35-18-7-6-16(19(32)28-23-30-29-20(36-23)15-4-2-1-3-5-15)14-17(18)27-21(33)24(8-9-24)31-10-12-34-13-11-31/h1-7,14,22H,8-13H2,(H,27,33)(H,28,30,32) CJUIOOKKKHRBDW-UHFFFAOYSA-N 300467 4-(difluoromethoxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 37 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300467&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294152 381749248 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575515 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C27H28F2N6O3S/c28-25(29)38-21-9-6-18(22(36)31-26-33-32-23(39-26)17-4-2-1-3-5-17)16-20(21)30-24(37)27(10-11-27)35-14-12-34(13-15-35)19-7-8-19/h1-6,9,16,19,25H,7-8,10-15H2,(H,30,37)(H,31,33,36) JRAKYUMORODASZ-UHFFFAOYSA-N 300468 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-(difluoromethoxy)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 38 Protein Wnt-3a Human 200 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300468&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294153 381749249 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575516 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C27H28F2N6O3S/c28-25(29)38-21-9-6-18(22(36)31-26-33-32-23(39-26)17-4-2-1-3-5-17)16-20(21)30-24(37)27(10-11-27)35-14-12-34(13-15-35)19-7-8-19/h1-6,9,16,19,25H,7-8,10-15H2,(H,30,37)(H,31,33,36) JRAKYUMORODASZ-UHFFFAOYSA-N 300468 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-(difluoromethoxy)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 38 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300468&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294153 381749249 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575517 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)CC4 InChI=1S/C23H24F2N6O3S/c1-30-9-11-31(12-10-30)14-19(32)26-17-13-16(7-8-18(17)34-22(24)25)20(33)27-23-29-28-21(35-23)15-5-3-2-4-6-15/h2-8,13,22H,9-12,14H2,1H3,(H,26,32)(H,27,29,33) RZAYXPOLDBZMMO-UHFFFAOYSA-N 300470 4-(difluoromethoxy)-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 40 Protein Wnt-3a Human 530 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300470&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294337 381749251 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575518 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)CC4 InChI=1S/C23H24F2N6O3S/c1-30-9-11-31(12-10-30)14-19(32)26-17-13-16(7-8-18(17)34-22(24)25)20(33)27-23-29-28-21(35-23)15-5-3-2-4-6-15/h2-8,13,22H,9-12,14H2,1H3,(H,26,32)(H,27,29,33) RZAYXPOLDBZMMO-UHFFFAOYSA-N 300470 4-(difluoromethoxy)-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 40 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300470&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294337 381749251 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575519 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OC(F)F InChI=1S/C25H26F2N6O3S/c26-24(27)36-20-9-6-17(22(35)29-25-31-30-23(37-25)16-4-2-1-3-5-16)14-19(20)28-21(34)15-32-10-12-33(13-11-32)18-7-8-18/h1-6,9,14,18,24H,7-8,10-13,15H2,(H,28,34)(H,29,31,35) PFGQKZRTHFZWDT-UHFFFAOYSA-N 300471 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-4-(difluoromethoxy)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 41 Protein Wnt-3a Human 720 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300471&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294338 381749252 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575520 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OC(F)F InChI=1S/C25H26F2N6O3S/c26-24(27)36-20-9-6-17(22(35)29-25-31-30-23(37-25)16-4-2-1-3-5-16)14-19(20)28-21(34)15-32-10-12-33(13-11-32)18-7-8-18/h1-6,9,14,18,24H,7-8,10-13,15H2,(H,28,34)(H,29,31,35) PFGQKZRTHFZWDT-UHFFFAOYSA-N 300471 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-4-(difluoromethoxy)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 41 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300471&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294338 381749252 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575521 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)N4CCN(C)CC4 InChI=1S/C24H26F2N6O3S/c1-15(32-12-10-31(2)11-13-32)20(33)27-18-14-17(8-9-19(18)35-23(25)26)21(34)28-24-30-29-22(36-24)16-6-4-3-5-7-16/h3-9,14-15,23H,10-13H2,1-2H3,(H,27,33)(H,28,30,34) YIQDKSIDVLRXSB-UHFFFAOYSA-N 300472 4-(difluoromethoxy)-3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide trifluoroacetate (1:1)::US10130633, Example 42 Protein Wnt-3a Human 106 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300472&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462561 381749253 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575522 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)F)N4CCN(C)CC4 InChI=1S/C24H26F2N6O3S/c1-15(32-12-10-31(2)11-13-32)20(33)27-18-14-17(8-9-19(18)35-23(25)26)21(34)28-24-30-29-22(36-24)16-6-4-3-5-7-16/h3-9,14-15,23H,10-13H2,1-2H3,(H,27,33)(H,28,30,34) YIQDKSIDVLRXSB-UHFFFAOYSA-N 300472 4-(difluoromethoxy)-3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide trifluoroacetate (1:1)::US10130633, Example 42 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300472&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462561 381749253 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575523 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C25H27N5O4S/c1-33-16-19-8-7-18(21(31)27-24-29-28-22(35-24)17-5-3-2-4-6-17)15-20(19)26-23(32)25(9-10-25)30-11-13-34-14-12-30/h2-8,15H,9-14,16H2,1H3,(H,26,32)(H,27,29,31) BGQBRJJYUADPJT-UHFFFAOYSA-N 300473 4-(methoxymethyl)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 43 Protein Wnt-3a Human 110 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300473&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294339 381749254 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575524 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C25H27N5O4S/c1-33-16-19-8-7-18(21(31)27-24-29-28-22(35-24)17-5-3-2-4-6-17)15-20(19)26-23(32)25(9-10-25)30-11-13-34-14-12-30/h2-8,15H,9-14,16H2,1H3,(H,26,32)(H,27,29,31) BGQBRJJYUADPJT-UHFFFAOYSA-N 300473 4-(methoxymethyl)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 43 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300473&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294339 381749254 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575525 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C6(N5CCN(C4CC4)CC5)CC6 InChI=1S/C28H32N6O3S/c1-37-18-21-8-7-20(24(35)30-27-32-31-25(38-27)19-5-3-2-4-6-19)17-23(21)29-26(36)28(11-12-28)34-15-13-33(14-16-34)22-9-10-22/h2-8,17,22H,9-16,18H2,1H3,(H,29,36)(H,30,32,35) PYXKGNMJTOCFNK-UHFFFAOYSA-N 300474 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-(methoxymethyl)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 44 Protein Wnt-3a Human 196 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300474&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294340 381749255 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575526 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C6(N5CCN(C4CC4)CC5)CC6 InChI=1S/C28H32N6O3S/c1-37-18-21-8-7-20(24(35)30-27-32-31-25(38-27)19-5-3-2-4-6-19)17-23(21)29-26(36)28(11-12-28)34-15-13-33(14-16-34)22-9-10-22/h2-8,17,22H,9-16,18H2,1H3,(H,29,36)(H,30,32,35) PYXKGNMJTOCFNK-UHFFFAOYSA-N 300474 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-(methoxymethyl)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 44 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300474&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294340 381749255 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575527 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCN(C)CC4)CC5 InChI=1S/C26H30N6O3S/c1-31-12-14-32(15-13-31)26(10-11-26)24(34)27-21-16-19(8-9-20(21)17-35-2)22(33)28-25-30-29-23(36-25)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,34)(H,28,30,33) YYIIMHWKKZNWNN-UHFFFAOYSA-N 300475 4-(methoxymethyl)-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide hydrochloride (1:1)::US10130633, Example 45 Protein Wnt-3a Human 190 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300475&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461487 381749256 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575528 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCN(C)CC4)CC5 InChI=1S/C26H30N6O3S/c1-31-12-14-32(15-13-31)26(10-11-26)24(34)27-21-16-19(8-9-20(21)17-35-2)22(33)28-25-30-29-23(36-25)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,34)(H,28,30,33) YYIIMHWKKZNWNN-UHFFFAOYSA-N 300475 4-(methoxymethyl)-3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide hydrochloride (1:1)::US10130633, Example 45 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300475&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90461487 381749256 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575529 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C24H28N6O3S/c1-29-10-12-30(13-11-29)15-21(31)25-20-14-18(8-9-19(20)16-33-2)22(32)26-24-28-27-23(34-24)17-6-4-3-5-7-17/h3-9,14H,10-13,15-16H2,1-2H3,(H,25,31)(H,26,28,32) QUSUGGQCMYEKLG-UHFFFAOYSA-N 300476 4-(methoxymethyl)-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 46 Protein Wnt-3a Human 690 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300476&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294341 381749257 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575530 COCc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C24H28N6O3S/c1-29-10-12-30(13-11-29)15-21(31)25-20-14-18(8-9-19(20)16-33-2)22(32)26-24-28-27-23(34-24)17-6-4-3-5-7-17/h3-9,14H,10-13,15-16H2,1-2H3,(H,25,31)(H,26,28,32) QUSUGGQCMYEKLG-UHFFFAOYSA-N 300476 4-(methoxymethyl)-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 46 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300476&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294341 381749257 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575531 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C25H27N5O5S2/c1-37(33,34)16-19-8-7-18(21(31)27-24-29-28-22(36-24)17-5-3-2-4-6-17)15-20(19)26-23(32)25(9-10-25)30-11-13-35-14-12-30/h2-8,15H,9-14,16H2,1H3,(H,26,32)(H,27,29,31) XPXFEVSLAOPVTB-UHFFFAOYSA-N 300477 4-[(methylsulfonyl)methyl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 47 Protein Wnt-3a Human 90.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300477&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294542 381749258 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575532 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C25H27N5O5S2/c1-37(33,34)16-19-8-7-18(21(31)27-24-29-28-22(36-24)17-5-3-2-4-6-17)15-20(19)26-23(32)25(9-10-25)30-11-13-35-14-12-30/h2-8,15H,9-14,16H2,1H3,(H,26,32)(H,27,29,31) XPXFEVSLAOPVTB-UHFFFAOYSA-N 300477 4-[(methylsulfonyl)methyl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 47 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300477&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294542 381749258 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575533 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C6(N5CCN(C4CC4)CC5)CC6 InChI=1S/C28H32N6O4S2/c1-40(37,38)18-21-8-7-20(24(35)30-27-32-31-25(39-27)19-5-3-2-4-6-19)17-23(21)29-26(36)28(11-12-28)34-15-13-33(14-16-34)22-9-10-22/h2-8,17,22H,9-16,18H2,1H3,(H,29,36)(H,30,32,35) LMXNQMCNDQEEEI-UHFFFAOYSA-N 300478 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 48 Protein Wnt-3a Human 130 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300478&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294543 381749259 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575534 CS(=O)(=O)Cc3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C6(N5CCN(C4CC4)CC5)CC6 InChI=1S/C28H32N6O4S2/c1-40(37,38)18-21-8-7-20(24(35)30-27-32-31-25(39-27)19-5-3-2-4-6-19)17-23(21)29-26(36)28(11-12-28)34-15-13-33(14-16-34)22-9-10-22/h2-8,17,22H,9-16,18H2,1H3,(H,29,36)(H,30,32,35) LMXNQMCNDQEEEI-UHFFFAOYSA-N 300478 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 48 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300478&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294543 381749259 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575535 CN5CCN(C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)CC4)CC5 InChI=1S/C26H30N6O4S2/c1-31-12-14-32(15-13-31)26(10-11-26)24(34)27-21-16-19(8-9-20(21)17-38(2,35)36)22(33)28-25-30-29-23(37-25)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,34)(H,28,30,33) DYFZAXBGBVBDTJ-UHFFFAOYSA-N 300479 3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 49 Protein Wnt-3a Human 45.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300479&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294544 381749260 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575536 CN5CCN(C4(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3CS(C)(=O)=O)CC4)CC5 InChI=1S/C26H30N6O4S2/c1-31-12-14-32(15-13-31)26(10-11-26)24(34)27-21-16-19(8-9-20(21)17-38(2,35)36)22(33)28-25-30-29-23(37-25)18-6-4-3-5-7-18/h3-9,16H,10-15,17H2,1-2H3,(H,27,34)(H,28,30,33) DYFZAXBGBVBDTJ-UHFFFAOYSA-N 300479 3-({[1-(4-methylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-4-[(methylsulfonyl)methyl]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 49 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300479&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294544 381749260 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575537 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H22F3N5O4S/c25-24(26,27)36-18-7-6-16(19(33)29-22-31-30-20(37-22)15-4-2-1-3-5-15)14-17(18)28-21(34)23(8-9-23)32-10-12-35-13-11-32/h1-7,14H,8-13H2,(H,28,34)(H,29,31,33) BXYZWBYNNCMHGD-UHFFFAOYSA-N 300480 3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 50 Protein Wnt-3a Human 97.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300480&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294545 381749261 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575538 O=C(Nc2nnc(c1ccccc1)s2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C24H22F3N5O4S/c25-24(26,27)36-18-7-6-16(19(33)29-22-31-30-20(37-22)15-4-2-1-3-5-15)14-17(18)28-21(34)23(8-9-23)32-10-12-35-13-11-32/h1-7,14H,8-13H2,(H,28,34)(H,29,31,33) BXYZWBYNNCMHGD-UHFFFAOYSA-N 300480 3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 50 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300480&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294545 381749261 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575539 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC(F)(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C27H27F3N6O3S/c28-27(29,30)39-21-9-6-18(22(37)32-25-34-33-23(40-25)17-4-2-1-3-5-17)16-20(21)31-24(38)26(10-11-26)36-14-12-35(13-15-36)19-7-8-19/h1-6,9,16,19H,7-8,10-15H2,(H,31,38)(H,32,34,37) KSVSLGRGYJVNII-UHFFFAOYSA-N 300481 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 51 Protein Wnt-3a Human 373 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300481&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294546 381749262 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575540 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC(F)(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C27H27F3N6O3S/c28-27(29,30)39-21-9-6-18(22(37)32-25-34-33-23(40-25)17-4-2-1-3-5-17)16-20(21)31-24(38)26(10-11-26)36-14-12-35(13-15-36)19-7-8-19/h1-6,9,16,19H,7-8,10-15H2,(H,31,38)(H,32,34,37) KSVSLGRGYJVNII-UHFFFAOYSA-N 300481 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 51 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300481&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86294546 381749262 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575541 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OC(F)(F)F InChI=1S/C25H25F3N6O3S/c26-25(27,28)37-20-9-6-17(22(36)30-24-32-31-23(38-24)16-4-2-1-3-5-16)14-19(20)29-21(35)15-33-10-12-34(13-11-33)18-7-8-18/h1-6,9,14,18H,7-8,10-13,15H2,(H,29,35)(H,30,32,36) NDIHTZSIBMIILM-UHFFFAOYSA-N 300483 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 53 Protein Wnt-3a Human 820 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300483&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291644 381749264 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575542 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4nnc(c3ccccc3)s4)ccc5OC(F)(F)F InChI=1S/C25H25F3N6O3S/c26-25(27,28)37-20-9-6-17(22(36)30-24-32-31-23(38-24)16-4-2-1-3-5-16)14-19(20)29-21(35)15-33-10-12-34(13-11-33)18-7-8-18/h1-6,9,14,18H,7-8,10-13,15H2,(H,29,35)(H,30,32,36) NDIHTZSIBMIILM-UHFFFAOYSA-N 300483 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 53 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300483&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291644 381749264 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575543 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H23F3N6O3S/c1-31-9-11-32(12-10-31)14-19(33)27-17-13-16(7-8-18(17)35-23(24,25)26)20(34)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,27,33)(H,28,30,34) BUDSEUSTGYWPCA-UHFFFAOYSA-N 300484 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 54 Protein Wnt-3a Human 130 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300484&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 78425808 381749265 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575544 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H23F3N6O3S/c1-31-9-11-32(12-10-31)14-19(33)27-17-13-16(7-8-18(17)35-23(24,25)26)20(34)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13H,9-12,14H2,1H3,(H,27,33)(H,28,30,34) BUDSEUSTGYWPCA-UHFFFAOYSA-N 300484 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 54 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300484&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 78425808 381749265 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575545 NC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C24H24N6O4S/c25-19(31)17-7-6-16(20(32)27-23-29-28-21(35-23)15-4-2-1-3-5-15)14-18(17)26-22(33)24(8-9-24)30-10-12-34-13-11-30/h1-7,14H,8-13H2,(H2,25,31)(H,26,33)(H,27,29,32) NNRFVLAYYGPARZ-UHFFFAOYSA-N 300486 2-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-4-(5-phenyl-1,3,4-thiadiazol-2-yl)terephthalamide::US10130633, Example 56 Protein Wnt-3a Human 190 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300486&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291646 381749267 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575546 NC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C24H24N6O4S/c25-19(31)17-7-6-16(20(32)27-23-29-28-21(35-23)15-4-2-1-3-5-15)14-18(17)26-22(33)24(8-9-24)30-10-12-34-13-11-30/h1-7,14H,8-13H2,(H2,25,31)(H,26,33)(H,27,29,32) NNRFVLAYYGPARZ-UHFFFAOYSA-N 300486 2-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-4-(5-phenyl-1,3,4-thiadiazol-2-yl)terephthalamide::US10130633, Example 56 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300486&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291646 381749267 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575547 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O4S/c1-14(31-9-11-34-12-10-31)19(32)27-17-13-16(7-8-18(17)35-23(24,25)26)20(33)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) NZNXXRYDQGCBFK-UHFFFAOYSA-N 300487 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 57 Protein Wnt-3a Human 500 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300487&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291647 381749268 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575548 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C23H22F3N5O4S/c1-14(31-9-11-34-12-10-31)19(32)27-17-13-16(7-8-18(17)35-23(24,25)26)20(33)28-22-30-29-21(36-22)15-5-3-2-4-6-15/h2-8,13-14H,9-12H2,1H3,(H,27,32)(H,28,30,33) NZNXXRYDQGCBFK-UHFFFAOYSA-N 300487 3-{[2-(morpholin-4-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 57 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300487&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291647 381749268 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575549 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O3S/c1-15(33-12-10-32(2)11-13-33)20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) QWBOSJFOAGJZPT-UHFFFAOYSA-N 300488 US10130633, Example 260::3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 273::US10130633, Example 58 Protein Wnt-3a Human 270 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300488&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291851 381749269 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575550 CC(C(=O)Nc3cc(C(=O)Nc2nnc(c1ccccc1)s2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C24H25F3N6O3S/c1-15(33-12-10-32(2)11-13-33)20(34)28-18-14-17(8-9-19(18)36-24(25,26)27)21(35)29-23-31-30-22(37-23)16-6-4-3-5-7-16/h3-9,14-15H,10-13H2,1-2H3,(H,28,34)(H,29,31,35) QWBOSJFOAGJZPT-UHFFFAOYSA-N 300488 US10130633, Example 260::3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 273::US10130633, Example 58 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300488&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291851 381749269 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575551 Fc1cc(F)cc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)C2(CC2)N2CCOCC2)c1 InChI=1S/C27H23F5N4O4/c28-18-11-17(12-19(29)13-18)21-3-1-16(15-33-21)24(37)34-20-2-4-23(40-27(30,31)32)22(14-20)35-25(38)26(5-6-26)36-7-9-39-10-8-36/h1-4,11-15H,5-10H2,(H,34,37)(H,35,38) PXNZOIRDQDZNGP-UHFFFAOYSA-N 300490 6-(3,5-difluorophenyl)-N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]nicotinamide::US10130633, Example 60 Protein Wnt-3a Human 290 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300490&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291853 381749271 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575552 Fc1cc(F)cc(c1)-c1ccc(cn1)C(=O)Nc1ccc(OC(F)(F)F)c(NC(=O)C2(CC2)N2CCOCC2)c1 InChI=1S/C27H23F5N4O4/c28-18-11-17(12-19(29)13-18)21-3-1-16(15-33-21)24(37)34-20-2-4-23(40-27(30,31)32)22(14-20)35-25(38)26(5-6-26)36-7-9-39-10-8-36/h1-4,11-15H,5-10H2,(H,34,37)(H,35,38) PXNZOIRDQDZNGP-UHFFFAOYSA-N 300490 6-(3,5-difluorophenyl)-N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]nicotinamide::US10130633, Example 60 Protein Wnt-3a Human 41000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300490&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291853 381749271 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575553 FC(F)(F)Oc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H25F3N4O4/c28-27(29,30)38-23-9-7-20(16-22(23)33-25(36)26(10-11-26)34-12-14-37-15-13-34)32-24(35)19-6-8-21(31-17-19)18-4-2-1-3-5-18/h1-9,16-17H,10-15H2,(H,32,35)(H,33,36) ZIRCYRARYKCFJB-UHFFFAOYSA-N 300491 N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]-6-phenylnicotinamide::US10130633, Example 61 Protein Wnt-3a Human 120 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300491&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291855 381749272 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575554 FC(F)(F)Oc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H25F3N4O4/c28-27(29,30)38-23-9-7-20(16-22(23)33-25(36)26(10-11-26)34-12-14-37-15-13-34)32-24(35)19-6-8-21(31-17-19)18-4-2-1-3-5-18/h1-9,16-17H,10-15H2,(H,32,35)(H,33,36) ZIRCYRARYKCFJB-UHFFFAOYSA-N 300491 N-[3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)phenyl]-6-phenylnicotinamide::US10130633, Example 61 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300491&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291855 381749272 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575555 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2F)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H27FN4O4/c1-35-24-9-7-19(16-23(24)31-26(34)27(10-11-27)32-12-14-36-15-13-32)30-25(33)18-6-8-22(29-17-18)20-4-2-3-5-21(20)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) XMMJCCFKGWLHAG-UHFFFAOYSA-N 300492 6-(2-fluorophenyl)-N-[4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)phenyl]nicotinamide::US10130633, Example 62 Protein Wnt-3a Human 180 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300492&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458826 381749273 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575556 COc1ccc(NC(=O)c2ccc(nc2)-c2ccccc2F)cc1NC(=O)C1(CC1)N1CCOCC1 InChI=1S/C27H27FN4O4/c1-35-24-9-7-19(16-23(24)31-26(34)27(10-11-27)32-12-14-36-15-13-32)30-25(33)18-6-8-22(29-17-18)20-4-2-3-5-21(20)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) XMMJCCFKGWLHAG-UHFFFAOYSA-N 300492 6-(2-fluorophenyl)-N-[4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)phenyl]nicotinamide::US10130633, Example 62 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300492&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90458826 381749273 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575557 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4ccc(c3ccccc3F)nc4)ccc5OC(F)(F)F InChI=1S/C28H27F4N5O3/c29-22-4-2-1-3-21(22)23-9-6-19(16-33-23)34-27(39)18-5-10-25(40-28(30,31)32)24(15-18)35-26(38)17-36-11-13-37(14-12-36)20-7-8-20/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,34,39)(H,35,38) HCSYYUWBSJWLDC-UHFFFAOYSA-N 300493 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 63 Protein Wnt-3a Human 140 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300493&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291854 381749274 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575558 O=C(CN2CCN(C1CC1)CC2)Nc5cc(C(=O)Nc4ccc(c3ccccc3F)nc4)ccc5OC(F)(F)F InChI=1S/C28H27F4N5O3/c29-22-4-2-1-3-21(22)23-9-6-19(16-33-23)34-27(39)18-5-10-25(40-28(30,31)32)24(15-18)35-26(38)17-36-11-13-37(14-12-36)20-7-8-20/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,34,39)(H,35,38) HCSYYUWBSJWLDC-UHFFFAOYSA-N 300493 3-{[(4-cyclopropylpiperazin-1-yl)acetyl]amino}-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 63 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300493&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86291854 381749274 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575559 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300494 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 64 Protein Wnt-3a Human 37.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300494&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292056 381749275 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575560 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N4CCN(C)CC4 InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300494 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 64 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300494&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292056 381749275 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575561 C[C@@H](N1CCN(C)CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300495 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 65 Protein Wnt-3a Human 150 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300495&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293217 381749276 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575562 C[C@@H](N1CCN(C)CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300495 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 65 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300495&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86293217 381749276 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575563 C[C@H](N1CCN(C)CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300496 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 66 Protein Wnt-3a Human 130 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300496&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460173 381749277 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575564 C[C@H](N1CCN(C)CC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccccc1F |r| InChI=1S/C27H27F4N5O3/c1-17(36-13-11-35(2)12-14-36)25(37)34-23-15-18(7-10-24(23)39-27(29,30)31)26(38)33-19-8-9-22(32-16-19)20-5-3-4-6-21(20)28/h3-10,15-17H,11-14H2,1-2H3,(H,33,38)(H,34,37) MGZGHUHBXOZLPF-UHFFFAOYSA-N 300496 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-{[(2S)-2-(4-methylpiperazin-1-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 66 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300496&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460173 381749277 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575565 O=C(Nc2ccc(c1ccccc1F)nc2)c6ccc(OC(F)(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C30H29F4N5O3/c31-23-4-2-1-3-22(23)24-9-6-20(18-35-24)36-27(40)19-5-10-26(42-30(32,33)34)25(17-19)37-28(41)29(11-12-29)39-15-13-38(14-16-39)21-7-8-21/h1-6,9-10,17-18,21H,7-8,11-16H2,(H,36,40)(H,37,41) LZIDJDMKKTZXMT-UHFFFAOYSA-N 300497 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 67 Protein Wnt-3a Human 13.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300497&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292057 381749278 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575566 O=C(Nc2ccc(c1ccccc1F)nc2)c6ccc(OC(F)(F)F)c(NC(=O)C5(N4CCN(C3CC3)CC4)CC5)c6 InChI=1S/C30H29F4N5O3/c31-23-4-2-1-3-22(23)24-9-6-20(18-35-24)36-27(40)19-5-10-26(42-30(32,33)34)25(17-19)37-28(41)29(11-12-29)39-15-13-38(14-16-39)21-7-8-21/h1-6,9-10,17-18,21H,7-8,11-16H2,(H,36,40)(H,37,41) LZIDJDMKKTZXMT-UHFFFAOYSA-N 300497 3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]-4-(trifluoromethoxy)benzamide::US10130633, Example 67 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300497&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292057 381749278 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575567 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H24F4N4O4/c28-20-4-2-1-3-19(20)21-7-6-18(16-32-21)33-24(36)17-5-8-23(39-27(29,30)31)22(15-17)34-25(37)26(9-10-26)35-11-13-38-14-12-35/h1-8,15-16H,9-14H2,(H,33,36)(H,34,37) CWKJBWOIRXMPCC-UHFFFAOYSA-N 300498 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 68 Protein Wnt-3a Human 5.17 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300498&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292058 381749279 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575568 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H24F4N4O4/c28-20-4-2-1-3-19(20)21-7-6-18(16-32-21)33-24(36)17-5-8-23(39-27(29,30)31)22(15-17)34-25(37)26(9-10-26)35-11-13-38-14-12-35/h1-8,15-16H,9-14H2,(H,33,36)(H,34,37) CWKJBWOIRXMPCC-UHFFFAOYSA-N 300498 N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 68 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300498&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292058 381749279 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575569 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-18(5-10-25(24)40-28(30,31)32)27(38)34-20-6-9-23(33-13-20)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) XTYSNFAOAGFDBE-UHFFFAOYSA-N 300500 N-[6-(3-fluorophenyl)pyridin-3-yl]-3-{[2-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 70 Protein Wnt-3a Human 85.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300500&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292060 381749281 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575570 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1cccc(F)c1)nc2)ccc3OC(F)(F)F)N4CC5CCC(C4)O5 InChI=1S/C28H26F4N4O4/c1-16(36-14-21-7-8-22(15-36)39-21)26(37)35-24-12-18(5-10-25(24)40-28(30,31)32)27(38)34-20-6-9-23(33-13-20)17-3-2-4-19(29)11-17/h2-6,9-13,16,21-22H,7-8,14-15H2,1H3,(H,34,38)(H,35,37) XTYSNFAOAGFDBE-UHFFFAOYSA-N 300500 N-[6-(3-fluorophenyl)pyridin-3-yl]-3-{[2-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 70 Protein Wnt-3a Human 6300 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300500&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292060 381749281 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575571 O=C(Nc2ccc(c1cc(F)cc(F)c1)nc2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H23F5N4O4/c28-18-11-17(12-19(29)14-18)21-3-2-20(15-33-21)34-24(37)16-1-4-23(40-27(30,31)32)22(13-16)35-25(38)26(5-6-26)36-7-9-39-10-8-36/h1-4,11-15H,5-10H2,(H,34,37)(H,35,38) MLVCMJLSFJONIA-UHFFFAOYSA-N 300501 N-[6-(3,5-difluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 71 Protein Wnt-3a Human 160 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300501&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292247 381749282 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575572 O=C(Nc2ccc(c1cc(F)cc(F)c1)nc2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H23F5N4O4/c28-18-11-17(12-19(29)14-18)21-3-2-20(15-33-21)34-24(37)16-1-4-23(40-27(30,31)32)22(13-16)35-25(38)26(5-6-26)36-7-9-39-10-8-36/h1-4,11-15H,5-10H2,(H,34,37)(H,35,38) MLVCMJLSFJONIA-UHFFFAOYSA-N 300501 N-[6-(3,5-difluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-4-(trifluoromethoxy)benzamide::US10130633, Example 71 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300501&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292247 381749282 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575573 NC(=O)c3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H26FN5O4/c28-21-4-2-1-3-19(21)22-8-6-18(16-30-22)31-25(35)17-5-7-20(24(29)34)23(15-17)32-26(36)27(9-10-27)33-11-13-37-14-12-33/h1-8,15-16H,9-14H2,(H2,29,34)(H,31,35)(H,32,36) LSZLMEPWOXYMJR-UHFFFAOYSA-N 300505 N4-[6-(2-fluorophenyl)pyridin-3-yl]-2-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)terephthalamide::US10130633, Example 75 Protein Wnt-3a Human 27.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300505&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608465 381749286 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575574 NC(=O)c3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H26FN5O4/c28-21-4-2-1-3-19(21)22-8-6-18(16-30-22)31-25(35)17-5-7-20(24(29)34)23(15-17)32-26(36)27(9-10-27)33-11-13-37-14-12-33/h1-8,15-16H,9-14H2,(H2,29,34)(H,31,35)(H,32,36) LSZLMEPWOXYMJR-UHFFFAOYSA-N 300505 N4-[6-(2-fluorophenyl)pyridin-3-yl]-2-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)terephthalamide::US10130633, Example 75 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300505&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 117608465 381749286 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575575 Cc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H27FN4O3/c1-18-6-7-19(16-24(18)31-26(34)27(10-11-27)32-12-14-35-15-13-32)25(33)30-20-8-9-23(29-17-20)21-4-2-3-5-22(21)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) UHDJRDQGPOCDFM-UHFFFAOYSA-N 300506 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methyl-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 76 Protein Wnt-3a Human 54.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300506&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292251 381749287 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575576 Cc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H27FN4O3/c1-18-6-7-19(16-24(18)31-26(34)27(10-11-27)32-12-14-35-15-13-32)25(33)30-20-8-9-23(29-17-20)21-4-2-3-5-22(21)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) UHDJRDQGPOCDFM-UHFFFAOYSA-N 300506 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methyl-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 76 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300506&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292251 381749287 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575577 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(Cl)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C26H24ClFN4O3/c27-20-7-5-17(15-23(20)31-25(34)26(9-10-26)32-11-13-35-14-12-32)24(33)30-18-6-8-22(29-16-18)19-3-1-2-4-21(19)28/h1-8,15-16H,9-14H2,(H,30,33)(H,31,34) PYKWRQILRWMKNC-UHFFFAOYSA-N 300509 4-chloro-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 79 Protein Wnt-3a Human 64.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300509&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292441 381749290 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575578 O=C(Nc2ccc(c1ccccc1F)nc2)c5ccc(Cl)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C26H24ClFN4O3/c27-20-7-5-17(15-23(20)31-25(34)26(9-10-26)32-11-13-35-14-12-32)24(33)30-18-6-8-22(29-16-18)19-3-1-2-4-21(19)28/h1-8,15-16H,9-14H2,(H,30,33)(H,31,34) PYKWRQILRWMKNC-UHFFFAOYSA-N 300509 4-chloro-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 79 Protein Wnt-3a Human 15000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300509&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292441 381749290 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575579 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H27FN4O4/c1-35-24-9-6-18(16-23(24)31-26(34)27(10-11-27)32-12-14-36-15-13-32)25(33)30-19-7-8-22(29-17-19)20-4-2-3-5-21(20)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) OYXSUAHLPHEGQU-UHFFFAOYSA-N 300510 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 80 Protein Wnt-3a Human 150 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300510&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292442 381749291 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575580 COc3ccc(C(=O)Nc2ccc(c1ccccc1F)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H27FN4O4/c1-35-24-9-6-18(16-23(24)31-26(34)27(10-11-27)32-12-14-36-15-13-32)25(33)30-19-7-8-22(29-17-19)20-4-2-3-5-21(20)28/h2-9,16-17H,10-15H2,1H3,(H,30,33)(H,31,34) OYXSUAHLPHEGQU-UHFFFAOYSA-N 300510 N-[6-(2-fluorophenyl)pyridin-3-yl]-4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 80 Protein Wnt-3a Human 10000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300510&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292442 381749291 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575581 COc3ccc(C(=O)Nc2ccc(c1ccccc1)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H28N4O4/c1-34-24-10-7-20(17-23(24)30-26(33)27(11-12-27)31-13-15-35-16-14-31)25(32)29-21-8-9-22(28-18-21)19-5-3-2-4-6-19/h2-10,17-18H,11-16H2,1H3,(H,29,32)(H,30,33) PLWUISXQMGAZMN-UHFFFAOYSA-N 300511 4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(6-phenylpyridin-3-yl)benzamide::US10130633, Example 81 Protein Wnt-3a Human 15.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300511&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292443 381749292 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575582 COc3ccc(C(=O)Nc2ccc(c1ccccc1)nc2)cc3NC(=O)C5(N4CCOCC4)CC5 InChI=1S/C27H28N4O4/c1-34-24-10-7-20(17-23(24)30-26(33)27(11-12-27)31-13-15-35-16-14-31)25(32)29-21-8-9-22(28-18-21)19-5-3-2-4-6-19/h2-10,17-18H,11-16H2,1H3,(H,29,32)(H,30,33) PLWUISXQMGAZMN-UHFFFAOYSA-N 300511 4-methoxy-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(6-phenylpyridin-3-yl)benzamide::US10130633, Example 81 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300511&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 86292443 381749292 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575583 O=C(Nc2ccc(c1ccccc1)cn2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H25F3N4O4/c28-27(29,30)38-22-8-6-19(16-21(22)32-25(36)26(10-11-26)34-12-14-37-15-13-34)24(35)33-23-9-7-20(17-31-23)18-4-2-1-3-5-18/h1-9,16-17H,10-15H2,(H,32,36)(H,31,33,35) MCDAQFFHHGMCAQ-UHFFFAOYSA-N 300525 3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 95 Protein Wnt-3a Human 50.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300525&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459673 381749306 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575584 O=C(Nc2ccc(c1ccccc1)cn2)c5ccc(OC(F)(F)F)c(NC(=O)C4(N3CCOCC3)CC4)c5 InChI=1S/C27H25F3N4O4/c28-27(29,30)38-22-8-6-19(16-21(22)32-25(36)26(10-11-26)34-12-14-37-15-13-34)24(35)33-23-9-7-20(17-31-23)18-4-2-1-3-5-18/h1-9,16-17H,10-15H2,(H,32,36)(H,31,33,35) MCDAQFFHHGMCAQ-UHFFFAOYSA-N 300525 3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 95 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300525&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459673 381749306 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575585 COC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C24H26N6O4S/c1-29-10-12-30(13-11-29)15-20(31)25-19-14-17(8-9-18(19)23(33)34-2)21(32)26-24-28-27-22(35-24)16-6-4-3-5-7-16/h3-9,14H,10-13,15H2,1-2H3,(H,25,31)(H,26,28,32) XMSVDRORLCIVKG-UHFFFAOYSA-N 300535 methyl 2-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-[(5-phenyl-1,3,4-thiadiazol-2-yl)carbamoyl]benzoate::US10130633, Example 105 Protein Wnt-3a Human 300 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300535&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462207 381749316 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575586 COC(=O)c3ccc(C(=O)Nc2nnc(c1ccccc1)s2)cc3NC(=O)CN4CCN(C)CC4 InChI=1S/C24H26N6O4S/c1-29-10-12-30(13-11-29)15-20(31)25-19-14-17(8-9-18(19)23(33)34-2)21(32)26-24-28-27-22(35-24)16-6-4-3-5-7-16/h3-9,14H,10-13,15H2,1-2H3,(H,25,31)(H,26,28,32) XMSVDRORLCIVKG-UHFFFAOYSA-N 300535 methyl 2-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-[(5-phenyl-1,3,4-thiadiazol-2-yl)carbamoyl]benzoate::US10130633, Example 105 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300535&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462207 381749316 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575587 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(N)cc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300541 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 111 Protein Wnt-3a Human 58.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300541&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459603 381749322 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575588 CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccc(N)cc1)nc2)ccc3OC(F)(F)F)N4CCOCC4 InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300541 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 111 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300541&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459603 381749322 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575589 CC(=O)Nc4ccc(c3ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)C(C)N1CCOCC1)c2)cn3)cc4 InChI=1S/C28H28F3N5O5/c1-17(36-11-13-40-14-12-36)26(38)35-24-15-20(5-10-25(24)41-28(29,30)31)27(39)34-22-8-9-23(32-16-22)19-3-6-21(7-4-19)33-18(2)37/h3-10,15-17H,11-14H2,1-2H3,(H,33,37)(H,34,39)(H,35,38) RRHCZKGLBZOYOW-UHFFFAOYSA-N 300543 N-[6-(4-acetamidophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 113 Protein Wnt-3a Human 890 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300543&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459377 381749324 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575590 CC(=O)Nc4ccc(c3ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)C(C)N1CCOCC1)c2)cn3)cc4 InChI=1S/C28H28F3N5O5/c1-17(36-11-13-40-14-12-36)26(38)35-24-15-20(5-10-25(24)41-28(29,30)31)27(39)34-22-8-9-23(32-16-22)19-3-6-21(7-4-19)33-18(2)37/h3-10,15-17H,11-14H2,1-2H3,(H,33,37)(H,34,39)(H,35,38) RRHCZKGLBZOYOW-UHFFFAOYSA-N 300543 N-[6-(4-acetamidophenyl)pyridin-3-yl]-3-{[2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 113 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300543&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459377 381749324 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575591 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(cc1)N(C)C |r| InChI=1S/C28H30F3N5O4/c1-18(36-12-14-39-15-13-36)26(37)34-24-16-20(6-11-25(24)40-28(29,30)31)27(38)33-21-7-10-23(32-17-21)19-4-8-22(9-5-19)35(2)3/h4-11,16-18H,12-15H2,1-3H3,(H,33,38)(H,34,37) YDONXTCQJOTDAZ-UHFFFAOYSA-N 300545 N-{6-[4-(dimethylamino)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 115 Protein Wnt-3a Human 52.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300545&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459980 381749326 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575592 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(cc1)N(C)C |r| InChI=1S/C28H30F3N5O4/c1-18(36-12-14-39-15-13-36)26(37)34-24-16-20(6-11-25(24)40-28(29,30)31)27(38)33-21-7-10-23(32-17-21)19-4-8-22(9-5-19)35(2)3/h4-11,16-18H,12-15H2,1-3H3,(H,33,38)(H,34,37) YDONXTCQJOTDAZ-UHFFFAOYSA-N 300545 N-{6-[4-(dimethylamino)phenyl]pyridin-3-yl}-3-{[(2S)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 115 Protein Wnt-3a Human 4700 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300545&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459980 381749326 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575593 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(N)cc1 |r| InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300547 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[(2R)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 117 Protein Wnt-3a Human 14.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300547&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459482 381749328 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575594 C[C@@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(N)cc1 |r| InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300547 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[(2R)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 117 Protein Wnt-3a Human 10000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300547&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459482 381749328 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575595 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(N)cc1 |r| InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300548 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[(2R)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 118 Protein Wnt-3a Human 57.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300548&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460397 381749329 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575596 C[C@H](N1CCOCC1)C(=O)Nc1cc(ccc1OC(F)(F)F)C(=O)Nc1ccc(nc1)-c1ccc(N)cc1 |r| InChI=1S/C26H26F3N5O4/c1-16(34-10-12-37-13-11-34)24(35)33-22-14-18(4-9-23(22)38-26(27,28)29)25(36)32-20-7-8-21(31-15-20)17-2-5-19(30)6-3-17/h2-9,14-16H,10-13,30H2,1H3,(H,32,36)(H,33,35) DQJNFUCPLJAFHW-UHFFFAOYSA-N 300548 N-[6-(4-aminophenyl)pyridin-3-yl]-3-{[(2R)-2-(morpholin-4-yl)propanoyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 118 Protein Wnt-3a Human 16000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300548&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460397 381749329 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575597 FC(F)(F)Oc1ccc(NC(=O)c2cc([nH]n2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H22F3N5O4/c24-23(25,26)35-20-7-6-16(12-18(20)28-21(32)14-31-8-10-34-11-9-31)27-22(33)19-13-17(29-30-19)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,27,33)(H,28,32)(H,29,30) KDVHWTVDKJTZQT-UHFFFAOYSA-N 300554 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1H-pyrazole-3-carboxamide::US10130633, Example 124 Protein Wnt-3a Human 84.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300554&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 137553939 381749335 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575598 FC(F)(F)Oc1ccc(NC(=O)c2cc([nH]n2)-c2ccccc2)cc1NC(=O)CN1CCOCC1 InChI=1S/C23H22F3N5O4/c24-23(25,26)35-20-7-6-16(12-18(20)28-21(32)14-31-8-10-34-11-9-31)27-22(33)19-13-17(29-30-19)15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2,(H,27,33)(H,28,32)(H,29,30) KDVHWTVDKJTZQT-UHFFFAOYSA-N 300554 N-{3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)phenyl}-5-phenyl-1H-pyrazole-3-carboxamide::US10130633, Example 124 Protein Wnt-3a Human 13000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300554&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 137553939 381749335 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575599 Nc4ccc(c3ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCOCC1)c2)cn3)cc4 InChI=1S/C25H24F3N5O4/c26-25(27,28)37-22-8-3-17(13-21(22)32-23(34)15-33-9-11-36-12-10-33)24(35)31-19-6-7-20(30-14-19)16-1-4-18(29)5-2-16/h1-8,13-14H,9-12,15,29H2,(H,31,35)(H,32,34) HBBUYRQYTWGYPU-UHFFFAOYSA-N 300556 N-[6-(4-aminophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 126 Protein Wnt-3a Human 36.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300556&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459663 381749337 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575600 Nc4ccc(c3ccc(NC(=O)c2ccc(OC(F)(F)F)c(NC(=O)CN1CCOCC1)c2)cn3)cc4 InChI=1S/C25H24F3N5O4/c26-25(27,28)37-22-8-3-17(13-21(22)32-23(34)15-33-9-11-36-12-10-33)24(35)31-19-6-7-20(30-14-19)16-1-4-18(29)5-2-16/h1-8,13-14H,9-12,15,29H2,(H,31,35)(H,32,34) HBBUYRQYTWGYPU-UHFFFAOYSA-N 300556 N-[6-(4-aminophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]-4-(trifluoromethoxy)benzamide::US10130633, Example 126 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300556&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459663 381749337 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575601 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)cn3)ccc4OC(F)(F)F InChI=1S/C25H23F3N4O4/c26-25(27,28)36-21-8-6-18(14-20(21)30-23(33)16-32-10-12-35-13-11-32)24(34)31-22-9-7-19(15-29-22)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,33)(H,29,31,34) OEZXPVZTYHPRBN-UHFFFAOYSA-N 300561 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 131 Protein Wnt-3a Human 100 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300561&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459713 381749342 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575602 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2)cn3)ccc4OC(F)(F)F InChI=1S/C25H23F3N4O4/c26-25(27,28)36-21-8-6-18(14-20(21)30-23(33)16-32-10-12-35-13-11-32)24(34)31-22-9-7-19(15-29-22)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H,30,33)(H,29,31,34) OEZXPVZTYHPRBN-UHFFFAOYSA-N 300561 3-[(morpholin-4-ylacetyl)amino]-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide::US10130633, Example 131 Protein Wnt-3a Human 13000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300561&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459713 381749342 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575603 CC4CCN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)cn2)ccc3OC(F)(F)F)CC4 InChI=1S/C27H27F3N4O3/c1-18-11-13-34(14-12-18)17-25(35)32-22-15-20(7-9-23(22)37-27(28,29)30)26(36)33-24-10-8-21(16-31-24)19-5-3-2-4-6-19/h2-10,15-16,18H,11-14,17H2,1H3,(H,32,35)(H,31,33,36) CMAIWNCQGOARKU-UHFFFAOYSA-N 300562 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide formiate::US10130633, Example 132 Protein Wnt-3a Human 70.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300562&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122535834 381749343 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575604 CC4CCN(CC(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1)cn2)ccc3OC(F)(F)F)CC4 InChI=1S/C27H27F3N4O3/c1-18-11-13-34(14-12-18)17-25(35)32-22-15-20(7-9-23(22)37-27(28,29)30)26(36)33-24-10-8-21(16-31-24)19-5-3-2-4-6-19/h2-10,15-16,18H,11-14,17H2,1H3,(H,32,35)(H,31,33,36) CMAIWNCQGOARKU-UHFFFAOYSA-N 300562 3-{[(4-methylpiperazin-1-yl)acetyl]amino}-N-(5-phenylpyridin-2-yl)-4-(trifluoromethoxy)benzamide formiate::US10130633, Example 132 Protein Wnt-3a Human 11000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300562&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 122535834 381749343 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575605 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC5CC5 InChI=1S/C27H27FN4O4/c28-22-4-2-1-3-21(22)23-9-6-19(16-29-23)30-27(34)18-5-10-25(36-20-7-8-20)24(15-18)31-26(33)17-32-11-13-35-14-12-32/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,30,34)(H,31,33) HBSDSTAAGRGCRW-UHFFFAOYSA-N 300563 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 133 Protein Wnt-3a Human 130 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300563&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459826 381749344 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575606 O=C(CN1CCOCC1)Nc4cc(C(=O)Nc3ccc(c2ccccc2F)nc3)ccc4OC5CC5 InChI=1S/C27H27FN4O4/c28-22-4-2-1-3-21(22)23-9-6-19(16-29-23)30-27(34)18-5-10-25(36-20-7-8-20)24(15-18)31-26(33)17-32-11-13-35-14-12-32/h1-6,9-10,15-16,20H,7-8,11-14,17H2,(H,30,34)(H,31,33) HBSDSTAAGRGCRW-UHFFFAOYSA-N 300563 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-[(morpholin-4-ylacetyl)amino]benzamide::US10130633, Example 133 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300563&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459826 381749344 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575607 O=C(Nc2ccc(c1ccccc1F)nc2)c6ccc(OC3CC3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C29H29FN4O4/c30-23-4-2-1-3-22(23)24-9-6-20(18-31-24)32-27(35)19-5-10-26(38-21-7-8-21)25(17-19)33-28(36)29(11-12-29)34-13-15-37-16-14-34/h1-6,9-10,17-18,21H,7-8,11-16H2,(H,32,35)(H,33,36) OTOQGUOSYIPQCP-UHFFFAOYSA-N 300564 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 134 Protein Wnt-3a Human 31.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300564&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460134 381749345 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575608 O=C(Nc2ccc(c1ccccc1F)nc2)c6ccc(OC3CC3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C29H29FN4O4/c30-23-4-2-1-3-22(23)24-9-6-20(18-31-24)32-27(35)19-5-10-26(38-21-7-8-21)25(17-19)33-28(36)29(11-12-29)34-13-15-37-16-14-34/h1-6,9-10,17-18,21H,7-8,11-16H2,(H,32,35)(H,33,36) OTOQGUOSYIPQCP-UHFFFAOYSA-N 300564 4-(cyclopropyloxy)-N-[6-(2-fluorophenyl)pyridin-3-yl]-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)benzamide::US10130633, Example 134 Protein Wnt-3a Human 12000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300564&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90460134 381749345 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575609 O=C(Nc2ccc(c1ccccc1F)nc2)c7ccc(OC3CC3)c(NC(=O)C6(N5CCN(C4CC4)CC5)CC6)c7 InChI=1S/C32H34FN5O3/c33-26-4-2-1-3-25(26)27-11-6-22(20-34-27)35-30(39)21-5-12-29(41-24-9-10-24)28(19-21)36-31(40)32(13-14-32)38-17-15-37(16-18-38)23-7-8-23/h1-6,11-12,19-20,23-24H,7-10,13-18H2,(H,35,39)(H,36,40) WUXIYFKQIOIKPO-UHFFFAOYSA-N 300566 4-(cyclopropyloxy)-3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]benzamide::US10130633, Example 136 Protein Wnt-3a Human 75.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300566&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459704 381749347 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575610 O=C(Nc2ccc(c1ccccc1F)nc2)c7ccc(OC3CC3)c(NC(=O)C6(N5CCN(C4CC4)CC5)CC6)c7 InChI=1S/C32H34FN5O3/c33-26-4-2-1-3-25(26)27-11-6-22(20-34-27)35-30(39)21-5-12-29(41-24-9-10-24)28(19-21)36-31(40)32(13-14-32)38-17-15-37(16-18-38)23-7-8-23/h1-6,11-12,19-20,23-24H,7-10,13-18H2,(H,35,39)(H,36,40) WUXIYFKQIOIKPO-UHFFFAOYSA-N 300566 4-(cyclopropyloxy)-3-({[1-(4-cyclopropylpiperazin-1-yl)cyclopropyl]carbonyl}amino)-N-[6-(2-fluorophenyl)pyridin-3-yl]benzamide::US10130633, Example 136 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300566&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90459704 381749347 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575611 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(Cl)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22ClF3N6O3S/c1-32-7-9-33(10-8-32)13-19(34)28-17-12-14(5-6-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-3-2-4-16(24)11-15/h2-6,11-12H,7-10,13H2,1H3,(H,28,34)(H,29,31,35) DZKLRJPRYPLYLJ-UHFFFAOYSA-N 300581 N-[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 151 Protein Wnt-3a Human 250 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300581 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300581&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462425 381749362 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575612 CN4CCN(CC(=O)Nc3cc(C(=O)Nc2nnc(c1cccc(Cl)c1)s2)ccc3OC(F)(F)F)CC4 InChI=1S/C23H22ClF3N6O3S/c1-32-7-9-33(10-8-32)13-19(34)28-17-12-14(5-6-18(17)36-23(25,26)27)20(35)29-22-31-30-21(37-22)15-3-2-4-16(24)11-15/h2-6,11-12H,7-10,13H2,1H3,(H,28,34)(H,29,31,35) DZKLRJPRYPLYLJ-UHFFFAOYSA-N 300581 N-[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]-3-{[(4-methylpiperazin-1-yl)acetyl]amino}-4-(trifluoromethoxy)benzamide::US10130633, Example 151 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300581 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300581&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462425 381749362 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575613 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC3CC3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C26H27N5O4S/c32-22(28-25-30-29-23(36-25)17-4-2-1-3-5-17)18-6-9-21(35-19-7-8-19)20(16-18)27-24(33)26(10-11-26)31-12-14-34-15-13-31/h1-6,9,16,19H,7-8,10-15H2,(H,27,33)(H,28,30,32) WZBAQYZHNIQOIY-UHFFFAOYSA-N 300589 4-(cyclopropyloxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 159 Protein Wnt-3a Human 54.0 US Patent 10.7270/Q2FN188G aid1796056 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300589 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300589&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462159 381749370 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2 575614 O=C(Nc2nnc(c1ccccc1)s2)c6ccc(OC3CC3)c(NC(=O)C5(N4CCOCC4)CC5)c6 InChI=1S/C26H27N5O4S/c32-22(28-25-30-29-23(36-25)17-4-2-1-3-5-17)18-6-9-21(35-19-7-8-19)20(16-18)27-24(33)26(10-11-26)31-12-14-34-15-13-31/h1-6,9,16,19H,7-8,10-15H2,(H,27,33)(H,28,30,32) WZBAQYZHNIQOIY-UHFFFAOYSA-N 300589 4-(cyclopropyloxy)-3-({[1-(morpholin-4-yl)cyclopropyl]carbonyl}amino)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)benzamide::US10130633, Example 159 Protein Wnt-3a Human >50000 US Patent 10.7270/Q2FN188G aid1796057 US10130633 Thede, K; Scott, W; Bender, E; Golz, S; Hagebarth, A; Lienau, P; Puehler, F; Basting, D; Schneider, D; Mowes, M; Richter, A; Zorn, L; Liu, N; Monning, U; Siegel, F 11/20/2018 3/28/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300589 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004930&target=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300589&enzyme=Protein+Wnt-3a&column=ki&startPg=0&Increment=50&submit=Search 90462159 381749370 1 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK 8TZR,7DRT,7URD Protein Wnt-3a WNT3A_HUMAN P56704 Q3SY79 Q3SY80 Q969P2